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ABSTRACT 
 
 Adenosine triphosphate (ATP) is the energy currency of all living cells and its 
production is a key reaction in the energy metabolism of living organisms.  Cells produce most 
of the ATP they require through ATP synthase, a unique molecular rotary motor driven by the 
movement of protons across the lipid membrane.  In E.coli, ATP synthase is composed of a 
soluble domain called F1, which houses the catalytic sites, and a transmembrane domain called 
F0 that shuttles protons across the membrane to drive ATP production in the F1 sector.  The F0 
domain is built of three subunit types: subunit a and a dimer of subunit b form the stator of the 
motor, while a decameric c ring forms the rotor.  The dynamic interface between a and c10 
forms the proton channel.  The ultimate goal of this work is to determine the structure of the 
proton transport machinery and understand the molecular mechanism of proton translocation in 
ATP synthase.  We have characterized some of the key events in the stepwise assembly of the 
F0--complex.  We have designed and validated a model protein, consisting of genetically fused 
subunits a and c, for structural studies.  We have made progress towards determining the 
structure of the proton channel, including the development of a novel procedure for purification 
of subunit a and the a/c fusion protein, and crystallization of subunit a.  Medical applications of 
this work include the potential development of novel antibiotic compounds, as well as the 
characterization and potential treatment of three human diseases caused by disruptions in 
proton transport through F0. 
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1   Introduction 
 Living systems cannot survive without energy input.  Energy is transformed from 
environmental sources to forms that can sustain life by respiration and photosynthesis.  Two  
forms of energy that serve the needs of living cells are ion gradients and ATP.  Ion gradients 
require membrane compartments to work, while ATP can act as a chemical carrier to distribute 
energy anywhere in the aqueous phase of the cell.  In bacterial cells and mitochondria, energy 
can be generated through oxidative phosphorylation (OxPhos).  Various exergonic processes 
feed into the OxPhos pathway.  ATP synthase (also known as F1F0-ATPase), is the final step in 
OxPhos and facilitates transformation between the two universal forms of energy.  ATP 
synthase can harnesses the power of ion gradients to produce ATP and it can consume ATP to 
restore the ion gradient if necessary. 
 
 ATP synthase is a molecular rotary motor powered by the proton motive force, or, in 
some cases, by a sodium motive force.  It is composed of a soluble catalytic domain (F1) which 
converts adenosine diphosphate (ADP) and inorganic phosphate (Pi) to ATP, and a 
transmembranous domain (F0) which facilitates the movement of protons across biological 
membranes to drive catalytic activity in the F1 domain.  Proton transport though F1F0 catalyzes 
ATP synthesis by a unique rotational mechanism: the F0 domain contains a molecular turbine, 
which spins as protons flow across the membrane along their gradient.  The rotational force is 
then converted to chemical energy in the F1 catalytic sites.  ATP synthase is among a class of 
enzymes which couple the transit of ions across membranes with chemical catalysis.  A detailed 
understanding of how proton transit drives ATP synthesis is desirable because of the central 
metabolic role of ATP synthase.  High resolution structures and detailed mechanisms of ATP 
synthesis and hydrolysis in the F1 domain are known.  However, three key questions in the field 
of F1F0-ATPase research remain.  First, what is the detailed molecular structure of the F0 
domain?  Second, how is torque generated within the F0 domain?  Finally, what is the stepwise 
mechanism of assembly of the F1 and F0 components? 
  
 Our work aims to address these questions by taking a unique approach to understanding 
the steps involved in F0 domain assembly, and to determining the high resolution structure of 
the proton channel.  The proton transport machinery of F1F0-ATPase is highly dynamic, which 
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makes structural analysis of the proton channel challenging.  We have designed and generated 
two model proteins, which contain the components of the proton transport machinery, to 
facilitate crystallographic structure studies.  The model proteins also provide a convenient tool 
for studying the stepwise assembly mechanism of the F0 domain.  A high-resolution structure of 
the proton channel of ATP synthase has the potential to advance our understanding of a 
fundamental metabolic process in all living organisms, facilitate the characterization of human 
illness, and allow for the rational design of novel antibiotic compounds.	  
	   	  3 
2   Review of the literature. 
2.1   Bioenergetics and ATP production. 
 ATP is the energy currency of living cells.  Decades of research have gone into 
understanding how cells produce and consume the energy that fuels life as we know it.  In 
1929, a German chemist named Karl Lohmann discovered the energy rich ATP molecule.  
Cells generate the bulk of the ATP they require by oxidative phosphorylation, a process which 
was discovered in the 1930s (Engelhardt, 1932).  Initially the OxPhos research community 
believed that substrate level phosphorylation, through a high energy intermediate, was pivotal 
to the synthesis of ATP (Boyer et al., 1954; Slater, 1953).  Extensive efforts were made to 
identify the intermediate.  Several candidate compounds were proposed, but none withstood 
experimental scrutiny (Allchin, 1997).  In 1961, Boyer famously identified phosphohistidine as 
the elusive intermediate in oxidative phosphorylation (Boyer, 1963).  However, his success was 
short-lived.  It was later discovered that contamination with enzymes from the citric acid cycle 
gave a false indication that led Boyer to erroneously claim phosphohistidine as an intermediate 
in OxPhos (Kreil and Boyer, 1964; Mitchell et al., 1964). 
 
 It was noted that OxPhos could only take place in intact membrane compartments 
(Penefsky et al., 1960; Ziegler et al., 1958), which was puzzling to the research community at 
the time because disruption of the membrane should not have affected the stability of a 
chemical intermediate.  The chemisomotic theory, introduced by Peter Mitchell 1961, offered 
an entirely new concept of energy transformation through OxPhos.  Mitchell linked OxPhos to 
energy stored in the form of a transmembrane proton gradient, rather than a chemical 
intermediate (Mitchell, 1961).  The chemiosmotic hypothesis outlines how the accumulation of 
protons on one side of a membrane generates a gradient, which powers ATP synthesis as 
thermodynamic forces drive protons across the membrane along their electrochemical gradient.  
Peter Mitchell’s chemiosmotic model revolutionized the field, and he is credited as the father of 
bioenergetics.  However, a detailed understanding of how the energy of proton shuttling 
powered ATP synthesis was still decades away. 
 
In 1945, Lardy and Elvehjem proposed that OxPhos may be linked to the ATPase 
activity of mitochondria (Lardy and Elvehjem, 1945).  Efraim Racker’s research group set out 
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to identify the source of this activity.  By 1958 the membrane associated ATPase, termed 
soluble protein factor 1 (F1), was isolated (Pullman et al., 1958) although its central role in 
metabolism was not yet understood.  The membrane associated oligomycin sensitive factor (F0) 
of the ATPase was later identified and is now known to facilitate the translocation of protons 
across the membrane (Kagawa and Racker, 1966).  Racker’s group also demonstrated that F1F0 
ATPase could catalyze ATP synthesis using the energy of the transmembrane proton gradient, 
which was consistent with Mitchell’s chemiosmotic hypothesis (Racker and Kandrach, 1973; 
Ragan and Racker, 1973). 
 
The ion gradient that drives ATP synthesis is referred to as the proton motive force 
(PMF).  The PMF is generated by a series of enzymatic complexes embedded in the inner 
membrane, called the electron transport chain.  The oxidation of nicotinamide adenine 
dinucleotide (NADH) and flavin adenine dinucleotide (FADH2), and transfer of electrons 
through the chain creates the electrochemical proton gradient (Figure 2.1).  In E. coli, oxidation 
of a single NADH molecule causes ten protons to shuttle from the cytosolic side of the 
membrane to the periplasm (Lehninger et al., 2008) to build the gradient.  Complexes I and III 
both shuttle four protons for each NADH oxidized, while complex IV shuttles two protons.  
The flow of protons through ATP synthase along their gradient, from the periplasm to the 
cytosol, drives the synthesis of ATP at a ratio of approximately 3 ATP per NADH oxidized. 
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Figure 2.1:  Oxidative phosphorylation and the electron transport chain.  Each complex in 
the electron transport chain is labeled on the left.  The orientation of each complex in the 
membrane is shown and the path of electrons through each complex is indicated with black 
arrows labeled e-.  The transport of protons through each complex is shown with a green arrow.  
‘Q’ denotes ubiquinone and ‘cyt c’ denotes cytochrome c. 
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 The free energy associated with the PMF describes the gradient’s capacity to do work 
and is defined by Formula 2.1. 
 ΔG = 2.303RT(ΔpH) + ZF(ΔΨ)                (Formula 2.1) 
Where, R – the universal gas constant – is 8.31 J  K−1  mol−1, T is temperature in Kelvin, F – the 
Faraday constant – is 9.64x104  J/V*mol, ΔpH is the difference in pH between the cytoplasm 
and periplasm (in E. coli), and Z – proton charge – is +1.  The PMF describes the 
electrochemical potential difference between the aqueous compartments on opposite sides of 
the membrane and has units of mV.  The PMF has two major components, an electrical term 
(ΔΨ) and a concentration term (ΔpH).  These terms are related by Formula 2.2. 
PMF = ΔΨ – (2.303RT/F)ΔpH                 (Formula 2.2) 
Where, ΔΨ is the electrical potential difference between the cytoplasmic space and the 
periplasm and R, T, F and ΔpH are the same as described for formula 2.1.  At room temperature 
(25 oC) 2.303RT/F is equal to 59 mV.  The PMF of growing Escherichia coli (E. coli) cells is 
usually between -140 mV and -180 mV (Foster, 2004) and is mostly in the form of ΔΨ.  
 
F1F0 ATPase has a dual role as an ATP synthase and an ATPase.  Under aerobic growth 
conditions cellular respiration maintains the proton gradient and F1F0 produces ATP at a high 
rate, as described above.  However, in bacterial cells growing under anaerobic conditions, 
equilibrium shifts toward the reverse reaction and ATP is hydrolyzed to actively pump protons 
from the cytosol to the periplasm.  The ATPase function allows bacterial cells to maintain the 
proton gradient and keep cellular processes such as flagella rotation and nutrient transport 
running during anaerobic growth.  The ATP used to restore the proton gradient during 
anaerobic growth comes from substrate level phosphorylation.  A diagram of proton cycling is 
shown in Figure 2.2. 
 
 
 
 
	   	  7 
cytoplasm H+ 
! H
+ 
!
H+ 
!
H+ 
!
A - Aerobic Growth 
Electron transport chain 
F1F0 
Flagella Proton–nutrient 
symporter 
H+ 
!
H+ 
!
periplasm 
peptidoglycan 
outer membrane 
inner membrane 
cytoplasm 
H+ 
!
B - Anaerobic Growth 
Electron transport chain 
F1F0 
Flagella Proton–nutrient 
symporter 
H+ 
!
H+ 
!
periplasm 
outer membrane 
inner membrane 
peptidoglycan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2:  Proton cycling in E. coli cells.  Under aerobic growth conditions (A) the electron 
transport chain maintains the proton gradient, which drives the synthesis of ATP through F1F0, 
and supports proton-nutrient symporters and flagellar movement.  Under anaerobic conditions 
(B) the electron transport chain is silent and F1F0 hydrolyzes ATP to actively pump protons into 
the periplasmic space.  Proton-nutrient symporters and flagella use the gradient generated by 
F1F0 to maintain activity. 
 
 
2.2   F1F0-ATPase: form and function. 
ATP synthase is a molecular rotary motor (Yoshida et al., 2001) that catalyzes synthesis 
and hydrolysis of ATP coupled with the movement of protons across lipid membranes.  ATP 
synthase is responsible for producing the bulk of ATP required by cells.  It is a ubiquitous 
enzyme that has a similar structure in plants, animals and bacteria.  ATP synthase is found in 
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the inner mitochondrial membrane of eukaryotic cells, the inner cellular membrane of bacteria, 
and in the thylakoid membrane of plant chloroplasts. 
 
All forms of F1F0 ATPase contain an extramembranous F1 complex which catalyzes 
synthesis or hydrolysis of ATP, and a transmembrane F0 complex which facilitates transport of 
protons across the lipid membrane.  The complete primary sequence of the ATP synthase 
subunits from E. coli was first determined in 1984 (Walker et al., 1984).  In E. coli, the F1 
complex is composed of five subunits, named α,β,γ,δ, and ε, that have molecular weights of 
55.3 kDa, 50.3 kDa, 31.6 kDa, 19.3 kDa and 14.9 kDa respectively.  The F1 subunits are 
present in a ratio of α3β3γδε (Yoshida et al., 1979).  The F0 complex is made up of three 
subunits, a, b and c, that have molecular weights of 30.3 kDa, 17.3 kDa and 8.3 kDa, 
respectively; and are present in a stoichiometry of a1b2c10 (Jiang et al., 2001).  Figure 2.3 
illustrates the interactions between the complexes of the enzyme. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3:  E. coli ATP synthase and its orientation in the lipid bilayer.  The direction of 
proton flow is shown for ATP synthesis.  The proton channel is shown at the interface of 
subunit a and the c10 ring. 
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 ATP synthase contains three catalytically active sites, located within the α3β3 hexamer, 
which work in a sequential cooperative mechanism to produce ATP.  The stator of the ATP 
synthase motor is composed of subunits a and b.  The b subunit also functions to hold the α3β3δ 
components of F1 stationary.  The rotor of ATP synthase is made up of the c-ring, subunit γ, 
and subunit ε.  One end of the γ shaft is accommodated in the hollow core of the α3β3 hexamer 
and the other rests on top of the c-ring.  During ATP synthesis, protons flow through the F0 
sector from the periplasmic side of the membrane to the cytoplasm.  Subunit a and the c-ring 
are both components of the proton channel.  Subunit a contributes two-half channels which 
shuttle protons to and from the c-ring.  Protons bind to the individual c monomers and induce 
the stepwise rotation of the c10γε rotor.  The γ subunit is asymmetrical and interacts with each 
of the three β subunits differently; rotation of γ causes conformational changes in the β active 
sites which allow for the binding of ADP and inorganic phosphate (Pi), catalysis, and release of 
synthesized ATP.  The catalytic cycle is reversible and ATP can be actively hydrolyzed in the 
F1 portion of the enzyme to drive proton transit across the membrane. 
 
 
2.3  Molecular structure of ATP synthase. 
 The complete structure of ATP synthase from T. thermophilus was recently solved by 
cryo-electron microscopy (cryo-EM) (Lau and Rubinstein, 2011).  The 9.7 Å resolution 
structure of the intact enzyme is the first of its kind and provides a comprehensive structural 
picture of ATP synthase (Figure 2.4).  There is also large body of high resolution structural 
work on ATP synthase.  The cryo-EM structure of intact ATP synthase converged well with 
available high resolution structures of individual subunits from T. thermophilus and provides a 
detailed understanding of how the individual subunits interact to form the mature enzyme.  
Unlike E. coli ATP synthase, T. thermophilus ATP synthase has two peripheral stalks, which 
are equivalent to the single b2 stalk in E. coli.  The peripheral stalks interact directly with the I 
subunit (equivalent to subunit a in E. coli) and function to hold the catalytic head of the enzyme 
in position above the rotational components. 
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Figure 2.4:  Mosaic diagrams of ATP synthase from T. thermophilus (A) and bovine 
mitochondrial ATP synthase (B).  The cryo-EM shells are shown as transparent grey for the 
T. thermophilus structure and purple / green for the mitochondrial ATP synthase structure. 
Ribbon diagrams of high resolution crystal structures from individual subunits were fitted into 
the cryo-EM maps and are shown in a variety of colors.  The 9.7 Å resolution cryo-EM 
structure from T. thermophilus provides the first structural view of subunit I (equivalent to 
subunit a in E. coli) and its interaction with subunit L (equivalent to subunit c in E. coli); 
subunits I and L are shown in green and purple respectively (Panel A).  [Images taken from 
(Lau and Rubinstein, 2011; Rees et al., 2009)].  Images reprinted with permission from Nature 
and PNAS. 
  
 
High resolution structural data is available for nearly all F1 subunits, in a variety of 
species.  The first detailed structural picture of the catalytic machinery came from John 
Walker’s group in 1994 (Abrahams et al., 1994).  Abrahams and co-authors solved the 2.8 Å 
resolution crystal structure of the α3β3 hexamer along with the γ subunit from bovine 
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mitochondrial ATP synthase (Figure 2.5).  The high resolution structure from Walker’s group 
gave detailed insight into the catalytic cycle of ATP synthase.  The structure showed that three 
active sites are present at the interface of each αβ pair and that the bulk of the binding site is 
located in the β subunit.  The structure also showed the central location of the γ subunit in the 
core of the α3β3 hexamer.  The intrinsic asymmetry of the γ subunit allows it to interact with 
each of the β subunits differently, creating the conditions necessary to drive the catalytic cycle 
in the three active sites in a sequential fashion. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5: Crystallographically determined structure of F1 ATPase.  The γ subunit is 
shown in purple and the α and β subunits are shown in red and yellow respectively.  A) Top 
down view of the α3β3 hexamer.  The empty, loose, and tight binding sites are labeled αβE, 
αβDP, and αβTP respectively.  B) Cross section of F1 viewed from the side. Alpha helices are 
labeled with letters A – I and beta sheets are labeled with numbers 1 – 9. [Images taken from 
(Abrahams et al., 1994) and modified; PDB-ID 1C0W].  Reprinted with permission from 
Nature. 
 
 
 Both the δ and ε subunits of the F1 domain have been extensively characterized and high 
resolution structures are available for each (Uhlin et al., 1997; Wilkens et al., 1997; Wilkens 
and Capaldi, 1998).  The δ subunit of E. coli ATP synthase is believed to facilitate the tight 
binding of the F1 and F0 sectors through interactions with both subunit α of F1 and subunit b of 
F0 (Rodgers et al., 1997; Wilkens et al., 2005).  The ε subunit of E. coli ATP synthase stably 
interacts with both the γ shaft (Rodgers and Wilce, 2000) and the cytoplasmic loops of the c-
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ring (Gibbons et al., 2000).  Several groups have conclusively demonstrated that the 
conformational state of ε plays an important role in regulating the ATPase activity of the F1 
domain.  The ε subunit may either adopt an inhibitory ‘upward’ conformation in which C-
terminal domain interacts with the αβ subunits of the catalytic head, or an un-inhibitory 
‘downward’ conformation which does not make contact with α3β3 (Hasurath et al., 2001; 
Tsunoda et al., 2001; Wilkens and Capaldi, 1998). 
 
In contrast to the detailed structural models for F1 from various species, the structural 
features of the F0 domain are less well known.  The general structure of the F0 domain has been 
determined by atomic force microscopy (Singh et al., 1996; Takeyasu et al., 1996) and electron 
microscope scanning (Birkenhager et al., 1995).  These techniques have shown that subunit a 
and the b dimer lie at the periphery of the c10 ring.  Subunit b has been shown to preferentially 
interact with subunit a (Stalz et al., 2003), but direct interactions with subunit c have also been 
observed (Jones et al., 2000).  Furthermore, subunit a has been shown to lie counterclockwise 
of subunit b when the ATP synthase complex is viewed from the cytoplasm (Duser et al., 
2008). 
 
Subunit b functions as a peripheral stalk that holds F1 and F0 together; it is a 156 amino 
acid helical protein (Walker et al., 1984) that is composed of two distinct domains.  The N-
terminal domain, which is a single transmembrane alpha helix, anchors the elongated soluble C-
terminal domain to the lipid bilayer (Walker et al., 1984).  In E. coli, two b subunits form a 
dimer that protrudes ~110 Å into the cytoplasm where it forms strong interactions with the α 
and δ subunits of F1 (Dunn and Chandler, 1998; McLachlin and Dunn, 2000; Rodgers and 
Capaldi, 1998).  The structures of the soluble C-terminal domain and transmembranous N-
terminal domain of subunit b have been solved separately (Dmitriev et al., 1999a; Del Rizzo et 
al., 2002).  The transmembrane segments of the b dimer appear to cross the membrane in a 
nearly parallel orientation (approximately 23o) with a close association between the monomers.  
Crosslinking between the dimers at positions 2, 6, and 10 indicates that they are 4 – 8 Å apart. 
 
Several independent studies have demonstrated that subunits a and b interact closely.  
Staltz and co-authors successfully co-purified subunit b with hexahistidine tagged subunit a in 
stoichiometric amounts (Stalz et al., 2003).  The first cytoplasmic loop of subunit a has been 
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implicated in interactions with subunit b (Long et al., 2002).  The central region of cytoplasmic 
loop 1 (residues 75-90) was found to be inaccessible to site specific labeling.  Long et al. 
postulated that this region was likely involved in protein – protein interactions with subunit b 
and was therefore shielded from labeling.  They also demonstrated that aK74C forms crosslinks 
with an unknown partner in subunit b, supporting the involvement of subunit a’s first 
cytoplasmic loop in the ab2 interaction.  Other crosslinking studies have also been conducted to 
assess the interactions between subunits a and b.  Residue 2 of subunit b has been shown to be 
in close proximity to aG227 and aL228 through double cysteine substitution and crosslinking 
analysis (Fillingame et al., 2000).  Hermolin and co-authors as well as Aris and co-authors 
independently observed crosslinking between subunits a and b, although the actual contact 
points were not named (Aris and Simoni, 1983; Hermolin et al., 1983).  bR36C and bA32C 
were shown to form crosslinks to unidentified residues in subunit a (Greie et al., 2000; 
McLachlin et al., 2000).  aP240 has also been shown to interact directly with bG9 by mutation 
studies (Kumamoto and Simoni, 1986). 
 
Double cysteine replacement studies have shown that the amino acid at position 2 of 
subunit b forms strong crosslinks with positions 74, 75 and 78 of subunit c (Jones et al., 2000).  
These interactions occur in the periplasmic space.  To date, no crosslinking residues between 
subunit b and subunit c have been found within the transmembrane segments.  The lack of 
direct contact in the transmembranous regions suggests that subunits b and c are not involved in 
close structural interactions.  Jones and co-authors demonstrated that only one c subunit 
interacts directly with subunit b (Jones et al., 2000).  Whether both b subunits interact with a 
single c, or if one b subunit is involved in the interaction and the other is displaced farther to the 
periphery remains unknown. 
 
The c subunit of F0 spans the lipid membrane twice and has an alpha-helical hairpin 
arrangement (Girvin et al., 1998).  Each c promoter contains a highly conserved aspartic acid or 
glutamic acid residue, located centrally in the membrane slab, which functions to transport 
protons.  In E. coli, ten copies of the c subunit form a ring structure in the complete enzyme 
(Jiang et al., 2001) and aspartic acid 61 is the proton carrier.  The high resolution structure of 
the c-ring from the sodium transporting ATP synthase of I. tartaricus was first solved in 2005 
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(Meier et al., 2005).  Atomic level resolution structures are also available for the c rings of the 
proton transporting ATP synthases from P. sativum (Saroussi et al., 2012), S. cerevisiae 
(Symersky et al., 2012), B. pseudofirmus (Preiss et al., 2010), S. oleracea (Vollmar et al., 
2009), and S. platensis (Pogoryelov et al., 2009).  Figure 2.6 shows the structure of the proton 
transporting S. cerevisiae c-ring. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6:  Crystallographically determined structure of the S. cerevisiae mitochondrial 
c-ring.  A) Top down view.  B) Side view.  The position of the E59 (D61 in E. coli) is shown as 
a space filling model.  In both panels each monomer is a different color for ease of distinction. 
[Image taken from (Symersky et al., 2012), PDB-ID 3U2F].  Reprinted with permission from 
Nature. 
 
 
The structure of E. coli monomeric subunit c has been solved by NMR (Girvin et al., 
1998) and the oligomeric ring has been modeled (Dmitriev et al., 1999b; Rastogi and Girvin, 
1999).  The oligomeric models are based on extensive cross linking analyses between the 
transmembrane helix (TMH) segments of neighboring c subunits (Jones et al., 1998).  The cross 
linking studies that allowed positioning of the c subunits relative to one another have recently 
been further supported by solid state NMR investigations which placed I55, A62 and G69 and 
F76 on the outer surface of the oligomer (Todokoro et al., 2010).  In these models the c-ring 
contains twelve monomers, which was based on the expression of functional c-rings built of 
genetically fused c dimers and trimers that produced rings containing the equivalent of a 
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maximum of twelve c monomers (Jones and Fillingame, 1998).  However, the c-ring is now 
known to be composed of ten individual c monomers (Jiang et al., 2001) rather than twelve.  
The decameric c-ring has also been modeled and agrees well with the constraints used for the 
model presented by Rastogi and Girvin (Fillingame and Dmitriev, 2002). 
 
The cryo-EM structure of the intact proton translocating ATP synthase from T. 
thermophilus (Lau and Rubinstein, 2011) gives the first true images of how subunit a and c10 
ring interact.  This work shows that subunit I, equivalent to subunit a in E. coli, is made up of 
two four-helix bundles and each bundle makes physical contact with two adjacent L subunits (c 
subunits in E. coli).  Hakulinen and co-authors also used cryo-EM to solve the 7.0 Å structure 
of crystallized F0 from I. Tartaricus (Hakulinen et al., 2012).  Their findings supported the 
work presented by Lau and Rubinstein and showed that subunit a forms a four-helix bundle and 
two individual helices interact directly with two c subunits.  Taken together with the work of 
Lau and Rubnistein, Hakulinen and co-authors postulated that the four helix bundle is a 
conserved feature of subunit a.  However, the electron density maps showed that three helices 
from the stator were in contact with the c-ring; the authors were not able to distinguish if the 
third c-helix was involved in interaction of subunit a or b. 
 
 
2.3.1   Structural investigations into subunit a. 
Transmembrane topology. 
The transmembrane topology of E. coli subunit a has been established independently by 
three different groups of authors.  Currently, subunit a is believed to contain five TMH 
segments with the amino terminus located in the periplasmic space and the carboxyl terminus 
located in the cytoplasm.  Subunit a does not contain cysteine in its native form and cysteine 
substitution mutagenesis has been used extensively to investigate its structural elements.  
Fillingame’s group conducted cysteine replacement studies where individual residues in the 
extramembranous regions of subunit a were systematically mutated to cysteine, and probed 
using sulfhydryl reagents (Valiyaveetil and Fillingame, 1998).  Reciprocal labeling patterns 
were observed when inside-out and right-side-out membrane preparations were probed; 
indicating the cytoplasmic or periplasmic location of each residue tested.  Residues placed on 
the cytoplasmic side of the membrane in this study were V71, M266, K169, and E196; and 
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residues placed on the periplasmic side of the membrane were S3, E131, P230.  The findings of 
this study were supported by the work of Long and co-authors, who used the reciprocal reaction 
of 3-(N-maleimidylpropionyl)-biocytin (MBP), a cysteine binding probe, and 4-acetamido-4′-
maleimidylstilbene-2,2′-disulfonic acid (AMS), a compound that blocks reaction of MBP, to 
probe single cysteine substitution mutants (Long et al., 1998).  Positions S69, G172, K176 and 
H271 were placed on the cytoplasmic side of the membrane, and P8, R24, S27 and E131 were 
placed on the periplasmic side of the membrane in these studies.  The five helix model was 
further supported by Wada and co-authors, who used an in-cell method to label the periplasmic 
loops of subunit a (Wada, 1999).  Whole cells were treated with polymyxin B nanopeptide to 
permeabilize the outer membrane and make the periplasmic space accessible to MPB labeling.  
The cytoplasmic loops remained inaccessible to labeling.  In this study, residues A2, S27, T37, 
E131, P230, W231 and W232 were placed in the periplasmic space.  Figure 2.7 summarizes the 
residues placed in the cytoplasmic and periplasmic loops of subunit a. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7:  Residues of the a subunit probed for cytoplasmic and periplasmic 
accessibility.  The TMH segments of subunit a are shown in grey.  The residue number at 
membrane entrance and exit of each TMH is indicated.  Residues identified as cytoplasmic are 
shown in green and residues identified as periplasmic are shown in blue. [The subunit a model 
in this Figure was adapted from (Vik et al., 2000)].  Reprinted with permission from BBA. 
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Assembling the helix bundle. 
Extensive biochemical analyses have been conducted to determine the interactions 
between the TMH segments of subunit a.  They include: 1) second site suppressor mutation 
studies, 2) double cysteine substitutions and cross-linking analysis, 3) chemical labeling 
combined with proteolysis, 4) spin label difference nuclear magnetic resonance (NMR), and 5) 
site-directed mutagenesis. 
 
Second site suppressors are point mutations that partially or completely restore loss of 
enzymatic function that is caused by a primary mutation at a different locus.  Second site 
suppressor mutations are indicators of close spatial proximity between the residues involved 
and can be used to elucidate tertiary structural elements.  Six suppressor mutant pairs have been 
identified in subunit a of E. coli ATP synthase.  They are, G213N – L251V (Kuo and 
Nakamoto, 2000), E219C – A145E, H245C – D119H (Valiyaveetil, 1998), R210Q – Q252R 
(Hatch et al., 1995), H245G – G218D/K (Hartzog and Cain, 1994), and E219H – H245E  (Cain 
and Simoni, 1988).  Although these suppressor pairs provide a rough approximation of how 
helices II, III, IV and V align with one another, they do not offer a clear representation of how 
the helical faces interact (Figure 2.8-A). 
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Figure 2.8:  Subunit a residue pairs involved in second site suppression and zero distance 
crosslinking.  A)  Second site suppressor mutants.  Residues involved in each suppressor pair 
are connected by red lines.  B)  Cross links between transmembrane helical segments.  Residue 
pairs, substituted for cysteine, found to form zero distance disulfide bonds are connected with 
purple lines.  [The subunit a model in this figure was adapted from (Vik et al., 2000)].  See text 
for references.  Reprinted with permission from BBA. 
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The helical packing arrangement determined by the second site suppressor data was 
supported and further defined by a series of crosslinking experiments (Schwem and Fillingame, 
2006).  Schwem and Fillingame introduced pairs of cysteine substitutions in different regions of 
subunit a and analyzed the proximity of the sulfhydryl group pairs that formed disulfide bonds 
in the presence of oxidizing reagents.  Nine pairs of cysteine substitutions were demonstrated to 
be in close spatial proximity through the formation of zero-distance crosslinks: L210 – H144, 
L120 – G218, L120 – H245, L120 – I246, N148 – E219, N148 – H245, G218 – I248, D119 – 
G218 (Figure 2.8 B). 
 
The work of Zhang and Vik supports the placement of suppressor pair 119 – 245.  They 
demonstrated that W241 of TMH-V faces TMH-II using a chemical proteolysis approach that 
cleaves peptide bonds in close proximity to the locus of a covalently bound proteolytic probe 
(Zhang and Vik, 2003b).  This work also provided the first evidence on the spatial orientation 
of TMH-I in relation to the rest of the helix bundle; D44 of helix I was shown to be oriented 
toward TMH-II using the same proteolytic approach. 
 
PROXYL is a paramagnetic spin label that is commonly used in conjunction with NMR 
techniques to investigate membrane protein topography and inter-residue distances across space 
(Hubbell et al., 1998).  The presence of an unpaired electron on the spin label causes rapid 
relaxation of the neighboring nuclei.  Residues within 15 – 20 Å of the spin label can be 
identified on HSQC or TROSY spectra.  The interactions between TMH-IV and TMH-V were 
investigated using spin label difference NMR in a mixed organic solvent (Dmitriev et al., 
2008).  Dmitriev and co-authors introduced the PROXYL spin label at positions 222 and 223, 
and observed broadening of tryptophan signals at positions 231, 232, 235 and 241.  The spin 
label difference data was converted into distance constraints and residues 213, 232, 235 and 
241 were calculated to lie with in 21.5 Å of residues 222/223.  These experiments indicated that 
TMH-V and TMH-IV fold back on one another via a hairpin loop that stretches from residue 
234 to 239.  They also showed that the periplasmic ends of transmembrane spans IV and V lie 
adjacent to one another and the distance between the helical faces widens at an approximate 
thirty degree angle as the TMHs approach the cytoplasmic side of the membrane. 
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 Howitt and co-authors used site directed mutagenesis to probe a cluster of charged 
residues on the periplasmic ends of TMHs I, II and III for structural interactions (Howitt et al., 
1990).  They demonstrated that D44, D124 and R140 are not directly involved in proton 
transport and are more likely involved in structural stability of the a subunit.  Individual 
mutations at positions 44, 124 and 140 partially disrupted proton transport.  Mutation of D44 to 
asparagine in conjunction with either D124N or R140Q abolished oxidative phosphorylation.  
However, when the D124N and R140Q mutations were combined, proton transport was 
restored to the level seen in the individual mutants, suggesting that D124 and R140 likely form 
a salt bridge that stabilizes the structure of subunit a.  Howitt and co-authors also suggest that 
the salt bridge between D124 and R140 is not an obligatory requirement for subunit a stability.  
The 124 – 140 salt bridge only becomes essential when D44 is also mutated; suggesting that 
D44 is involved in a second stabilizing salt bridge pair with another unknown residue.  It 
appears that stability of subunit a is dependent on at least one of these salt bridge interactions 
remaining intact. 
 
The TMH segments of subunit a can be treated as rigid bodies that conform to standard 
helical torsion angles and hydrogen bonding constraints.  Residues involved in zero distance 
crosslinks, salt bridges, and second site suppression on adjacent helices are expected to face one 
another.  Interaction of subunit a’s R210 with subunit c’s D61 is well established and pivitol to 
functionality of the F0 domain (Cain, 2000; Valiyaveetil, 1997).  TMH-IV is assumed to be 
oriented outward to allow the critical R210 residue to interact with D61 of subunit c. 
 
The loops between the transmembrane segments of subunit a have been shown to be 
structurally important for the functionality of ATP synthase (Moore et al., 2008).  Moore and 
co-authors demonstrated that cytoplasmic loops one and two directly interact with one another 
using crosslinking experiments; specific interactions between residues V86C – E195C and 
M93C – E195C were identified.  TMHs III and IV are believed to have ordered helical 
extensions that protrude beyond the 30 Å lipid bilayer and into the cytoplasm (Moore et al., 
2008; Zhang and Vik, 2003a).  Moore and co-authors also used crosslinking analysis to 
characterize the interactions between the cytoplasmic helical extensions of TMH III and IV.  
They found crosslinks between double cysteine substituted mutants at positions, V157 – L203, 
I161 – S202, I161 – L203, I161 – S205, L160 – L203, L160 – S205, and K165 – S202.  A 
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computational model of TMH-II – TMH-V of subunit a, based on the biochemical data 
described above, is shown in Figure 2.9.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9:  Computational model of subunit a based on the available biochemical data 
(Dmitriev, unpublished data).  Helices II-V of subunit a are shown.  The position of TMH-I of 
subunit a is still unclear as only limited biochemical evidence of its position relative to the 
other TMH segments is available.  The periplasmic and cytoplasmic locations of the loops are 
indicated. 
 
 
Structural interactions at the a/c interface. 
Subunits a and c are known to interact closely; in E. coli ATP synthase the R210 of 
subunit a and the D61 of subunit c are known to interact directly and are both critical to proton 
transport through F0 (Cain, 2000; Valiyaveetil and Fillingame, 1997).  However, the detailed 
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molecular architecture of the a-c10 interface remains largely unknown.  Similarly to the 
structural investigations into subunit a, the interactions between a and c have been examined 
using second site suppressor mutation studies and crosslinking analysis. 
 
Subunit c contains a second site suppressor pair for the critical D61 residue.  The 
cD61G mutation can be partially rescued by cA24D.  Third site suppressor mutants to the 
cD61G/cA24D mutation have been found in subunit a.  Fraga and co-authors demonstrated that 
point mutations at positions A217, I221 and L224 in subunit a can restore activity when co-
expressed with the cD61G/cA24D mutation (Fraga et al., 1994).  These findings suggest that 
A217, I221 and L224 lie on one face of TMH-IV of subunit a and interact directly with TMH-II 
of subunit c. 
 
Two different studies have identified residues in both TMH-IV and TMH-V of subunit a 
that interact with TMH-II of subunit c.  The interactions between subunits a and c have been 
extensively mapped using site directed mutagenesis to introduce pairs of cysteine residues at 
key positions in both subunits a and c.  F0 complexes containing cysteine substitutions in both 
subunits a and c were treated with oxidizing agents and examined for dimer formation.  The 
interactions between aTHM-IV and cTMH-II were first described by Jiang and Fillingame 
(Jiang and Fillingame, 1998).  The interaction points between a and c identified in this study 
were a207 – cI55, aN214 – cA62, aN214 – cM65, aI221 – cG69, aI223 – cL72, aL224 – cY73, 
and aI225 – cY73.  The distance between the interacting residues is assumed to be 
approximately 4 – 8 Å, as calculated by zero distance crosslink geometry.  In 2008 Moore and 
Fillingame described the packing interactions between helix five of subunit a and TMH-II of 
subunit c (Moore and Fillingame, 2008b).  The crosslinking pairs identified in this study were 
a248 – c62, a248 – c63, a248 – c65, a251 – c59, a251 – c62, a252 – c62, a252 – c65, a262 – 
c53, a262 – c54, a262 – c55, and a263 – c54  (Moore, 2008; Moore and Fillingame, 2008a).  
TMH-IV and TMH-V of subunit a were demonstrated to crosslink to two separate, presumably 
adjacent, c monomers.  Figure 2.10 summarizes the crosslinking data that defines the 
interactions between subunit a’s TMH-V and TMH-IV with subunit c’s TMH-II. 
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Figure 2.10:  Interactions between subunit a and subunit c determined by crosslinking 
studies.  TMH segments from subunit a are colored orange and TMH segments from subunit c 
are colored blue.  A) Interactions between TMH-IV of subunit a and TMH-II of subunit c.  B) 
Interactions between TMH-V of subunit a and TMH-II of subunit c.  See text for references.  
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 The cytoplasmic loops of subunit a have also been shown to be involved in direct 
interactions with subunit c through cysteine replacement studies.  The loop between 
transmembrane segments III and IV is known to span approximately 34 amino acids starting at 
position 168 and ending at 202 (Long, 1998; Vik et al., 1998).  N-(3-Maleimidopropionyl) 
biocytin (MPB) is commonly used to define the extramembranous portions of integral 
membrane proteins because it reacts with the ionized thiol group on cysteine in the aqueous 
phase.  The loop segment between residues 185 – 202 was shown to be resistant to labeling 
with MPB (Zhang and Vik, 2003a).  Zhang and co-authors postulated that the amino terminal 
half of the loop was highly aqueous accessible and therefore readily labeled, and that the lack of 
labeling between positions 185 – 202 was consistent with shielding from MPB by protein – 
protein interactions.  This 185 – 202 region is conserved between species (Appendix-I contains 
a multiple sequence alignment of subunit a from various species), also pointing to specific 
structural interactions (Vik et al., 1990).  Treatment with a photo-activated crosslinking agent 
caused single cysteine substitutions in the carboxyl terminal part of the loop to crosslink with 
subunit c, demonstrating direct interaction between cytoplasmic loop 2 of subunit a and subunit 
c.  Although the crosslinking partner residues in subunit c are unknown, these results show that 
residues 165, 169, 173, 174, 177, 178, 182, 183 and 184 of subunit a fold within 10 -15 
angstroms of subunit c.  The model of subunit a and its interaction with two c subunits, based 
on the biochemical evidence discussed above, is presented in Figure 2.11. 
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Figure 2.11:  Computational model of subunit a and its interaction with the c-ring.  The 
model is oriented looking downward from the cytoplasm.  Helices II - V of subunit a are 
labeled and shown in yellow.  The C-terminus of subunit a is labeled ‘C’.  Four copies of 
subunit c are shown in shades of blue.  Arginine 210 of subunit a and aspartic acid 61 of the 
two c subunits in direct interaction with subunit a are shown as spacefilling diagrams. 
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2.4   The binding change mechanism and rotational catalysis. 
Paul Boyer’s binding change mechanism describes the process by which ATP synthase 
produces ATP from ADP and Pi (Boyer, 1993; Boyer, 1979).  Two avenues of experimental 
evidence lead to the introduction of the binding change mechanism.  First, the rapid and 
reversible synthesis and hydrolysis of ATP, measured by O18 exchange, continued within the 
catalytic sites of ATP synthase even after the submitochondrial particles under study were de-
energized (Boyer et al., 1973).  This suggested that the equilibrium between ATP and ADP / Pi 
was close to unity, leading Boyer to believe that the energetic barrier to ATP synthesis was 
release of bound ATP from the active site, rather than formation of ATP itself.  Supporting 
evidence came from Harris and co-authors who conclusively demonstrated the tight binding of 
ATP to the αβ catalytic sites (Harris et al., 1973).  Second, the research groups of 
Moundrianakis and Boyer independently demonstrated that multiple active sites on ATP 
synthase worked together sequentially (Adolfsen and Moudrianakis, 1976; Kayalar et al., 
1977).  Boyer realized that participation of alternating sites and conformational changes 
between binding states may overcome the energy barrier to allow release of ATP from the 
binding site, prompting him to propose the binding change mechanism. 
 
The binding change mechanism states that three nonequivalent active sites on F1 work 
cooperatively to synthesize ATP (Figure 2.12).  At any given time one site adopts the ‘tight’ 
conformation, the second site adopts the ‘loose’ conformation, and the third site adopts the 
‘empty’ conformation.  The rotation of the gamma subunit, along with the c-ring, relative to the 
α3β3 hexamer induces conformational changes that allow each heterodimer to cycle through 
each conformational state.  Therefore, the binding of ADP and Pi, formation of ATP, and 
release of ATP is accomplished in all three active sites with each rotation of gamma.  The 
rotation of γ causing transitions between active site states was termed ‘rotational catalysis’ 
(Boyer, 1993).  John Walker’s F1 structure supported the basis for the binding change 
mechanism and rotational catalysis (Abrahams et al., 1994).  Paul Boyer and John Walker 
shared a Nobel prize for their contributions to the field of bioenergetics in 1997. 
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Figure 2.12:  Schematic diagram of the binding change mechanism.  The α3β3 hexamer is 
shown in three different binding states (one in each panel).  The green arrow in the center of 
each α3β3 hexamer represents the relative position of subunit γ.  The αβ pair bound to ATP is in 
the ‘tight’ conformation.  The binding site transitions to the ‘open’ conformation upon ATP 
release.  The αβ pair bound to ADP and Pi is in the ‘loose’ conformational state.  The 
translocation of protons across the membrane with each successive movement through the 
conformational states is indicated with black arrows.  [Image taken from (Lehninger et al., 
2008)].  Reprinted with permission from Freeman & Company / Worth Publishers. 
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Although Walker’s structure confirmed the binding change mechanism, it did not 
provide direct evidence for rotational catalysis.  The first evidence supporting rotational 
catalysis was provided by Duncan and co-authors (Duncan et al., 1995).  Duncan and co-
authors used Walker’s bovine F1 structure to identify interacting residues on the γ and β 
subunits of the E. coli homolog; they then introduced the D380C point mutation on subunit β.  
Crosslinking between γC87 and a particular β subunit containing the D380C mutation 
immobilized the γ subunit and abolished activity.  Reduction of the disulfide bond restored 
activity and subsequent oxidation caused the γ subunit to crosslink to a different β subunit.  
Duncan and co-authors demonstrated that γC87 interacted directly with all three β subunits 
throughout the catalytic cycle using this method.  When the disulfide bond was reduced and 
ATP synthase was left inactive, i.e., in the absence of ATP, the same γβ pair re-formed upon 
oxidation.  The rotational catalysis hypothesis was also supported by (Noji and Yoshida, 2001).  
Yoshida’s group fixed F1 of ATP synthase to glass slides, using affinity tags on the α subunits, 
and linked single fluorescent actin filaments to individual γ subunits.  Rotation of single 
filaments was observed by microscopy upon the addition of ATP. 
 
2.5   Molecular mechanisms of torque generation in the F0 domain. 
 The mechanism of proton transit through F0 is not well defined.  Arginine 210 of 
subunit a and aspartic acid 61 of subunit c are located centrally in the membrane and are both 
critical to proton transport through F0 (Cain, 2000; Valiyaveetil and Fillingame, 1997).  
Mutagenesis studies showed that no tested amino acid substitution at position 210 could sustain 
ATP synthase function, however, R210A was able to facilitate passive proton transport (Hatch 
et al., 1995; Valyaveetil and Fillingame, 1997) indicating that R210 is not obligatorily 
protonated during proton transit.  The positive charge of R210 is believed to stabilize the cD61 
proton carrier through salt bridge interactions (Fillingame et al., 2002; Ishmukhametov et al., 
2008) (Figure 2.13). 
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Figure 2.13:  Computational models of the F0 complex – Panels ‘A’ and ‘B’ show the top 
and side views of subunit a and the c10 oligomer, respectively.  Twelve c subunits are shown 
but the presently accepted stoichiometry is 10 (Jiang et al., 2001).  Subunit a is shown in 
orange (TMHs II – V are numbered with roman numerals).  aTMH-I is not shown in the 
models.  The two c subunits involved in direct interaction with subunit a are shown in green 
and blue, the rest of the c10 oligomer is shown in grey.  Arginine 210 of subunit a and D61 of 
subunit c are both critical for proton transport and their interaction is indicated with arrows.  
[Image taken from (Rastogi and Girvin, 1999), and modified; PDB-ID 1C17].  Reprinted with 
permission from Nature. 
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 Junge and co-authors proposed a model in which subunit a contains two-half channels 
that facilitate proton transport through F0 by shuttling protons to and from the D61 residue of 
subunit c (Junge et al., 1997).  Three bodies of experimental evidence support the two-half 
channel hypothesis: 1) crosslinking studies between subunit a and the c-ring, 2) structural 
evidence provided by cryo-EM, and 3) definition of the aqueous access channels by cysteine 
reactivity with silver ions. 
 
 Crosslinking studies aimed at understanding the structural interactions between subunit 
a and the c-ring (Kyle J. Moore, 2008; Moore and Fillingame, 2008a; Moore and Fillingame, 
2008b), previously discussed in section 2.3.1, demonstrated that TMH-IV and TMH-V of 
subunit a interact with two adjacent c monomers.  This work was strongly supported by the 
findings of Lau and co-authors as well as Hakulinen and co-authors.  The work of Lau and co-
authors showed that subunit I from T. thermophilus (equivalent to subunit a in E. coli) is made 
up of two four-helix bundles and each bundle makes physical contact with two adjacent L 
subunits (c subunits in E. coli) (Lau and Rubinstein, 2011).  Hakulinen and co-authors solved 
the 7.0 Å structure of crystallized F0 from I. Tartaricus (Hakulinen et al., 2012) and found that 
subunit a forms a four-helix bundle and two individual helices interact directly with two c 
subunits.  The differential contact points with the c-ring, observed in E. coli, T. thermophilus, 
and I. tartaricus, create distinct chemical environments on the respective c subunits and 
therefore create the required conditions for the two half channel hypothesis; one c subunit with 
periplasmic access and the other with access to the cytoplasm. 
 
 Cysteine mutagenesis has been used extensively to probe the aqueous accessible 
channels of subunit a.  Silver ions and N-ethylmaleimide (NEM) are good probes for 
determining the aqueous accessibility of particular residues (Lu and Miller, 1995; Tamura et 
al., 2001).  Both silver and NEM react with the ionized thiol group on cysteine, which generally 
requires water.  NEM is used to determine the boundaries of individual transmembrane 
segments because it is bulky and likely will not enter narrow aqueous channels.  Silver ions 
have a small hydrodynamic radius and may enter constricted aqueous access channels within 
transmembrane proteins.  Therefore, if a residue, which is embedded in the lipid membrane, is 
highly reactive with silver there is an aqueous channel that allows solvent access to the 
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particular residue under study.  Agenvine and co-authors as well as Moore and co-authors 
demonstrated that several residues in transmembrane segments II, IV and V (extending from 
the cytoplasmic side of the membrane to the periplasmic side) were accessible to solvent using 
this method (Angevine and Fillingame, 2003; Angevine et al., 2003; Angevine et al., 2007; 
Moore et al., 2008; Moore and Fillingame, 2008a).  Aqueous accessible residues are assumed 
to line the proton channels.  The data collected from these studies indicates that the periplasmic 
half channel is located at the interface of aTMH-II and aTMH-III, while the cytoplasmic half 
channel is located at the interface of aTMH-IV and aTMH-V.  Figure 2.14 summarizes the 
aqueous accessible residues identified in these studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14: Aqueous accessible residues of subunit a.  The sensitivity of specific residues to 
cysteine labeling with silver varies.  The aqueous accessible residues identified by Moore and 
co-authors are categorized by > 85 % sensitivity (red filled circle), 66 – 85 % sensitivity 
(orange filled circle), and 46 – 65 % sensitivity (tan filled circle).  The aqueous accessible 
residues identified by Angevine and co-authors are categorized by > 90 % sensitivity (yellow 
circle), 79 – 90 % sensitivity (green circle), and 50 – 75 % sensitivity (pink circle).  The critical 
R210 residue is shown in purple.  [The subunit a model in this Figure was adapted from (Vik et 
al., 2000)].   
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The mechanistic mode of proton shuttling through the half channels in subunit a is still 
poorly understood.  There are three theoretical forms that the half channels may adopt: 1) A 
channel of sufficient width to allow convection of water molecules; 2) a narrow channel 
containing ordered water molecules; and 3) a channel that excludes water altogether and relies 
on hydrogen bonding networks to provide the hydrophilic environment required for proton 
transport (Nagle and Morowitz, 1978).  Several cysteine substitution experiments have shown 
that residues buried deep within the membrane are susceptible to silver ion inhibition, 
suggesting that the channels are either open to water or contain ordered waters.  However, 
gating of proton transit through the channel is poorly understood and it is reasonable to 
speculate that protons move through both aqueous accessible regions as well as hydrogen 
bonding networks within the half channels. 	  
Multiple models for proton transport through F0 have been proposed.  The 
commonalities between the current models are as follows: protons enter through the 
periplasmic half channel of subunit a and bind to cD61, in its carboxylate form.  Each 
protonation event causes the c-ring to rotate 360 relative to subunit a.  After making a complete 
turn about the rotor each protonated cD61 comes into close proximity with aR210.  It has been 
proposed that the positive charge of R210 is necessary for controlling the pKa of cD61, which 
facilitates proton binding and release from subunit c (Fillingame et al., 2002).  Although the 
model shown in Figure 2.15 generally describes the currently accepted mechanism of proton 
transport, the detailed mechanism of torque generation has been under some debate. 
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Figure 2.15:  Schematic diagram of the proton channel.  The c-ring is shown in green and 
subunit a is shown in purple.  The path of proton flow is indicated with red arrows.  Protonated 
D61 residues are shown as black circles.  The D61 residues of each c protomer involved in 
active proton binding or release are shown as white circles.  The direction of c-ring rotation is 
indicated with a black arrow.  [Figure adapted from (Dimroth et al., 2000)].  Reprinted with 
permission from BBA. 
 
 
One model for torque generation involves swiveling of individual helices within both 
subunits a and c (Aksimentiev et al., 2004; Elston et al., 1998; Fillingame et al., 2002; Rastogi 
and Girvin, 1999; Vik and Antonio, 1994; Xing et al., 2004).  Atomic level resolution 
structures are available for the c-rings of a number of proton transporting ATP synthases.  In 
each case, the essential carboxylic acid (D61 in E. coli) is located near the middle of the second 
TMH of the hairpin.  The structure of E. coli monomeric c was solved by NMR at pH 8.0 
(Rastogi and Girvin, 1999) and pH 5.0 (Girvin et al., 1998) and showed that the protonation 
state of D61 impacts the structural conformation of the c monomers.  Protonation of D61 was 
proposed to cause cTMH-II to swivel 140o relative to TMH-I, and drive rotation of the ring 
(Rastogi and Girvin, 1999).  Figure 2.16 illustrates the proton transport mechanism proposed by 
Rastogi and Girvin.  However, the protonation state of cE56 (equivalent to D61 of E.coli) from 
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thermophillic bacillus PS3 does not have significant impact on the structure, and raises debate 
over the applicability of the swiveling mechanism (Nakano et al., 2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.16:  The theoretical model of proton translocation posited by Rastogi and Girvin.  
A) Resting state of R210.  The D61 on the yellow c subunit is protonated and the D61 on the 
green c subunit is deprotonated.  B) Protonation of the D61 on the green c subunit causes the 
swiveling of cTMH-II into the stable proton bound conformation.  C) Fully protonated 
intermediate state, both the green and purple c subunits are in the proton bound form.  D) 
Release of the proton from the purple c subunit to facilitate adoption of the resting state at the 
next position in the c-ring.  [Image taken from (Rastogi and Girvin, 1999) and modified].  
Reprinted with permission from Nature. 
 
 
 Helical swiveling has also been proposed within subunit a.  Fillingame and co-authors 
posited that swiveling of TMH-IV of subunit a may gate access to the half channels and 
facilitate deprotonation and re-protonation of cD61 (Fillingame et al., 2003).  This model 
differed from the model presented by Rastogi and Girvin by showing that cTMH-II swiveling 
occurs when D61 is deprotonated, rather than as a result of protonation.  The coordinated 
swiveling of cTMH-II and aTMH-IV was implicated as the mechanism of torque generation. 
 
Aksimentiev and co-authors conducted extensive computational modeling studies based 
on the models proposed by the research groups of Girvin and Fillingame (Aksimentiev et al., 
2004).  Their modeling indicates that two adjacent c subunits are involved in a cooperative 
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mechanism where they are both in the deprotonated state for a brief period of time.  The 
presence of two deprotonated D61 residues significantly reduces dissociation energy of the 
aR210-cD61 salt bridge and facilitates transfer of the salt bridge from one c-monomer to the 
next. 
 
A second, and currently more accepted model of torque generation involves the 
Brownian ratchet mechanism (Junge et al., 1997).  The Brownian ratchet mechanism states that 
the c-ring experiences small thermal oscillations relative to subunit a governed by Brownian 
motion.  These thermal oscillations provide the initial force required to facilitate rotation of the 
c-ring in response to protonation and deprotonation of individual c subunits.  The Brownian 
ratchet mechanism also assumes that the carboxyl groups on the c-ring must be protonated and 
neutral when facing in the lipid phase; but may be deprotonated and charged when facing 
subunit a.  Electrostatic dynamics prevent the ring from slipping through the a/c interface when 
D61 is not protonated. 
 
The high resolution crystal structure of the c-ring of S. platensis ATP synthase supports 
the Brownian ratchet mechanism posited by Junge and co-authors (Pogoryelov et al., 2009).  In 
this model, the c-ring is thought to oscillate back and forth relative to subunit a in a Brownian 
fashion.  When a given c-subunit, in its proton locked conformation, interacts with the a 
subunit’s critical arginine residue, the E62 (equivalent to E. coli D61) assumes an open 
conformation which allows the proton to be released.  While E62 is deprotonated it is thought 
to be stabilized by a salt bridge with subunit a’s critical arginine.  Brownian movement of the 
rotor is regulated by the deprotonated c subunit, which cannot exit the a-c interface.  An 
incoming proton may then bind E62, allowing the neutralized glutamic acid to re-enter the 
hydrophobic membrane in its proton locked conformation under Brownian motion. 
 
The Brownian ratchet mechanism is also supported by high resolution crystal structure 
of the c-ring from S. cerevisiae, which was solved in the open conformation (Symersky et al., 
2012).  Symersky and co-authors showed that the introduction of a hydrophilic environment 
around the binding sites causes them to open, rather than concerted helical movements (as with 
the model proposed by Girvin and co-authors) or interaction with subunit a’s critical arginine 
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(as proposed by Pogoryelov and co-authors).  A diagram of the Brownian ratchet model for 
proton transport through F0 is shown in Figure 2.17. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.17:  The mechanism of proton transport based on the high resolution structure of 
the c-ring from S. cerevisiae.  The proton channel leading to the mitochondrial matrix is 
shown in light blue and the channel entering from the intermembrane space is shown in dark 
blue.  A) The hydrophilic environment of the matrix channel facilitates opening of the proton 
binding site and proton release (1).  R176 (equivalent to R210 in E. coli) is paired with the de-
protonated E59 (equivalent to D61 in E. coli) (2).  B) R176 releases the de-protonated E59 (1) 
to stabilize the upcoming E59 facing the matrix (2).  Release of E59 from R176 allows the 
deprotonated E59 to bind an uncoming proton from the intermembrane space, and exit the a/c 
interface.  [Image taken from (Symerkey et al., 2012)].  Reprinted with permission from Nature. 
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In the models discussed above, the conserved D61 residue is assumed to undergo 
protonation and deprotonation to facilitate proton transport across the membrane.  However, 
Boyer postulated that protons may be transported as hydronium ions (Boyer, 1988).  In order 
for this to occur the binding sites within the c-ring must have capacity to accept three hydrogen 
bonds, which is theoretically plausible based on the high resolution structure of the c-ring from 
B. pseudofirmus (Preiss et al., 2010).  However, extensive computational modeling has shown 
that the ion coordination in B. pseudofirmus is more likely to occur through protonation of the 
critical carboxylate group (Leone et al., 2010).  Several structures of other proton transporting 
c-rings have supported the assumption that proton transport occurs through obligatory 
protonation of the D61 (or equivalent) residue by demonstrating that the critical carboxylic acid 
group is directly involved in hydrogen bonding as a donor (Pogoryelov et al., 2009; Vollmar et 
al., 2009) (Figure 2.18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.18:  Crystallographically determined structure of the proton binding site of the 
S. platensis c-ring.  Glu62 is the critical proton carrier in S. platensis.  In this structure oxygen 
Oε1 serves as a hydrogen bond acceptor for the hydroxyl group of Tyr67.  Oxygen Oε2 acts as 
a hydrogen bond acceptor from the Nε2 group of Gln29 and a hydrogen bond donor for the 
backbone oxygen of Phe60 (purple dashed line).  Pogoryelov and co-authors state that 
hydrogen bond donation by the Oε2 oxygen conclusively identifies Glu62 as the obligatorily 
protonated proton carrier.  [Image taken from (Pogoryelov et al., 2009); PDB-ID 2WIE].  
Reprinted with permission from Nature. 
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Sodium dependent F-type ATPases have been shown to facilitate sodium transport in a 
similar fashion to the proton transporting F1F0.  The c-ring structures of two sodium 
transporting F-type ATPases have been solved by X-ray crystallography and provide detailed 
perspective on ion shuttling through the F0 domain (Meier et al., 2005; Murata et al., 2005; 
Vonck et al., 2002).  In the I. tartarticus structure sodium atoms are coordinated by the side 
chain oxygens of Q32 and E65 on one c subunit, and the hydroxyl oxygen on S66 and carbonyl 
oxygen of V63 on the adjacent c subunit (Figure 2.19).  The coordination network is also 
stabilized by several hydrogen bonds.  Researchers have hypothesized that the hydrogen bond 
network serves to keep E65 deprotonated at physiological pH to facilitate sodium binding.  
Although the structure of the a subunit is unknown, they postulate that interaction with subunit 
a shifts the hydrogen bonding network and protonation state of E65 to release sodium ions from 
the binding site. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.19: The sodium coordination site of the c-ring structure from I. tartaricus.  The 
sodium atom (yellow) is coordinated by E65 and Q32 on one c subunit (dark green) and C63 
and S66 on the adjacent c subunit (light green). [Image taken from von Ballmoos et al., 2009; 
PDB-ID 2WGM].  Reprinted with permission from Annu. Rev. Biochem. 
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2.6   Membrane insertion and assembly of the F0-complex. 
The membrane incorporation requirements of the F0 subunits have been characterized.  
Subunit c is inserted into the membrane via a novel pathway that is independent of Sec-
translocase and requires only the YidC chaperone protein (Kol et al., 2006).  Insertion of 
subunit c is dependent on positively charged residues in the cytoplasmic loop (Kol et al., 2008).  
Subunit a has a membrane targeting signal in its amino terminus that facilitates its 
incorporation into the membrane (Vik et al., 2000) via the signal recognition particle and Sec-
translocase pathway (Yi et al., 2004).  The YidC chaperone also plays a role in subunit a 
integration into the membrane in conjunction with the Sec-translocase machinery (Yi et al., 
2003).  Insertion of subunit a into the membrane is known to be dependent on the presence of 
subunits b and c as well as the PMF (Hermolin and Fillingame, 1995; Yi et al., 2003).  The b 
subunit is inserted into the membrane via the Sec-translocase pathway. 
 
In yeast cells, OxaI is the functional equivalent of YidC in E. coli.  ATP synthase 
assembly is severely impaired in the absence of OxaI / YidC.  Saint-Georges and co-authors 
identified a point mutation in one of the subunits of yeast cytochrome-bc1, Qcr9p, which 
facilitates membrane insertion of the ATP synthase F0 domain subunits in the absence of OxaI  
(Saint-Georges et al., 2001).  These authors proposed that introduction of a positively charged 
residue in the transmembrane portion of Qcr9p allowed interactions with negatively charged 
residues in the transmembrane segments of other respiratory chain complexes (i.e., the D61 or 
equivalent proton carrier of the ATP synthase subunit c) to facilitate co-insertion.  Subunit a 
that is not associated with subunits b and c is highly toxic to cells and is rapidly degraded by 
FtsH protease (Akiyama, 2002; Akiyama et al., 1996).  It is interesting to speculate that this  
mechanism of co-insertion of a and c through charge-charge interactions may occur to prohibit 
the toxic a subunit from entering the membrane unpaired. 
 
The assembly mechanism of the F0 domain is largely unknown.  Subunit c purified from 
E. coli has the capacity to self-assemble into ring structures (Arechaga et al., 2002).  However, 
in this study spontaneous ring assembly was shown to be a slow process.  Self-assembly of the 
c10 ring is not likely to occur in live bacteria because the high energy demands of rapid cell 
division may not be met if ATP synthase cannot assemble quickly.  The uncI is a 14 kDa 
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protein encoded on the atp operon that is not a component of the mature F1F0.  uncI has been 
demonstrated to chaperone the assembly of the c-ring in P. modestum, and this functionality is 
likely conserved across species (Ozaki et al., 2008; Suzuki et al., 2007). 
 
2.7   Membrane protein structure determination. 
Structure and function are closely related in biological systems.  Therefore, elucidation 
of complex tertiary structural elements can yield detailed information about how proteins and 
enzymes function in a living system.  In addition to basic research efforts, protein structure 
determination is quickly becoming a cornerstone in human health research.  Structural 
perturbations brought on by disease-causing mutations may be identified and evaluated for 
structure-based drug design.  Also, enzymes from pathogens have been targeted using structure-
based drug design to successfully combat human illness (Chintakrindi et al., 2012; Martucci et 
al., 2009; Roberts et al., 1990; Traxler et al., 1997).  Membrane proteins are particularly 
attractive targets for structure-based drug design because many of them are involved in 
essential physiological processes, signal transducation for example, which contribute to disease. 
 
Membrane proteins constitute approximately one-third of all gene expression products 
in humans (Fagerberg et al., 2010).  Over 84,000 soluble protein structures have been solved, 
while only 308 unique membrane proteins structures have been determined to date (White, 
2012).  Of the 308 known membrane protein structures, only 13 unique alpha-helical membrane 
protein structures have been solved.  NMR spectroscopy, X-ray crystallography, and cryo-EM 
are the major methods for analyzing the three dimensional (3-D) features of both soluble and 
membrane proteins.  Limited success in membrane protein structure determination has been 
attributed to several challenges specific to membrane proteins such as difficulties with protein 
overexpression, purification, yield, stability, and crystallization. 
 
2.7.1  NMR spectroscopy for structure determination of membrane proteins. 
 In visible spectroscopy photons cause the system to move from a ground state to an 
excited state, which is measurable.  However, in NMR spectroscopy microwaves induce the 
transition between ground and excited spin states, which are split by an external magnetic 
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field.  The properties of individual nuclei determine their compatibility with NMR techniques.  
Nuclei have a quantum property called spin, which is described by a spin quantum number ‘I’.  
Nuclei with non-zero values of I are NMR detectable, some examples that are relevant to 
protein structure determination are 1H, 13C, and 15N.  The natural abundance of 13C and 15N is 
low and uniform labeling of protein samples is required for high-resolution NMR studies. 
 
The bulk magnetic field (B0) aligns the nuclear magnetic dipoles along an axis in both 
‘up’ and ‘down’ states, which are respectively parallel and antiparallel to the B0 (Figure 2.20).  
The up and down states are referred to as µ+1/2 and µ-1/2.  The µ+1/2 state is parallel to B0 and 
therefore low energy, while µ-1/2 is antiparallel to B0 and high energy.  More spins align parallel 
than antiparallel.  Transition between the µ states is induced by the application of a radio 
frequency (RF) pulse.  The RF pulse changes the equilibrium of the spin states and causes a 
small fraction of dipoles to tip from the parallel to the antiparallel alignment.  The movement of 
this small fraction of dipoles from the excited (antiparallel) state back to the ground state 
(parallel) is termed ‘relaxation’ and is the basis of NMR spectroscopic detection.  Measurement 
of the minuscule fraction of spin states that move from antiparallel to parallel produces the 
NMR signal used to determine protein structures.  The lifetime of the excited state determines 
the spectral resolution and is characterized by relaxation rate, i.e., the rate at which the excited 
system returns to the ground state.  Systems with long life times have slow relaxation rates and 
produce narrow well resolved spectral lines; while systems with short lifetime and fast 
relaxation rate produce broadened poorly resolved spectral lines.  The position of each spectral 
line corresponds to the chemical shift of a unique nucleus. 
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Figure 2.20:  The effect of an external magnetic field on nuclear magnetic dipoles.  A) 
Nuclear magnetic dipoles in the absence of a magnetic field.  Black and grey dots represent the 
distribution of dipoles in space.  B) Nuclear magnetic dipoles in the presence of an external 
magnetic field B0.  The dipoles may assume any position in the X-Y plane but may only be up 
or down on the Z axis.  [Image taken from (Rule and Hitchens, 2006)].  Reprinted with 
permission from Springer. 
 
 
Chemical shift is defined as the resonance frequency of a given nucleus relative to a 
standard.  The chemical shifts of distinct carbon nuclei, nitrogen nuclei, and protons in a protein 
molecule can be identified and assigned on NMR spectra.  Magnetization transfer through 
bonds (J-coupling) is used to connect chemical shifts of individual atoms in a single residue as 
well as to link the chemical shifts of neighboring amide backbone groups.  A phenomenon 
called the nuclear Overhauser effect (NOE) is magnetization transfer through space.  Measuring 
NOEs allows the calculation of distance constraints between assigned protons, and therefore, 
distances between larger structural elements.  Compilation of multiple distance constraints, 
paired with the assumption that the protein molecule has regular chemical geometry, can be 
used to produce a high resolution 3D protein model. 
 
NMR is a very sensitive technique for examining the local structural dynamics of 
proteins.  Structural dynamics can be studied to determine which amino acid residues are 
involved in ligand binding and catalysis.  Chemical shift changes can be monitored over a range 
of substrate concentrations and used to calculate binding and dissociation constants of ligands 
(Evans, 1995). 
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NMR does have some limitations, which are particularly relevant when working with 
membrane proteins.  Relaxation rates are critical to spectral resolution and are significantly 
impacted by the size of the protein under study.  Large proteins undergo rapid relaxation and 
tend to produce poor quality spectra.  Currently, structure determination by NMR is limited to 
proteins with molecular weights less than 40 to 60 kDa (Rule and Hitchens, 2006).  The highly 
hydrophobic nature of membrane proteins creates a need for membrane mimetics.  Historically, 
NMR experiments with membrane proteins have been carried out using detergent micelles.  
Detergent micelles increase the effective size of the protein under study and fast relaxation of 
protein – detergent complexes can complicate acquisition of high quality NMR spectra.  There 
are, however, several techniques used to study membrane proteins by NMR that aim to enhance 
spectral resolution. 
 
Enhancement of NMR spectral resolution can be achieved both by the design of the 
NMR experiment itself and by sample preparation and handling.  In heteronuclear single 
quantum coherence (HSQC) spectra each peak cooresponds to a single back bone or side chain 
amide group.  HSQC spectra provide an NMR ‘fingerprint’ which is often a starting point for 
structure calculation.  The two components of magnetization relaxation are T1, longitudinal 
relaxation, and T2, transverse relaxation.  In HSQC spectra where decoupling has not been 
applied peaks appear as multiplets as a result of J-coupling.  Each component of the multiplet 
has a different relaxation rate.  Transverse relaxation optimized spectroscopy (TROSY) is an 
NMR spectroscopic method designed to select the multiplet component with the slowest 
relaxation rate and narrowest peak width, which effectively suppresses T2 relaxation.  The 
selection process dramatically reduces line width and enhances spectral resolution; the cost for 
enhanced resolution is an approximate 50 % decrease in sensitivity.  Deuteration is also a 
commonly used method to improve spectral resolution of large and / or detergent bound 
proteins.  Perdeuteration decreases the dipolar interactions between 13C or 15N and their bound 
protons, which decreases relaxation rates.  Proton – proton coupling is also suppressed by 
deuteration which further improves resolution and reduces spectral complexity. 
 
Sample handling techniques that reduce the size of the protein – detergent complex or 
reduce the viscosity of the sample can also improve spectral resolution.  Relaxation rates can be 
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reduced by decreasing the size of the micellar complex, for instance, by using low molecular 
weight detergents.  Mixed polarity solvents have also been used in membrane protein NMR to 
circumvent the use of detergent micelles and the complications they impart on high resolution 
data collection (Dmitriev, 2004b; Girvin et al., 1998).  Subjecting the samples to high 
temperatures during data collection may also enhance spectral resolution by reducing the 
effective viscosity of the sample. 
 
Selective isotopic labeling and solid state NMR are emerging techniques which are 
useful for improving the resolution of membrane protein samples.  Selective isotopic labeling 
involves specific labeling of individual residues by cell free protein synthesis or in vivo labeling 
(Hiroaki et al., 2011; O'Grady et al., 2012; Torizawa, 2004).  In selectively labeled protein 
samples only specific backbone chemical shifts are observed, which simplifies the spectra and 
aids in residue assignment.  Solid state NMR is useful for individual proteins as well as large 
protein complexes (Judge and Watts, 2011).  Solid state NMR also offers a method to study the 
dynamic interactions between protein and lipid to give a more complete understanding of the 
functionalities of membrane proteins.  Fourteen non-redundant membrane protein structures 
have been solved using solid state NMR (Warschawski, 2012). 
 
Recently a group of researchers successfully determined the structure of a 247 amino 
acid membrane protein, sensory rhodopsin II (SRII), solubilized in detergent micelles using 
solution NMR (Gautier et al., 2010) (Figure 2.21).  The solution structure of  SRII is the first of 
its kind and agrees well with the crystal structures of SRII (Luecke et al., 2001; Royant et al., 
2001).  Sensory rhodopsins appear to lend themselves to structural investigation and provide 
proof of principle for alphahelical membrane protein structure determination.  Successful 
structure determination of sensory rhodopsins has been attributed to a unique combination of 
properties including their relatively small size, enhanced stability, and highly ordered internal 
structure.  Gautier and co-authors were able to produce high quality NMR spectra from this 
integral membrane protein through the use of optimized detergents, monodispersed protein 
samples, and high temperatures during data acquisition. 
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Figure 2.21:  Solution structure of SRII.  Left: ensemble NMR structure of receptor SRII.  
Right: retinal in the binding pocket from the NMR structure (pink) superimposed with the X-
ray structure (blue) side chain residues in purple and brown are taken from the NMR structure 
[Image taken from (Gautier et al., 2010); PDB-ID 2KSY].  Reprinted with permission from 
Nature. 
 
2.7.2  X-ray crystallography of membrane proteins. 
 X-ray crystallography is widely used for protein structure determination.  There are 
three main steps involved in protein X-ray crystallography.  The first step, which is often the 
most difficult, is to produce high quality protein crystals.  The crystals generated need to be 
larger than 0.001 mm3 and ideally should be free of cracks and blemishes.  After high quality 
crystals are obtained they must be subjected to X-ray diffraction.  During diffraction, X-rays 
enter the crystal at a fixed angle and scatter off of electron dense regions to produce a 
diffraction pattern.  The diffraction pattern contains the structural information of the 
crystallized protein.  The third and final step in protein crystallography is the generation of an 
accurate protein model. 
 
Crystallization of membrane proteins is particularly challenging because detergent 
solubilized membrane proteins are often unstable and have limited surfaces available for crystal 
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contacts (Bowie, 2001).  Detergents are a relatively poor substitute for the lipid bilayer, and can 
often interfere with crystal lattice packing.  In some cases, bicellar crystallization methods have 
been used to improve crystallization propensity of membrane proteins (Faham and Bowie, 
2002; Katona et al., 2003; Landau and Rosenbusch, 1996; Rosenbaum et al., 2011; Wu et al., 
2010).  Bicellar crystallization involves reconstitution of the target protein into bicelles, which 
are small lipid bilayer disks capped by detergent molecules (Figure 2.22).  Bicelles are 
advantageous for membrane protein crystal trials because they closely mimic cellular 
membranes.  They are relatively easy to work with, and keep the protein solubilized, which is 
ideal for crystallization by vapor diffusion and microbatch methods. 
 
Figure 2.22:  Graphical representations of membrane mimetics used in membrane protein 
crystallography.  The green globular alpha helical membrane protein is shown in detergent 
micelles (A), bicelles (B), and lipid bilayer (C).  [Image taken from (Arora and Tamm, 2001) 
and modified].  Reprinted with permission from Curr. Opin. Struct. Biol. 
 
There are two main types of crystal growth: type I and type II.  Membrane proteins 
crystallized in micelles or bicelles are typically type II crystals, where crystal contacts are 
limited to the polar regions.  Type II crystals are often fragile and difficult to work with.  Figure 
2.22 illustrates how micelles and bicelles select for type II crystal growth, because the detergent 
molecules shield the core of the protein from making crystal contacts.  For membrane proteins, 
crystal contacts within the polar regions as well as within the plane of the membrane are 
required for type I growth. 
 
Crystallization of membrane proteins within lipid bilayers is a relatively new technique.  
Lipidic cubic phase (LCP) crystallization was developed by Landau and Rosenbusch; and 
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utilizes highly organized, incredibly viscous, three dimensional, and continuous lipid bilayers 
(Landau and Rosenbusch, 1996).  LCP forms spontaneously upon mixing of monoolein and 
water at ideal ratios.  The structure of the LCP changes when the water to monoolein ratio is 
adjusted.  The target membrane protein can be re-constituted into LCP and stabilized in an 
environment that closely mimics the cellular membrane (Figure 2.23).  After the protein is 
reconstituted into LCP it can be mixed with precipitant solution to enhance the probability of 
nucleation.  Crystal growth in LCP systems occurs through re-arrangements in the lipid lattice 
that allow individual protein molecules to stack against one another within the plane of the 
membrane, as well as the ordered stacking of two-dimensional crystal sheets. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.23:  LCP facilitated membrane protein crystal formation and growth.  A) A 
diagram of the LCP structure is shown on the left and an enhanced view of the edge of the LCP 
matrix (with a reconstituted membrane protein) is depicted on the right.  [Image taken from: 
(Landau and Rosenbusch, 1996)].  Reprinted with permission from Elseiver Science.  B) The 
protein molecules diffuse freely within the plane of the membrane to form crystal plates.  The 
LCP matrix is also capable of remodeling to facilitate the stacking of crystal plates to form 3D 
crystals.  LCP matrix is shown in yellow and white, protein molecules are blue [Image taken 
from (Caffrey and Cherezov, 2009)].  Reprinted with permission from Nature. 
 
 
Optimal crystallization conditions are identified by trial and error, which often produces 
unwanted small molecule crystals consisting of salt, buffer or detergent.  There are several 
techniques that help to determine whether a crystal is composed of protein or small molecules.  
Crystal staining with dyes such as methylene blue or ponceau red is one of the most common 
methods of assessing protein content.  Protein crystals have relatively large pores and dye 
molecules can diffuse into the crystal to bind protein creating a dark blue or red appearance.  
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Salt crystals do not absorb dyes and remain colorless.  Birefringence is generally a property of 
salt crystals and most protein crystals exhibit low levels of birefringence.  However, proteins 
with a strong dipole moment may exhibit higher levels of birefringence and salt crystals with 
cubic internal ordering may exhibit none.  Potential protein crystals can be tested for 
birefringence using a polarized light source.  Finally, crystals of unknown composition can be 
diffracted with X-rays to determine protein content.  Both salt and protein crystals give distinct 
diffraction patterns that can be readily identified. 
 
Crystallization is a labor intensive process that requires testing thousands of 
combinations of experimental conditions.  Precipitant types and concentrations, buffer types, 
pH values, protein concentrations, and detergents must all be optimized, and changes in one 
component may alter the effects of other components.  High throughput screening methods are 
often necessary to identify initial conditions; laborious refined screening is required to optimize 
crystal quality.  However, the propensity of any given protein to crystallize is also heavily 
dependent on the physicochemical properties of the protein.  In some cases, favorable 
crystallization conditions can be predicted based on the properties of the protein (Chen et al., 
2007; Jia and Liu, 2006; Overton and Barton, 2006). 
 
Among the 13 unique α-helical membrane protein structures are several crystal 
structures from different types of G-protein coupled receptors (GPCRs).  GPCRs are a large 
family of integral membrane signaling proteins that are characteristically composed of seven 
transmembrane alpha helical segments and are responsible for cellular responses to hormones, 
neurotransmitters, olfaction, and light.  GPCRs are involved in a wide spectrum of human 
diseases and are attractive targets for structure determination and rational drug design.  Robert 
Lefkowitz and Brian Kobilka shared the 2012 Nobel prize for their crystallographic and 
mechanistic investigations on GPCRs.  The GPCR success stories serve as a benchmark for 
structure studies on a wide variety of alpha helical membrane proteins.  A structural diagram of 
the human β2 adrenergic G-protein coupled receptor is shown in Figure 2.24. 
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Figure 2.24:  The crystallographically determined structure of human β2 adrenergic 
GPCR.  Two views of the protein are shown.  Transmembrane alpha helical segments (marked 
TM) are shown in yellow and numbered.  The green patches represent areas that form direct 
interaction with specific protein binding partners.  [Image taken from (Rasmussen et al., 2007); 
PDB-ID 2R4R].  Reprinted with permission from Nature. 
 
 
 Bacteriorhodopsin and the K2P1 potassium transporting protein are both examples of 
transmembrane alpha helical ion transporters; high resolution structures determined X-ray 
crystallographically are available for each.  Bacteriorhodopsin is a well characterized proton 
pump that is composed of three identical monomers which form a trimeric structure in the 
membrane (Luecke et al., 1998).  Bacteriorhodopsin functions to maintain the PMF in H. 
salinarium in response to light, which in turn drives ATP synthase.  The human K2P1 
potassium channel is highly selective for potassium ions and consists four pore forming 
domains that arrange in a cone shape within the membrane (Miller and Long, 2012).  K2P1 and 
its homologues are heavily involved in cellular signaling, including regulating electrical 
signaling in excitable cells, hormone secretion, and maintenance of cell volume.  Structural 
diagrams of both bacteriorhodopsin and K2P1 are shown in Figure 2.25. 
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Figure 2.25:  The crystallographically determined structures of bacteriorhodopsin and the 
human K1P2 potassium transporter.  A) The trimeric biological complex of 
bacteriorhodopsin.  The  TMHs of bacteriorhodopsin monomers are shown in blue, yellow and 
green.  Individual ordered lipid molecules are shown in grey and red.  B) The tetrameric 
biological K2P1 potassium pore.  Potassium ions are shown in purple.  [Figures taken from 
(Luecke et al., 1998; Miller and Long, 2012)].  The PDB-IDs for bacteriorhodopsin and the 
K2P1 potassium pore are 1C3W and 3UKM respectively.  Images reprinted with permission 
from Science. 
 
 Protein NMR and crystallography are complementary methods.  Diffraction based 
methods have the potential to reveal larger structures in a shorter time, while NMR is time 
consuming and is not currently practical for proteins larger than 60-70 kDa.  However, NMR 
can reveal more about molecular dynamics in solution.  Also, NMR provides a means for 
determining the structure of proteins that will not readily crystallize.  There are several 
examples of protein structures that have been solved by both NMR and X-ray crystallographic 
methods. Generally, solution and crystal structures of the same protein agree with each other 
which shows both methods can be used to explain the relationship between form and function 
(Garbuzynskiy et al., 2005).  NMR and X-ray diffraction based models are more meaningful 
taken together than either alone. 
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2.8   Proton transport through ATP synthase and human health implications. 
Mitochondrial diseases are among the most common genetic disorders and are a 
growing concern for community health (DiMauro, 2007).  Mitochondrial diseases, often 
referred to as mitochondrial myopathies, are caused by mutations in mitochondrial 
deoxyribonucleic acid (DNA) that affect the cell’s ability to produce ATP.  Over 150 
pathogenic mutations have been identified on the mitochondrial genome (Figure 2.26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.26:  Morbidity map of the human mitochondrial genome.  Genes labeled A8 and 
A6 correspond to the c and a subunits of human ATP synthase respectively. [Image taken from 
(DiMauro, 2004)].  Reprinted with permission from BBA. 
 
 
There are three human diseases caused by mutations in the gene encoding subunit a of 
ATP synthase (Kucharczyk et al., 2009).  They are 1) neuropathy, ataxia and retinitis 
pigmentosa (NARP) syndrome (Tatuch and Robinson, 1993); 2) maternally inherited Leigh’s 
syndrome (MILS) (de Vries et al., 1993; Santorelli et al., 1994); and 3) familial bilateral striatal 
necrosis (FBSN) (De Meirleir et al., 1995).  A fourth disease, Leber’s hereditary optic 
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Disease Mutation 
(mtDNA) 
Amino acid 
(Human atp6) 
Equivalent 
amino acid (E. 
coli sub-a) 
Symptoms Prevalence 
NARP/MILS T8993G Leu156 ! 
Arg 
Leu207 ! Arg Dementia, seizures, 
neuropathy, 
neurogenic muscle 
weakness, ataxia, 
encephalopathy 
NARP  
1:12,000 
 T8993C Leu156 ! Pro Leu207 ! Pro MILS   
1:36,000 
 T9176G Leu217 ! 
Arg 
Leu259! Arg  
 T9176C Leu217 ! Pro Leu259 ! Pro 
  
LHON T9101C Ile192 ! Arg Ile242 ! Thr Optic nerve 
atrophy, pre-
excitation 
syndrome 
1:8500 
 
FBSN T8851C Trp109 ! Arg Phe185! Arg dystonia, 
herkinesia, 
spasticity, seizures, 
mental deterioration 
unknown 
!
neuropathy (LHON), has also been shown to be associated a point mutation in subunit a.  
However, LHON is also associated with a number of mutations in several of the OxPhos 
complexes and appears to be caused when protons leak across the membrane (Lamminen et al., 
1995).  LHON is characterized by bilateral optic nerve atrophy, pre-excitation syndrome, and a 
variety of neurological disorders.  It has a prevalence of 1 in 8,500 individuals, although only a 
minority of cases are related to the ATP synthase mutation (Man et al., 2003). 
 
NARP and MILS syndromes are both caused by one of four point mutations within 
subunit a (Table 2.1).  The mutations associated with NARP / MILS syndromes cause severe 
impairment of steady state ATP synthesis, likely due to partial blockage of proton passage 
through F0 (Baracca et al., 2000; Sgarbi et al., 2006).  ATP synthase containing the NARP / 
MILS mutations is correctly assembled and present at levels comparable to wild type (Rak et 
al., 2007).  In all known cases the T – G (Leucine to Arginine) mutations result in more 
aggressive forms of the diseases (Santorelli et al., 1996).  Researchers have speculated that the 
introduction of the positively charged arginine interferes with the proton channel (Vazquez-
Memije et al., 2009). 
 
Table 2.1:  Summary of the mutations, symptoms and prevalence of mitochondrial myopathies 
related to subunit a.  Note: The human equivalent of subunit a is expressed from the gene 
named “atp6”. 
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It seems counterintuitive that two distinct disorders are caused by the same mutations, 
however, in this case the distinguishing variable is mitochondrial heteroplasmy – also known as 
‘mutant load’ (White et al., 1999).  The NARP / MILS causing mutations do not occur in all of 
the mitochondria in the body.  Individuals with less than a 70 % mutant load are clinically 
asymptomatic, while individuals harboring between 70 – 90 % mutated mitochondria display 
NARP symptoms.  People with a mitochondrial mutation rate greater than 90 % display 
symptoms of MILS.  Although NARP and MILS are closely related disorders the clinical 
presentations are strikingly different.  Several acute symptoms characterize NARP syndrome, 
including retinitis pigmentosa, ataxia, seizures, dementia, sensory neuropathy and 
developmental delay.  The onset of MILS is typically 6 months of age and it is characterized by 
symptoms including brainstem dysfunction, progressive psychomotor decline and death within 
2 years.  NARP syndrome has a prevalence of 1 in 12,000 individuals and MILS has a 
prevalence of 1:36,000 (Santorelli and Tessa, 2004). 
 
FBSN is not well characterized.  It is an early onset disease characterized by brain 
lesions and neuronal cell death.  Symptoms include dystonia, hyperkinesia, spasticity, seizures, 
mental deterioration and disturbed behavior.  FBSN is caused by a mutation in the C-terminus 
of subunit a; specifically, T8851C which leads to substitution of tryptophan 109 for arginine 
(De Meirleir et al., 1995).  Reminiscent of the NARP / MILS mutations, the T109A FBSN 
mutation does not disrupt assembly of the F1F0 complex (Kucharczyk et al., 2012).  Although 
the T109A mutation is thought to be distant from the a/c interface it appears to exert long range 
structural perturbations that partially occlude proton translocation through subunit a 
(Kucharczyk et al., 2012). 
 
ATP synthase has also been the focus of infectious disease research.  Tuberculosis is 
one of the leading causes of death due to infection world-wide.  Recently, ATP synthase has 
been targeted in the design of novel antimycobacterial compounds called diarylquinolines 
(Andries et al., 2005).  Andries and co-authors demonstrated that Diarylquinoline – R207910 
exerts a potent antibiotic effect against a variety of drug resistant M. tuberculosis strains.  This 
compound was found to function by blocking proton transport through the F0 channel of M. 
tuberculosis ATP synthase by binding to subunit c (Huitric et al., 2010; Petrella et al., 2006; 
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Segala et al., 2012).  Andries and co-authors also demonstrated that the Diarqunioline – 
R207910 does not have significant impact on the human form of ATP synthase and is tolerated 
well by patients.  Diarlyquniolines are currently in use to fight tuberculosis infections (Andries 
et al., 2005). 
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3   Materials and Methods. 
3.1   Design of a model protein for structure studies. 
Our goal was to generate a stable, single peptide model of the a/c interface that was 
more amenable to structural studies than the complete F0 domain.  We designed two fusion 
protein constructs consisting of subunits a and c to achieve this goal.  The current model for 
subunit a places the C-terminus in the cytoplasm and the N-terminus in the periplasm 
(Valiyaveetil and Fillingame, 1998).  Both the ‘N’ and ‘C’ termini of subunit c are on the 
periplasmic side of the inner membrane of E. coli.  In the first fusion construct, the flexible 
connecting loop of subunit c’s TMH-II was fused to the C-terminus of subunit a (a-c/2 fusion).  
A second copy of the complete subunit c was fused to the C-terminal end of a-c/2 in a head-to-
tail fashion (Figure 3.1).  This protein fusion construct will be referred to as ‘a-c/2-c’ and is 
expected to have correct membrane topology.  The second fusion construct was prepared by 
fusing the N-terminus of subunit c to the C-terminus of subunit a with a flexible linker.  This 
construct does not have the additional connecting helix (c/2) present in the first construct.  
According to the current model of subunit a, the second construct, called ‘a-c’, should have 
incorrect membrane topology.  The a-c construct was made as a measure of completeness.  If 
the C-terminus of subunit a is on the periplasmic side of the membrane, contrary to the current 
model, then the a-c fusion construct will be the one with correct transmembrane topology. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.  The a/c fusion constructs.  Subunits a and c are shown as well as both fusion 
proteins.  The a-c protein is shown at the top right and the a-c/2-c protein is shown on the 
bottom right.  The cytoplasmic side of the membrane is on top and the periplasmic side is on 
the bottom.  (H6) represents the hexahistidine tag. 
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3.2  Plasmids and strains. 
3.2.1  Description of bacterial strains used in cloning and expression. 
C43(DE3) 
C41(DE3) was derived from BL21(DE3) [E. coli F- ompT hsdSB (rB- mB-) gal dcm 
(DE3)] and contains an uncharacterized mutation or mutations that make the cells tolerant of 
overexpression of transmembrane proteins (Miroux and Walker, 1996).  C43(DE3) was derived 
from C41(DE3) cells that grew robustly during expression of highly toxic membrane proteins 
(Miroux and Walker, 1996).  C43(DE3) is commercially available (Invitrogen, Burlington ON). 
 
OM202 
 The E. coli OM202 strain has a chromosomal deletion of the entire atp operon 
(Dmitriev, 2004a).  This strain was a gift from Robert Fillingame and is not commercially 
available. 
 
TOP10 
E. coli TOP10 cells are ideal for cloning and plasmid amplification because they are 
capable of highly efficient and stable replication of plasmid DNA.  The genotype of TOP10 is: 
F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara leu) 7697 
galU galK rpsL (StrR) endA1 nupG.  TOP10 E. coli are commercially available (Invitrogen, 
Burlington ON).  TOP10 can also be used to express protein from the pBAD102 TOPO 
directional vector system. 
 
DH5α 
The DH5α strain is commercially available (Invitrogen, Burlington ON) and is ideal for 
cloning and storage of plasmids because of its ability to take up and retain plasmid DNA.  
DH5a cells have the genotype: F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 endA1 
hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 gyrA96 relA1. 
  
3.2.2  Generation of Recombinase-A deficient variants of OM202 and C43(DE3) E. coli. 
OM202recA and C43recA strains were generated by P1 phage transduction, as 
previously described by Miller (Miller, 1972).  E. coli BLR(DE3) was used as a donor strain for 
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deficient Recombinase-A (recA, recominase-A gene; RecA, recombinase-A protein).  E. coli 
OM202 and C43(DE3) were the recipient strains.  BLR(DE3) is convenient for recA 
transduction because of the close proximity of a tetracycline resistance selectable marker to the 
recA gene, (recA)::Tn10(tetR), on the chromosome.  Primary screens for Tn10 transductants 
were conducted on Luria broth (LB) plates containing 120 µg/mL tetracycline.  Secondary 
screening for the recA deficient phenotype was done by ultraviolet (UV) irradiation at 254 nm.  
A single colony of each potential transductant was used to inoculate 5 ml of LB containing 120 
µg/mL tetracycline.  The cultures were grown at 37 0C, with shaking at 220 r.p.m., to an optical 
density (OD) of 0.3.  A 10 µl droplet of cell culture from each potential transductant was 
spotted on a series of LB-tetracycline plates and subjected to UV radiation with variable UV 
doses up to 0.04 J/cm2.  Cell growth was assessed following 16 hours of incubation at 37 oC in 
complete darkness.  Clones killed by a 0.02 J/cm2 dose were selected as recA deficient. 
 
3.2.3  Plasmids for expression of subunit a and the a/c constructs. 
All plasmids were isolated from liquid E. coli cultures using miniprep spin kits (Qiagen, 
Mississauga, ON).  A summary of the primers used in all cloning projects can be found in Table 
3.1.  A summary of the plasmids generated for overexpression and purification of wild type 
subunit a and the a/c fuion proteins can be found in Table 3.2.  The complete DNA sequence of 
the native E. coli atp operon can be found at http://www.ncbi.nlm.nih.gov/nuccore/j01594.1 
(accession number J01594.1).  A summary of the atp operon nomenclature is presented in 
Table 3.3.  All plasmids generated were verified by sequencing analysis.  All sequencing 
analysis was conducted at the DNA sequencing and Gene Synthesis laboratory at the Plant 
Biotechnology Institute (National Research Council).  Sequencing data was processed using the 
DNASTAR Lasergene 8 – SeqMan Pro software package. 
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Table 3.1: List of primers used in cloning. 
Primer Name Sequence 
B966FNheI 5’ - TGGCGTCTGAAGAACATTAAGCTAGCAACACTAC - 3’ 
BSR320 5’ - AAAACCAGGAACAACAGACCCAGCACCACC - 3’ 
ESR1285 5’ - AGCAACGCTTACTACGCGACAGC - 3’ 
HP_ara_EcoRI_R 5’ - GGTGTTCCATGAATTCGTATATCTCCTTCTTAAAG - 3’ 
HP_ara_SacI_F 5’ - CGTAGTAAGAGCTCCTTAAACGGTCTCCAGC - 3’ 
HP_cG23Dr 5’ - ACCGATCGCAGCATCGATTG - 3’ 
HP_cL31Fr 5’ - GAATTTACCCCCGAAGATGCCGAT - 3’ 
HP_F0_EcoRI_F 5’ - CAGCTTATCAGAATTCAAGCTTTCAAAGTTC - 3’ 
HP_F0_SacI_R 5’ - TCAGCCCCTGAGCTCTTACAGTTCAG - 3’ 
HP_L31F_a2cR 5’ - CGGCATCTTCGGGGGTAAATTCC - 3’ 
HP_Nhe957 5’ - CTGAAGAACATTAAGCTAGCAACACTAC - 3’ 
HP_NheI_a2cR 5’ - ATAAAAGGCTAGCTTACTACGCGACA - 3’ 
HP_NheI_BROD6 5' - GGGTAAAAGCTAGCATGCATCACCATCAC - 3' 
HP_pBAD_NheIR 5’ - GGTGTTCCATGCTAGCGTATATCTCCTTC - 3’ 
HP_pBAD_PmeIF 5’ - CGTAGTAAGTTTAAACTAAACGGTCTCCAGC - 3’ 
HP_PflMI224 5’ - CGTACATTCTCGCTGGTGGA - 3’ 
HP_PmeI_BROD6 5’ - CAGCCCGTTTAAACTTACAGTTCAGC - 3’ 
HP_Sph2547 5’ - CCATAACAACCGCACCTACAGAGTCGCGCTC - 3’ 
HPBA_RL1 5’ - TTGACGCGCTGCGCCTCCAGCTGATCCGGTACCATGTTCT 
      TCA - 3’ 
HPBA_RL3 5’ - TTGACGCGCTGCGCCAGCATTTCCTGAAGCTGAA 
       GCCGTTCCAGCTGATCCGGTACCATGTTCTTCA - 3’ 
pBADBFNcoI 5’ - GGTAAAAGGCACCATGGGACACCATCACC - 3’ 
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Table 3.2:  Summary of the plasmids generated for expression and purification. 
Plasmid Name Target expression 
product 
Description 
pBWU13 a Encodes the native atp operon 
 pBWU13 derivative plasmids   
pBROD2 a-c Encodes atp I, a-c, E, F, H 
pBROD4 a-c/2-c Encodes atp I, a-c/2-c, E, F, H 
pHP2 a-c Encodes the entire atp operon, except native atpE 
and atpB, which were replaced by the a-c gene. 
pBROD6 a-c/2-c Encodes the entire atp operon, except native atpE 
or atpB, which were replaced by a-c/2-c gene. 
pHP7 a-c Encodes the entire atp operon except native atpB 
which was replaced by a-c gene. 
pHP808 a-c/2-c Encodes the entire atp operon except native atpB 
replaced by a-c/2-c. 
pHP9 a Same as pBWU13 except atpE encodes the G23D 
point mutation. 
pHP10 a Same as pBWU13 except atpE encodes the L31F 
point mutation. 
pHP11 a-c Same as pHP7 except atpE encodes the G23D 
point mutation. 
pHP8012 a-c/2-c Same as pHP808 except atpE encodes the G23D 
point mutation. 
pHP13 a-c Same as pHP7 except atpE encodes the L31F 
point mutation. 
pHP8014 a-c/2-c Same as pHP808 except atpE encodes the L31F 
point mutation. 
pHP8015 a-c/2-c Same as pHP808 except the a-c/2-c fusion gene 
contains the L31F point mutation on cTMH-I. 
pHP8016 a-c/2-c Same as pHP808 except both the a-c/2-c fusion 
gene and native atp E contain the L31F mutation.  
pHPa210Q a Same as pBWU13 except that atpB contains 
R210Q mutation. 
pHPBA_1 a-c/2-c-linker-1 Same as pHP808 except that the GSAG sequence 
is inserted in the linker connecting subunits  
a and c.  
pHPBA_3 a-c/2-c-linker-3 Same as pHP808 except that the 
GSAGTASANSGA sequence is inserted in the 
linker connecting subuntis a and c.  
 pBAD derivative plasmids  
pHP805 a-c/2-c Encodes only the a-c/2-c fusion construct. 
pHP80-102 a-c/2-c Encodes the a-c/2-c and atpF. 
pHP8024 a-c/2-c Encodes atpI, a-c/2-c, atpE, and atpF. 
pHP8025 a Encodes atpI, atpB, atpE with the G23D mutation.   
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Table 3.3: The atp operon nomenclature. 
atp operon gene name Subunit expression product 
atpI I 
atpB a 
atpE c 
atpF b 
atpH δ 
atpA α 
atpG γ 
atpD β 
atpC ε 
 
 
Cloning the a-c constructs into the atp operon. 
 The pBWU13 plasmid is derived from pBR322 and encodes the entire wild type atp 
operon.  The atpB gene in pBWU13 was modified to insert a hexa-histidine tag (His6) at the N-
terminus of subunit a.  The a/c and a-c/2-c fusion genes with the His6-tag sequence were  
constructed previously (Rempel & Dmitriev, unpublished data) and cloned into pBWU13 
derivatives pBROD2 and pBPROD4 respectively.  The fusion genes were then cloned into the 
full atp operon in two different contexts.  In one case, both the genes encoding subunits a and c 
(atpB and atpE) were replaced with the fusion constructs.  In the second case the gene encoding 
subunit a (atpB) was replaced with the genes encoding the fusion proteins. 
 
  To replace the atpB and atpE genes with the a-c gene fusion, pBWU13 and pBROD2 
were restricted with HindIII and SphI.  The resultant fragments from pBWU13 were an 8408 
base pair vector fragment and a 2352 base pair fragment containing atpI’, atpB (subunit a), 
atpE (subunit c), and atpF (subunit b).  The fragments obtained from pBROD2 were a 3932 
base pair vector fragment and a 2334 base pair fragment containing atpI’, the gene encoding the 
a-c construct and atpF.  The 8408 base pair fragment from pBWU13 and the 2334 base pair 
fragment from pBROD2 were gel purified and ligated to produce the pHP2 plasmid.  pBROD6 
encodes the a-c/2-c construct in the context of the full atp operon, in the absence of native c, 
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a-c   b 
pBROD2 
HindIII 
SphI 
a-c/2-c  
 b 
β 
pBROD6 
HindIII 
SphI 
ε 
a-c   b 
β 
pHP2 
HindIII 
SphI 
ε 
a   
γ 
β pBWU13 
HindIII SphI 
c 
(atpB) (atpE) (atpB-E)
 (atpF) 
(atpB-E/
2-E) (atpF) (atpB-E)
 (atpF) 
and was constructed previously in a similar fashion to pHP2 (Rempel and Dmitriev, 
unpublished data).  See Figure 3.2 for plasmid maps of pBWU13, pBROD2, pBROD6 and 
pHP2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Plasmid diagrams of pBWU13, pBROD2, pHP2 and pBROD6.  The gene 
encoding wild type subunit a is shown in blue.  The genes encoding a-c and a-c/2-c are shown 
in purple and green respectively.  The positions of the other atp operon expression products are 
indicated on each plasmid as well as the positions of the HindIII and SphI restriction sites. 
 
 
 The gene encoding subunit a (atpB) was replaced with the genes encoding the fusion 
proteins using the pHP3 and pHP4 vectors.  pHP3 and pHP4 are pEXP1-DEST derivative 
vectors, designed for cell free synthesis, which encode the a-c/2-c and a-c constructs 
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respectively.  pHP3 and pHP4 both contain an NheI site immediately 3’ of the stop codon for 
each construct.  Both pHP3 and pHP4 were digested with PflMI and NheI.  The resulting 1150 
base pair fragment of pHP3 and the 960 base pair fragment of pHP4 encoded the a-c/2-c and a-
c fusion protein respectively.  To generate a pBWU13 vector fragment lacking the atpB gene, 
pBWU13 was amplified by around-the-plasmid PCR (Figure 3.3).  The reverse primer BSR320 
was designed to anneal downstream of the PflMI site within the atpB gene and the forward 
primer B966FNheI was designed to introduce an NheI site immediately 3’ of the atpE gene.  
PCR was conducted using Phusion DNA polymerase (Thermo Scientific – Finnzymes, 
Lafayette, CO).  The 10,700 base pair PCR product was restricted with PflMI and NheI and gel 
purified.  The 960 base pair fragment from pHP4 and the 1150 base pair fragment of pHP3 
were individually ligated with the 10,700 base pair PCR fragment to generate pHP7* and 
pHP808* respectively.  pHP7* and pHP808* were used to transform OM202recA E. coli cells.  
Several transformants were isolated and the pHP7* and pHP808* plasmid identity was verified 
by control restriction analysis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3:  PCR strategy for the amplification of the pBWU13 vector fragment lacking 
atpE (subunit c).  The positions of primers BSR320 (reverse) and B966FNheI (forward) are 
indicated with black arrows.  The NheI restriction site was introduced by primer B966FNheI, 
the site directed mutagenesis is indicated with a red ‘x’.  The positions of PflMI and NheI are 
shown. 
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Once clones with the correct restriction pattern were identified, the fragment containing  
atpI’ the a/c fusion gene, atpE and atpF were recloned from pHP7* and pHP808* into the 
original pBWU13 vector to eliminate possible errors introduced by PCR.  Single clones of 
pHP7*, pHP808*, and pBWU13 were digested with HindIII and SphI.  Digestion of pHP7* 
resulted a 2641 base pair fragment and an 8410 base pair fragment.  Digestion of pHP808* 
resulted in a 2773 base pair fragment and an 8410 base pair fragment.  Digestion of pBWU13 
resulted in a 2360 base pair fragment and an 8410 base pair fragment.  The 2641 base pair 
fragment of pHP7* and the 2773 base pair fragment of pHP808* were ligated into the 8410 
base pair vector fragment of pBWU13 to generate pHP7 and pHP808 respectively (Figure 3.4). 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 3.4:  Plasmid maps of pHP7 and pHP808.  pHP7 is shown on the left and pHP808 is 
shown on the right.  The a-c construct is in purple and the a-c/2-c is in green.  The relative 
positions of the other atp operon genes are shown.  The approximate locations of the HindIII 
and SphI restriction sites are indicated. 
 
 
Cloning and plasmid construction of the c10 assembly mutants.  
 The G23D and L31F mutations in subunit c prevent formation of the c10 ring within the 
membrane.  These mutations were introduced into atpE using the mega-primer method (Ke and 
Madison, 1997) with pBWU13 as the template (Table 3.4 and Figure 3.5).  The resulting PCR 
fragments containing cG23D and cL31F mutations were digested with NheI and SphI and 
purified.  pHP7 and pHP808 were digested with NheI and SphI and the vector fragment was 
purified.  The digested PCR products containing the subunit c mutants were ligated into the 
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pHP7 and pHP808 vector fragments to generate a set of vectors that encode each a/c construct 
in the presence of the c10 assembly mutations (Figure 3.6).  The pHP7 (a-c) derivative plasmids 
containing cG23D and cL31F were named pHP11 and pHP13 respectively.  The pHP808 (a-
c/2-c) derivative plasmids containing cG23D and cL31F mutations were named pHP8012 and 
pHP8014. 
 
Table 3.4: Primers used in generating the c10 assembly mutants.  Primer sequences are 
listed in Table 3.1. 
Final plasmid Primer #  
(Figure 3.5) 
Primer name 
pHP9 & pHP10 1 HP_PflMI224 
2 HP_cG23Dr (for pHP9)  
or HP_cL31Fr (for pHP10) 
3 HP_Sph2547 
pHP11 & pHP8012 1 HP_Nhe957 
2 HP_cG23Dr  
3 HP_Sph2574 
pHP8013 & pHP8014 1 HP_Nhe957 
2 HP_cL31Fr 
3 HP_Sph2547 
 
 
 
 
 
 
 
Figure 3.5:  General cloning strategy for introducing the c10 assembly mutations into 
pHP7 and pHP808.  Primer 1 was designed to introduce and NheI site immediately 3’ of the 
gene encoding subunit a on pBWU13.  Primer 2 was designed to introduce the GAU or UUC 
codons that encode the cG23D and cL31F mutations respectively.  Primers 1 and 2 amplified 
the region between subunit a and the c10 assembly mutations.  The resultant PCR products were 
used as mega-primers.  Primer 3 and the mega-primers amplified the region between the NheI 
site and SphI site of pBWU13. 
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Figure 3.6:  Plasmid maps of pHP7, pHP808, and their c10 assembly mutant derivatives.  
The gene encoding the a-c construct is shown in purple and the gene encoding the a-c/2-c 
construct is shown in green.  The approximate positions of the c10 assembly mutations are 
indicated with red arrows.  The relative positions of the other atp operon subunits are indicated.  
The NheI and SphI sites are also shown. 
 
 
A similar strategy was used to generate plasmids pHP9 and pHP10, which express wild 
type subunit a in the presence of cG23D and cL31F respectively, in the context of the full atp 
operon. 
 
Introducing the cL31F mutation into the a-c/2-c  fusion gene. 
The cL31F mutation was introduced into the fused c subunit of a-c/2-c by mega primer 
PCR (primers: HP_L31F_a2cF & HP_NheI_a2cR), using pBROD6 as a template.  The mega 
primer PCR product spanned the region from the cL31F mutation site to approximately 20 bp 
downstream of the a-c/2-c stop codon including an NheI restriction site.  The mega primer was 
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used in conjunction with a third primer (PlfMI224) that annealed over the PflMI site near the 3’ 
end of the a-c/2-c gene.  The resultant PCR product encoded the a-c/2-c fusion construct with 
the L31F mutation in the fused c subunit.  The PCR fragment as well as pHP808 and pHP8014 
were digested with PflMI and NheI.  The PCR fragment was ligated into both pHP808 and 
pHP8014 vector fragments to produce pHP8015 and pHP8016 respectively (Figure 3.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7:  Plasmid maps of pHP8015 and pHP8016.  The gene encoding the a-c/2-c 
fusion construct is shown in green.  The positions of the cL31F point mutations are indicated 
with red arrows.  The relative positions of the PflMI and NheI sites are shown. 
 
 
Cloning the R210Q mutation into subunit a of pBWU13 
The pVF2R210Q plasmid, which encodes the entire ATP operon with R210Q mutation 
in subunit a and is closely related to pBWU13 (Ishmukhametov et al., 2008), was provided to 
us by Dr. Steven Vik (South Methodist University, Dallas, TX).  pVF2R210Q and pBWU13 
were digested with PflMI and PpuMI (Figure 3.8).  The aR210Q fragment of pVF2R210Q and 
the vector fragment of pBWU13 were gel purified and ligated to produce pHP20Q, which is 
identical to pBWU13, except for the aR210Q mutation. 
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Figure 3.8:  Plasmid map of pBWU13.  The gene encoding subunit a is shown in blue.  The 
other subunits of the atp operon are shown.  Relative positions of the PflMI and PpuMI 
restriction sites used for cloning the R210Q mutation are indicated. 
 
 
Introducing the spacers into a-c/2-c 
Two linkers were designed to extend the loop between the fused a and c/2-c subunits; 
GSAG (linker 1) and GSAGTASANSGA (linker 2).  DNA sequences encoding linkers 1 and 2 
were introduced into the a-c/2-c fusion construct using the mega-primer method (Ke and 
Madison, 1997) with pHP808 as the template (Figure 3.9 and Table 3.5).  The resultant PCR 
fragments containing the a-c/2-c fusion construct with the extended linkers and pHP808 were 
digested with PflMI and SphI.  Following gel purification, the digested PCR products were 
ligated into the pHP808 vector fragment to generate plasmids pHPBA_1 and pHPBA_3, which 
encode the a-c/2-c-linker-1 and a-c/2-c-linker-2 proteins respectively.  The pHPBA_1 and 
pHPBA_3 plasmid sequences were transformed into OM202recA E. coli cells. 
 
 
 
 
	   	  68 
 
 
 
 
 
           
Figure 3.9: The megaprimer cloning strategy used to incorporate the linker extensions 
into a-c/2-c.  Primer #1 annealed over the PflMI restriction site.  Primer # 2 was designed to 
encode each linker sequence.  Primers 1 and 2 amplified the region between the PflMI site and 
the linkers.  The resultant PCR products were used as a mega primers.  Primer 3 and the mega 
primers amplified the region between SphI and PflMI sites of pHP808. 
 
 
Table 3.5:  Primers used in cloning pHPBA1 and pHPBA3.  Primer sequences are listed in 
Table 3.1. 
Final plasmid Primer #  (Fig 3.9) Primer name 
pHPBA1 1 HP_PflMI224 
2 HPBA_RL1 
3 HP_Sph2547 
pHPBA3 1 HP_PflMI224 
2 HPBA_RL3 
3 HP_Sph2547 
 
 
Cloning the a-c/2-c fusion construct into pBAD-102  
The a-c/2-c fusion protein was cloned into pBAD102, which contains an arabinose 
inducble promoter.  pOD1016 is a pBAD102 derivative vector that expresses the multi-drug 
transport protein Mdfa (Dmitriev, unpublished data).  The gene for Mdfa is flanked by two 
restriction sites; NcoI lies immediately 5’ of the start codon and PmeI lies immediately 3’ of the 
stop codon.  pOD1016 was digested with NcoI and PmeI and the pBAD102 vector fragment 
was isolated.  The gene encoding the a-c/2-c fusion protein was amplified from pBROD6 by 
PCR.  The primers used to amplify the a-c/2-c fusion construct were designed to introduce an 
NcoI restriction site immediately 5’ of the a-c/2-c start codon (pBADBFNcoI) and a PmeI site 
immediately 3’ of the stop codon (ESR1285).  The resultant PCR fragment was digested with 
	   	  69 
Mdfa 
N
co
I 
Pm
eI
 
 pOD1016 
a-c/2-c 
N
co
I 
Pm
eI
 
 pHP8024 
300 bp 900 bp N
co
I 
pHP805 
x 
NcoI and PmeI.  The gene for a-c/2-c contains an NcoI site, therefore, two fragments 
approximately 300 base pair and 900 base pair in length were obtained.  The 900 base pair 
fragment was ligated into the pBAD102 vector fragment to yield plasmid pHP805*, which was 
transformed into TOP10 E. coli cells.  pHP805* was digested with NcoI and then ligated with 
the 300 base pair fragment of the a-c/2-c gene.  The resulting plasmid was named pHP805 
(Figure 3.10). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10:  Plasmid maps of pOD1016 and pHP805.  The positions of the PmeI and NcoI 
restriction sites are shown.  The a-c/2-c fusion construct is shown in green and the position of 
the internal NcoI site is indicated with a red ‘x’.  The 300 and 900 base pair fragments from 
digestion of the a-c/2-c PCR fragment are labeled. 
 
 
Cloning the a-c/2-c fusion construct and atpF into pBAD-102. 
 The a-c/2-c fusion protein, along with the gene encoding subunit b, were cloned into 
pBAD102.  PCR was used to amplify the pBAD102 vector fragment from ODM1016.  The 
primers used to amplify the pBAD102 vector were designed to introduce an NheI site at the 5’ 
end of the multiple cloning site (HP_pBAD_NheIR) and a PmeI site (HP_pBAD_PmeIF) at the 
3’ end of the multiple cloning site.  In pBROD6, the a-c/2-c fusion construct is followed by a 
noncoding sequence from the atp operon, and then by the atpF gene.  This fragment was 
amplified by PCR using primers designed to introduce an NheI site immediately 5’ of the a-c/2-
c start codon (HP_PmeI_BROD6) and a PmeI site immediately 3’ of the atp F stop codon 
(HP_NheI_BROD6).  The PCR product and the pBAD102 vector fragment were digested with 
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NheI and PmeI, gel purified, and ligated.  The resulting plasmid, pHP80-102, was transformed 
into TOP10 E. coli cells (Figure 3.11). 
   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Plasmid map of pHP80-102.  The positions of the PmeI and NheI restriction sites 
are shown.  The gene encoding the a-c/2-c fusion construct is shown in green and the gene 
encoding subunit b is shown in light blue. 
 
 
Cloning atpI’ and the F0 genes into pBAD-102 
 The pBAD102 vector fragment was amplified by PCR, using primers to introduce an 
EcoRI site 5’ of the multiple cloning site (HP_ara_EcoRI_R) and a SacI site 3’ of the multiple 
cloning site (HP_ara_SacI_F).  The pBWU13 vector encodes a truncated version of the atpI 
gene, which is denoted as atpI’.  The atpI’ gene, and the genes encoding the a-c/2-c construct, 
subunit c, and subunit b, were amplified from pHP808 by PCR.  The primers were designed to 
introduce an EcoRI site immediately 5’ of atpI’ (HP_F0_EcoRI_F) and a SacI site immediately 
3’ of the atpF stop codon (HP_F0_SacI_R).  The 4024 base pair vector fragment and 2240 base 
pair fragment encoding the F0 genes were restricted with EcoRI and SacI, gel purified, and 
ligated.  The resultant plasmid, pHP8024, was used to transform TOP10 E. coli cells.  A similar 
procedure was used to clone the F0-encoding fragment of the atp operon with native atpB 
(subunit a) into pBAD.  The cG23D point mutation disrupts formation of the c-ring in the 
membrane.  pHP9 encodes the entire wild type atp operon, except atpE contains the cG23D 
mutation.  We amplified the F0 genes from pHP9 by PCR, digested the resultant fragment with 
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EcoRI and SacI, gel purified the restricted fragment, and ligated the fragment with the 4024 
base pair pBAD-102 vector fragment.  The pBAD-102 derivative plasmid encoding the genes 
for atpI’, native subunit a, subunit c with the G23D mutation, and subunit b was named 
pHP8025 (Figure 3.12). 
 
 
 
 
 
 
 
 
 
Figure 3.12:  Plasmid maps of pHP8024 and pHP8025.  The a-c/2-c gene is shown in green 
and native subunit a is shown in bright blue.  The relative positions of the F0 genes are shown.  
The positions of the EcoRI and SacI sites are indicated. 
 
 
3.3  E. coli culture growth and protein expression. 
Strains expressing wild type subunit a and the a/c constructs from vectors derived from 
pBWU13 were grown on M9 minimal media (40 mM Na2HPO4*7H2O, 22 mM KH2PO4, 8 mM 
NaCl, 18 mM NH4Cl, 2 mM MgSO4, 0.4 % glucose, 0.1 mM CaCl2) in the presence of 200 
µg/ml ampicillin.  Cells were grown at 37 0C, with shaking at 220 r.p.m., to late exponential 
phase and harvested by centrifugation at 6,000 x g for 15 minutes.  Raw cell samples for SDS-
PAGE were prepared in SDS sample buffer and incubated at 37 oC for 15 minutes.  SDS-PAGE 
was carried out using 10 % polyacrylamide gels (Schagger and von Jagow, 1987).  Expression 
was examined by Western blot analysis of whole cell samples. 
 
Expression experiments with pBAD derivative vectors were conducted essentially as 
described in the pBAD-102 manual from Invitrogen (pBAD TOPO Expression Kit Manual, 
2010).  TOP10 cells containing either pHP805 or pHP80-102 were induced with a range of 
arabinose concentrations from 0.00002 % to 0.2 %.  OM202recA cells containing pHP805, 
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pHP80-102, pHP8024, and pHP8025 were induced with a range of arabinose concentrations 
from 0.002 % to 0.8 %.  Cells were grown for 4 hours at 37 oC with shaking at 220 r.p.m. after 
the addition of arabinose.  Samples for SDS-PAGE and Western blot analysis were prepared as 
described in the preceding paragraph. 
 
3.4  Purification of subunit a and the a-c/2-c fusion protein from isolated F0 complex. 
C43(DE3) and C43recA E. coli cells expressing subunit a or the a-c/2-c fusion protein 
respectively were grown as described in section 3.3.   Membrane vesicle preparation for protein 
purification was done essentially as described by (Mosher et al., 1985).  The membranes were 
stripped of F1 with EDTA.  F0 was then extracted from the membrane with 
octylglucopyranoside and sodium cholate, and enriched by ammonium sulfate precipitation, 
essentially as described by Schneider and Altendorf (Schneider and Altendorf, 1984).  To 
dissociate F0-complex into individual subunits, isolated F0 was diluted to a final concentration 
of ~ 1 mg/mL in dissociation buffer (10 mM tris(hydroxymethyl)aminomethane (Tris) -HCl, 
pH 8.0, 1 mM EDTA, 1 mM dithiothreitol (DTT), 3 M LiBr, 1 % (w/v) deoxycholate, and 5 % 
Zwittergent 3-14) and incubated at room temperature for 20 hours with light stirring. 
 
 Dissociated F0 samples were subjected to nickel-nitrilotriacetic acid (Ni-NTA) affinity 
chromatography.  A column loaded with 3 ml Ni-NTA agarose was prewashed with ten bed 
volumes of equilibration buffer (10 mM Tris-HCl, pH 8.0, 1 mM DTT, 3 M LiBr, and 2 % 
sodium cholate).  The dissociated F0 samples were loaded onto the Ni-NTA column and 
allowed to flow through the resin at a rate of approximately 0.2 ml/min.  The column was 
sequentially washed with 5 bed volumes of equilibration buffer, 5 bed volumes of equilibration 
buffer containing 20 mM imidazole, and 10 bed volumes of LMPG-0 buffer (10 mM Tris, pH 
8.0, 1 mM DTT, and 0.01 % 1-myristoyl-2-hydroxy-sn-glycero-3-[phosphor-rac -(1-glycerol)] 
(LMPG)).  Stepwise elution was carried out in three stages: 2 bed volumes of LMPG-0 buffer 
containing 50 mM imidazole, 2 bed volumes of LMPG-0 buffer containing 100 mM imidazole, 
and 2 bed volumes of LMPG-0 buffer containing 250 mM imidazole.  Three milliliter fractions 
were collected and analyzed by SDS-PAGE.  In protein purifications intended for NMR 
experiments 10 mM KH2PO4 was substituted for 10 mM Tris in the LMPG-0 buffer. 
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 Vivaspin-20 centrifugal membrane concentration devices were used to concentrate 
purified subunit a and a-c/2-c.  All washes and treatments were carried out for 3 minutes at 
4,000 x g.  The Vivaspin devices were washed with 5 ml ddH2O to remove traces of azide.  The 
membrane was then washed with equilibration buffer (10 mM Tris, pH 8.0, 1 mM DTT, and 
0.01 % LMPG.  The membrane was treated with equilibration buffer containing 1 mg/mL 
bovine serum albumin (BSA), which was removed by decanting.  The membrane was then 
washed twice with equilibration buffer to remove residual BSA. 
 
 Fractions containing subunit a or a-c/2-c were pooled and concentrated to a final 
concentration between 5 – 12 mg/ml using the pre-treated Vivaspin concentration devices.  
Purified and concentrated protein was transferred into either NMR buffer (10 mM KH2PO4, pH 
6.0, 0.01 % LMPG), or crystallization buffer (15 mM 2-(N-morpholino)ethanseulfonic acid 
(MES) buffer, pH 6.0, 0.01% LMPG), and stored at 4 oC. 
 
3.5  Purification of subunit a and the a-c/2-c fusion protein from intact F1F0. 
Intact ATP synthase was isolated using a modified version of the protocol developed by 
Laubinger and Dimroth (Haji and Dmitriev, unpublished data; Laubinger and Dimroth, 1988). 
Membrane vesicles were isolated as described in section 3.4.  Membranes were suspended in 50 
mM 4-morpholinepropanesulfonic acid (MOPS) - KOH, pH 7.0, at 5 mg/mL total membrane 
protein.  ATP synthase was solubilized from the membranes by mixing with a final 
concentration of 0.2 % 1,2-diheptanoyl-sn-glycero-3-phosphocholine (DHPC) at room 
temperature for 30 minutes.  Soluble protein was isolated by ultracentrifugation at 200,000 x g 
for 30 minutes.  Final concentrations of 50 mM MgCl2 and 2 % polyethylene glycol (PEG) 
6000 were added to the protein solution and mixed for 20 minutes at room temperature.  The 
solution was subjected to centrifugation at 39,000 x g for 15 minutes.  The ATP synthase was 
precipitated from the supernatant with a final concentration of 10 % PEG-6000.  Precipitated 
ATP synthase was isolated by centrifugation at 39,000 x g for 20 minutes.  The protein pellet 
was resuspended in F1F0-Buffer (10 mM Tris-HCl, pH 8.0, 5 mM MgCl2, 1 mM DTT, 1 mM 
phenylmethylsulfonyl fluoride (PMSF) and 0.2 % DHPC).  Insoluble material was removed by 
centrifugation at 39,000 x g for 15 minutes.  Purified ATP synthase was stored under liquid 
nitrogen.  A flow diagram of the complete purification procedure is shown in Figure 3.13. 
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Figure 3.13:  Flow diagram of the F1F0 ATP synthase isolation procedure.  The major 
stages of purification are numbered 1 through 4.  Green boxes indicate experimental steps 
where ATP synthase is present.  Grey boxes indicate experimental steps where ATP synthase is 
not present. 
 
 
Isolated F1F0 was diluted to a final concentration of  1 – 3 mg/ml in dissociation buffer 
(10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 1 mM DTT, 3 M LiBr, 1 % (w/v) deoxycholate, and 5 
% Zwittergent 3-14) and incubated at room temperature for twenty hours.  The Ni-NTA 
purification was conducted essentially as described in section 3.4.  Ni-NTA fractions containing 
subunit a were pooled and exchanged into LMPG-0 buffer using the BSA pre-treated 
concentration devices.  The samples were concentrated to ~ 20 % of their original volume and 
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then diluted to their original volume in LMPG-0 buffer.  The concentration / dilution procedure 
was carried out three times to reduce the imidazole concentration to trace amounts.  After the 
final concentration step, the protein solution was mixed 1 : 10 in R2-Disociation buffer (10 mM 
Tris-HCl, pH 8.0, 1 mM DTT, 3 M LiBr and 0.01 % LMPG).  After dissociation, the samples 
were subjected to a second round of Ni-NTA chromatography as described in the previous 
paragraph, except, 0.01 % LMPG was substituted for sodium cholate in all cases. 
 
3.6   Size exclusion chromatography 
 Purified subunit a was subjected to size exclusion chromatography using the Superdex-
200 GL 10/300 (GE Healthcare, Baie d’Urfe, QC) column.  The column was pre-equilibrated 
with GF buffer (15 mM MES, pH 6.0, 150 mM NaCl, and 0.01% LMPG).  Purified subunit a 
was loaded onto the column and eluted in one bed volume of GF buffer at a rate of 0.4 mL / 
minute. 
 
3.7   Isolation of F1 from cellular membranes. 
Membranes were prepared as described in section 3.4.  A 5.7 µg sample of membranes 
from each strain was incubated in F1 Stripping buffer (1 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 
10 % v/v glycerol) at a ratio of 210 µl per 1 µg total membrane protein for 2 hours at room 
temperature.  The membranes were separated from soluble detached F1 by centrifugation at 
150,000 x g for one hour at room temperature.  F1 samples were kept at room temperature. 
 
3.8   Detergent exchange. 
Purified subunit a was exchanged into various detergents using Ni-NTA 
chromatography.  Subunit a was bound to Ni-NTA agarose pre-equilibrated with NMR buffer 
as described in section 3.4 and the column was washed with 10 bed volumes of exchange buffer 
(10 mM KH2PO4 pH 8.0, 1 mM DTT), supplemented with a detergent of choice.  Subunit a was 
then eluted from the Ni-NTA column with exchange buffer containing 250 mM imidazole.  
Eluted protein was pooled and buffer exchanged to remove imidazole and adjust the pH to 6.0, 
using pre-treated Vivispin-6 centrifugal concentration devices as described in section 3.4.  The 
samples were concentrated to a volume of approximately 400 µl for NMR studies. 
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3.9   NMR experiments. 
Unless otherwise stated, 1H, 15N-HSQC experiments were carried out at 600 or 750 
MHz at 310 or 315K.  There were 128 increments in t1 with 16 scans per increment. 
 
3.10   Dynamic light scattering. 
Wild type subunit a was examined by dynamic light scattering (DLS) on the DynaPro- 
MS800 instrument at the Saskatchewan Structural Sciences Centre using the Dynamics™ 
version 5.26.60 software package.  Protein samples for DLS were prepared in 50 mM KH2PO4 
pH 6.0 with 0.01 % LMPG and concentrated to approximately 7 mg/ml.  DLS experiments 
were carried out at 20 oC and 27 oC with instrument sensitivity set to maximum and scan 
number greater than 100. 
 
3.11  Crystallization trials. 
3.11.1  High throughput screening. 
Preliminary crystal screening for subunit a and the a-c/2-c construct was carried out at 
the High Throughput Crystallization Screening Facility at the Hauptman-Woodward Medical 
Research Institute (HWI-HTS) in Buffalo, New York.  Protein samples were concentrated to 5 - 
12 mg/mL in crystallization buffer (15 mM MES, pH 6.0 and 0.01 % LMPG).  Samples were 
subjected to the MSC4-1563 cocktail screen, also known as Membrane Protein Crystallization 
Screen Generation Four. 
 
3.11.2  Hanging drop vapor diffusion screens. 
Several refined screening conditions were tested in the presence of micelles or bicelles.  
The purification procedure described in section 3.4 produces subunit a suspended in micelles.  
Bicelles were prepared with water, 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), and 
3-([3-Cholamidopropyl]dimethylammonio)-2-hydroxy-1-propanesulfonate (CHAPSO) at a 
ratio of 6:3:1.  The water : DMPC : CHAPSO mixture was subjected to eight cycles of freezing 
in liquid nitrogen, heating to 55 oC, incubation on ice for 10 minutes, and vortexing.  To 
reconstitute subunit a into bicelles,  purified subunit a was mixed with bicelle solution at a ratio 
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4:1 and incubated on ice for 30 minutes.  Precipitant solution was added 1:1 to purified subunit 
a, suspended in either micelles or bicelles, and the droplets were suspended over 1 mL of well 
solution using ‘EasyXtal CrystalSupport’ trays (Qiagen, Valencia, California).  Table 3.6 lists 
the supplier and lot number of the various PEG types used in screening.  Most plates were set 
up in duplicate, one set was incubated at 21 oC and the other was incubated at 4 oC. 
 
 
Table 3.6: PEG parameters* for refined vapor diffusion screening conducted at the 
University of Saskatchewan. 
PEG type Supplier / (location) Lot number 
PEG 400 Fisher – Carbowax (Ottawa, ON, Canada) 121576 
PEG MME 550 Hampton Research (Aliso Viejo, CA, USA) 261180 
PEG 1500 Alfa Aesar (Ward Hill, MA, USA) 10161203 
PEG 2000 Alfa Aesar (Ward Hill, MA, USA) 10172606 
PEG 3350 J.T. Baker (Miami, FL, USA) Y19585 
PEG 4000 Alfa Aesar (Ward Hill, MA, USA) 10167045 
PEG 6000 Alfa Aesar (Ward Hill, MA, USA) 10156829 
PEG 8000 Fisher (Ottawa, ON, Canada) 110368 
*PEG quality varies greatly from brand to brand as well as between batches.  For 
reproducibility the PEG brand and lot number of each PEG molecular weight should be kept 
constant throughout crystal screening (Bergfors, 1999). 
 
 
3.11.3  Lipidic cubic phase screens. 
1-monooleoyl-rac-glycerol (monoolein) was melted at 45 oC and mixed with protein 
solution at a 2:3 (protein : monoolein) ratio.  The mixture was extruded through a 0.5 mm 
diameter syringe coupler and mixed until translucent.  The protein – monoolein mixture was 
loaded into a microdispenser syringe (Hamilton, Reno, NV).  Refined screens as well as 
standard screens were set up on LaminexTM Glass Base 200 micron plates (Molecular 
Dimensions, Suffolk, UK).  A single 0.2 µl dollop of protein – monoolein mixture was placed 
in the center of each well and overlaid with 1 µl of precipitant solution.  The plates were 
incubated at 20 oC. 
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3.12  Enzyme activity assays. 
3.12.1  Test for oxidative phosphorylation by cell growth on succinate. 
 A single colony of a given E. coli strain was streaked onto M63 minimal media agar 
plates containing 0.6 % succinate as the sole source of carbon.  Plates were incubated for 
approximately 24 hours at 37 oC.  Growth levels were examined and recorded. 
 
3.12.2  ATP dependent proton transport assay. 
ATP dependent proton transport was measured using 9-amino-6-chloro-2-
methoxyacridine (ACMA) fluorescence.  ACMA fluorescence was recorded at 490 nm with 
excitation at 410 nm.  Whole membrane vesicles containing 100 µg total protein were added to 
1 mL of ACMA quench buffer (20 mM Tricine-NaOH, pH 8.0, 10 mM MgCl2, 300 mM KCl).  
ACMA was added to the reaction mixture to a final concentration of 2 µM after base line 
fluorescence was recorded.  The reaction was initiated by addition of 0.2 mM ATP, pH 8.0. 
2µM Carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone (FCCP) was added to the 
reaction after approximately 3 minutes. 
 
When ACMA is added to the assay solution it freely diffuses across the membrane in its 
uncharged form.  When ATP is added to the reaction mixture, F1F0 hydrolyzes the ATP and 
actively pumps protons into the lumen of the vesicles, creating an acidic microenvironment.  
ACMA becomes protonated in the acidified vesicles and accumulates because it’s protonated 
form is positively charged and cannot cross the lipid bilayer.  A concentration dependent 
ACMA fluorescence quench is observed.  The proton gradient uncoupler FCCP shuttles protons 
out the lumen and dissipates the ΔpH; this is a control to show that the observed fluorescence 
quench is caused by the generation of a proton gradient (Figure 3.14). 
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9-Amino-6-chloro-2-methoxyacridine 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14:  The principle of the ATP driven proton translocation assay.  ATP synthase is 
shown in red and purple. The membrane vesicle is shown in blue.  The NH2 group of ACMA 
that becomes charged as a result of protonation is shown in blue.  The structure of ACMA is 
illustrated on the bottom left. 
 
3.12.3   Passive proton translocation assay. 
 Passive proton transport was measured similarly to the active transport assays described 
in section 3.12.2, except F1-stripped membrane vesicles were used instead of whole membrane 
vesicles, and NADH hydrolysis via NADH dehydrogenase was used to generate the proton 
gradient instead of ATP (Figure 3.15).  F1 was stripped from the membranes essentially as 
described in section 3.7, except the incubation in F1 stripping buffer was conducted for 16 hours 
at 4 oC.  The stripped membranes were resuspended in TMDG buffer (50 mM Tris-HCl, pH 
7.4, 5 mM MgCl2, 1 mM DTT, 10 % glycerol v/v, 1 mM PMSF), flash frozen using liquid 
nitrogen, and stored at -80 oC. 
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Figure 3.15:  The principle of the passive proton translocation assay.  The F0 domain of 
ATP synthase is shown in green and purple.  The membrane vesicle is shown in blue.  NADH 
dehydrogenase is shown in pink, green, and yellow.  A) The red arrows indicate the path of 
protons when F0 is intact and functional (left); the theoretical fluoresence trace is shown (right).  
B) The large red ‘X’ represents a blockage in the F0 pore which allows protons to accumulate 
inside the vesicle and facilitate ACMA quenching (left); the theoretical fluoresecnce trace is 
shown (right). 
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3.12.4   Assay for ATPase activity. 
Whole membrane vesicles, isolated F1, and F1-stripped membranes were assayed for 
ATPase activity by quantification of liberated inorganic phosphate over time.  Phosphate 
detection by malachite green was carried out essentially as described by (Ekman and Jager, 
1993).  Samples were suspended in TMDG buffer.  ATP was added to a final concentration of 2 
mM.  All assays were conducted at 37 oC. 
 
3.13   Other methods. 
3.13.1   Molecular Biology Methods. 
Plasmid preparation. 
 Single colonies were selected, used to inoculate 5 mL LB media containing antibiotic, 
and grown for 18 hours at 37 oC with shaking at 220 r.p.m.  Plasmids were isolated using Mini- 
Prep kits (Qiagen, Burlington, ON) and suspended in sterile water.  Plasmids were stored at      
– 20 oC. 
  
Restriction digestion. 
 All restriction exonucleases were supplied by New England Biolabs (NEB) (NEB, 
Ipswich, MA).  DNA restrictions were set up in 20 µl volumes with 0.5 – 2.0 µg of plasmid 
DNA, 5 U of each restriction enzyme, 2 µl of appropriate 10 x NEB reaction buffer, and 0. 1 µg 
BSA (if required).  Restriciton digestions were incubated at 37 oC for 30 minutes. 
 
Ligation reactions. 
 Ligation reactions were set up in 20 µl volumes.  Each reaction contained 50 ng vector 
DNA, 80 ng insert DNA, 2 µl of 10 x T4 DNA ligase buffer, and 400 U of T4 DNA ligase 
(NEB, Ipswich, MA).  Ligation mixtures were incubated for 18 hours at 16 oC. 
 
E. coli transformations. 
 Chemically competent E. coli cells were prepared using CaCl2, essentially as described 
by Dagert and Ehlrich (Dagert and Ehlrich, 1979).  Fifty microliters of competent cells were 
incubated with 0.3 µg plasmid DNA on ice, for 30 minutes.  The cells were then heat shocked 
for 45 seconds at 42 oC and re-equilibrated on ice for 10 minutes.   Equilibrated cells were 
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transferred into 1 mL of LB broth and incubated  at 37 oC for 1 hour with shaking at 220 r.p.m.  
After the 1 hour growth the cells were plated on LB agar containing antibiotic and incubated for 
18 hours at 37 oC. 	   	  
3.13.2   SDS-PAGE 
 SDS-PAGE was carried out essentially as described by Schagger & von Jagow 
(Schagger and von Jagow, 1987).  The stacking gel layer contained 3 % acrylamide and the 
separating gel contained 10 % acrylamide unless otherwise stated. 
 
3.13.3  Western blot analysis. 
Western blot analysis was carried out as previously described (Towbin et al., 1979).  
Protein was transferred to polyvinylidene fluoride (PVDF) membrane by electroblotting at 
either 0.4 or 0.9 Amp for 90 minutes.  To detect hexahistidine (His6) tagged proteins, Western 
blots were probed using the Qiagen monoclonal anti-pentahistidine horse radish peroxidase 
(HRP) conjugate antibody (1:10,000 dilution) (Qiagen, Mississauga, ON).  Western blots 
specific for subunit c were probed with a primary polyclonal rabbit anti-c antibody (1:60,000 
dilution in PBS with 0.1 % Tween-20 and 2 % BSA fraction-V) and with a secondary goat anti-
rabbit HRP conjugate antibody (1:10,000 dilution in PBS with 0.1 % Tween-20). 
 
3.13.4  Protein determination by the Lowry method. 
 Protein concentration determination was carried out as previously described (Lowry et 
al., 1951).  BSA standard curves ranging from 0.04 µg – 0.59 µg per sample were conducted 
with each assay. 
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4   Results. 
4.1  The a-c/2-c fusion protein is integrated into the membrane in the absence of native c.  
 We have generated two fusion proteins consisting of subunits a and c of E. coli ATP 
synthase (Section 3.1 contains a full description of the fusion constructs).  The transmembrane 
topology of subunit a has yet to be confirmed through high resolution structure determination; 
each fusion protein places subunit c in a different topology relative to subunit a to account for 
the two possible orientations of the carboxyl terminus of subunit a relative to the amino 
terminus of subunit c.  We asked two questions:  First, do the fusion proteins incorporate into 
the membrane?  Second, does membrane incorporation of the a/c fusion proteins require native 
subunit c? 
 
 Initially, expression experiments with both wild type subunit a and the a-c/2-c fusion 
protein were carried out using the E. coli OM202 parental strain.  RecA activity in the OM202 
parental strain caused damage pHP808 plasmid, and the resultant expression product was a 
truncated version of the a-c/2-c construct.  OM202recA was generated by P1 phage 
transduction to abolish RecA activity and allow expression of the full length a-c/2-c fusion 
protein (data not shown).  The a/c fusion proteins were expressed in two different backgrounds.  
In both cases the fusion proteins were expressed from pBWU13 derivative plasmids, which 
encode the entire atp operon.  However, in one case, the genes for both wild type subunits a and 
c were replaced with the fusion constructs.  In the second case, only wild type subunit a was 
replaced, leaving the gene expressing native c intact (Figure 4.1). 
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Figure 4.1:  Design of the a/c fusion proteins and plasmid construction.  A) Topology 
diagrams of the a/c fusion constructs. Subunits a and c are shown as well as both fusion 
construct expression products.  The a-c protein is shown at the top right and the a-c/2-c protein 
is shown on the bottom right.  The cytoplasmic side of the membrane is on top and the 
periplasmic side is on the bottom.  B) The fusion construct genes and their positioning in the 
pBWU13 parental vector is shown.  The a/c constructs replaced the genes encoding subunits a 
and c (atpB and atpE respectively) in the pBROD6 and pHP2 vectors.  The a/c constructs 
replaced the gene encoding native subunit a (atpB) in pHP808 and pHP7. 
 
 
 When the a-c/2-c fusion protein was expressed in the presence of the c10 ring, from 
pHP808, it was produced and incorporated into the membrane at levels comparable to wild type 
(Figure 4.2).  When the a-c/2-c fusion protein was expressed in the absence of the c10 ring 
expression and membrane incorporation were observed at a reduced level.  The a-c fusion 
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protein also showed membrane incorporation at levels comparable to wild type when co-
expressed with the c10 ring.  However, in the absence of the c10 ring the a-c construct was not 
incorporated into the membrane at a detectable level. 
 
 Previous reports have shown that insertion of subunit a into the membrane is dependent 
on the presence of subunit c (Hermolin and Fillingame, 1995; Yi et al., 2003).  Membrane 
incorporation of the a-c/2-c fusion protein in the absence of native subunit c indicated that the 
fusion protein was properly folded because the fused c subunit allowed membrane integration 
of subunit a.  Lack of membrane incorporation of the a-c construct in the absence of native 
subunit c was likely due to the incorrect transmembrane topology of the fused c subunit relative 
to a, which inhibited insertion of the a-c protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2:  Membrane incorporation of the a/c fusion proteins.  Western blot of cell 
membranes from the OM202recA strains containing no plasmid (a), expressing the a-c fusion 
protein from plasmid pHP2 (b) or pHP7 (d), the a-c/2-c fusion protein from plasmid pBROD6 
(c) or pHP808 (e), or wild type subunit a from plasmid pBWU13 (f) with (d-f) or without (a-c) 
co-expression of the wild type subunit c.  The Western blot was probed against the His6 tag on 
the a/c constructs and wild type subunit a.  Each lane contained 10 µg total membrane protein.  
Positions of the molecular weight markers and their masses in kDa are shown on the left.  
Subunit a and both fusion proteins display enhanced electrophoretic mobility which gives the 
appearance of lower than expected molecular weight, which is a common property of highly 
hydrophobic proteins. 
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4.2  An assembled c10 ring is not a prerequisite for membrane insertion of subunit a. 
 The results presented in section 4.1 showed that fused subunit c (of a-c/2-c) was 
sufficient to allow membrane incorporation of the fused a.  This suggested that monomeric 
subunit c, rather than a pre-formed c-ring, facilitated subunit a’s entry into the membrane.  To 
test this hypothesis further, we examined the effect of c10 ring assembly on the membrane 
incorporation of subunit a.  Formation of the c10 ring is disrupted by two distinct mutations in 
subunit c, G23D and L31F (Jans et al., 1983; Kol et al., 2006).  The cG23D or cL31F mutations 
do not disrupt membrane insertion of subunit c, but do disrupt the formation of c-rings in the 
membrane. 
 
 Wild type subunit a was expressed in the presence of the cG23D and cL31F mutations 
in the context of the full atp operon, from plasmids pHP9 and pHP10 respectively, in the 
OM202recA strain.  ATP dependent proton translocation was tested in the cell membranes 
prepared from these strains and showed that ATP synthase with the cG23D mutation was 
inactive (Figure 4.3) when compared to wild type.  In ATP synthase with the cL31F mutation 
only marginal activity was detected (Figure 4.3-B).  These results were consistent with 
disrupted ring formation and indicated that the G23D and L31F mutations provided a suitable 
platform for our study on how c-ring assembly affects incorporation of subunit a into the 
membrane. 
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Figure 4.3:  ATP dependent proton translocation in OM202recA/pHP9 (A), 
OM202recA/pHP10 (B), and OM202recA/pBWU13 (C) membranes.  pBWU13 expresses 
wild type ATP synthase.  pHP9 and pHP10 express native subunit a in the presence of the 
cG23D and cL31F mutations respectively.  The trace shown in panel A is representative of the 
traces obtained from both a/c fusion proteins in the presence of either c10 assembly mutation. 
 
We then expressed a/c fusion proteins in the presence of the cG23D and cL31F 
mutations.  As expected, these ATP synthase variants were not active (data not shown).  
Western blot analysis on membrane vesicles prepared from the c10 mutant strains showed that 
wild type subunit a incorporated into the membrane in the presence of both the cL31F and 
cG23D mutations (Figure 4.4).  This observation showed that formation of the c10 ring was not 
necessary for the incorporation of wild type subunit a into the membrane; supporting the results 
presented in section 4.1.  In the presence of the cG23D and cL31F mutations the a-c/2-c fusion 
protein incorporated at a reduced level, which was comparable to expression in the absence of 
native c, while the a-c construct was not integrated into the membrane.  The reduced membrane 
incorporation of the a/c fusion proteins when co-expressed with cG23D and cL31F was an 
unanticipated result and will be discussed further in section 5.4. 
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cG23D Expression Experiment (Re-built a/1/2c/c) 
Gel 1: Coomassie stained 10 % SVJ gel of membrane protein from strains expressing wild type a and the a-c constructs in 
the presence and absence of wild type subunit c and c10 assembly mutants.  Each lane contains 10 µg total membrane protein 
from OM202recA- background strains. 
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cG23D Expression Experiment (Re-built a/1/2c/c) 
Blot 1: (anti-HIS blot equivalent of gel 1): Western blot of membrane protein from strains expressing wild type a and the a-c 
constructs in the presence  and absence of wild type subunit c and c10 assembly mutants.  Each lane contains 10 µg total membrane 
protein from OM202recA- background strains. Anti-pentaHis antibody 1:10,000 was used. 
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cG23D Expression Experiment (Re-built a/1/2c/c) 
Blot 2: (anti-c blot equivalent of gel 1):  Western blot of membrane protein from strains expressing wild type a and the a-c constructs 
in the presence and absence of wild type subunit c and the c10  assembly mutants.  Each lane contains 10 µg total membrane protein from 
OM202recA- background strains. Anti-c antisera was used at 1:60,000 dilution and anti-rabbit HRP antibody was used at 1:10,000 
dilution factor. 
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Gel 2: Coomassie stained 10 % SVJ gel of membrane protein from strains expressing wild type a and the a-c constructs in the presence 
and absence of wild type subunit c and c10 assembly mutants.  Each lane contains 10 µg total membrane protein from OM202recA- 
background strains. 
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Figure 4.4:  Expression of subunit a and the a/c constructs in the presence of c10 assembly 
mutations.  Panels A, B and C correspond to expression experiments with the cG23D mutation. 
Panels D, E and F correspond to experiments with the cL31F mutation.  A and D: Coomassie 
stained SDS-PAGE gels containing 10 µg total membrane protein from the various strains in 
each lane.  B and E: Western blot equivalents of the gels in panels A and D, probed with anti-
His6 antibody.  Panels C and F: Western blot equivalents of the gels in panels A and D, probed 
with anti-c antibody.  The bands indicated by red arrows are caused by non-specific antibody 
binding. 
 
The results shown in Figure 4.4 prompted us to examine the effects of the L31F 
mutation on the a-c/2-c fusion variant more closely.  L31F was selected for further study 
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because subunit c is integrated into the membrane in stoichiometric amounts, but the c-ring 
does not form (Figure 4.4).  We constructed three pHP808 derivative plasmids containing the 
cL31F mutation.  In the pHP8014 plasmid the gene encoding subunit c contains the L31F point 
mutation.  In the pHP8015 plasmid the gene encoding a-c/2-c contains the L31F mutation.  In 
pHP8016 both the genes encoding native subunit c and a-c/2-c contain the L31F mutation. 
 
Expression of the a-c/2-c fusion protein in the presence of the L31F mutations was 
examined in the OM202recA parental strain.  Western blot analysis on membrane vesicles 
prepared from the a-c/2-c derivative strains showed that a-c/2-c incorporated into the 
membrane at levels comparable to wild type when L31F was present in the fused c subunit, as 
well as when L31F was present in both the fused and monomeric c (Figure 4.5).  However,  the 
a-c/2-c fusion protein was not efficiently integrated into the membrane when the L31F mutation 
was present only in monomeric c, which is consistent with the results shown in Figure 4.4.  
Interestingly, when monomeric c contained the L31F mutation it was not integrated into the 
membrane at stoichiometric amounts.  However, native c was integrated into the membrane 
regardless of the presence of the L31F mutation in the a-c/2-c protein. 	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Figure 4.5:  Western blot analysis of the membrane incorporation of a-c/2-c L31F 
derivatives.  A) Western blot probed with anti pentaHis-HRP antibody (Qiagen, Mississauga, 
ON) which targets the His6 tag on a-c/2-c.  B) Western blot probed with anti-c antibodies.  C) 
Coomassie stained 10 % SDS-PAGE gel equivalent of the blots shown in panels A and B.  
Each lane contains 10 µg total membrane protein.  Cell membranes from the OM202recA strain 
containing no plasmid (a), wild type ATP synthase (b), the a-c/2-c fusion protein (c), the a-c/2-
c protein coexpressed with monomeric c containing the L31F mutation (d), the a-c/2-c protein 
containing the L31F mutation (e-f) in the presence of native monomeric c (e) and in the 
presence of monomeric c containing the L31F mutation (f). 
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4.3  The a/c fusion proteins incorporate into the F0 domain. 
Once we had demonstrated that the a/c fusion proteins incorporated into the membrane 
we wanted to determine if they were integrated into the F0 domain.  The a/c constructs were 
expressed in E. coli cells in the context of the full atp operon (section 4.1), therefore, it was 
possible for them to assemble with b2 and c10.  We tested if the fusion proteins were 
incorporated into the F0 domain similar to wild type subunit a.  The F0 domain was purified 
from cells expressing the a/c constructs using a method established by Schneider and Altendorf 
(Schneider and Altendorf, 1984).  F0 isolated from wild type ATP synthase showed 3 major 
bands on SDS-PAGE, which correspond to subunits a, b and c (Figure 4.6).  Both the a-c and 
a-c/2-c constructs co-purified with subunits b and c and were present in the F0 preparations at 
ratios comparable to subunit a in the wild type F0 (Figure 4.6).  Co-purification of the a/c fusion 
proteins with subunits b and c indicated that the a/c fusion proteins were properly folded and 
incorporated into an assembled F0 complex. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6:  Silver stained 10 % SDS-PAGE gel of the isolated F0 complexes from wild 
type ATP synthase and the a/c variants.  0.2 µg, 1.0 µg and 5 µg of each type of F0 was 
loaded.  The location of each fusion construct is indicated with arrows.  The positions of 
subunits a, b and c are indicated in wild type F0. 
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4.4  F1F0-ATPase containing the a-c/2-c construct is correctly assembled. 
 Once we had confirmed that the a/c fusion proteins were integrated into F0 we wanted to 
determine if the entire F1F0 complex was assembled with the a-c/2-c fusion protein.  Intact wild 
type F1F0 was isolated using a modified version (Haji and Dmitriev, unpublished data) of the 
protocol developed by Laubinger and Dimroth for isolation of the P. modestum F1F0-ATPase 
(Laubinger and Dimroth, 1988).  Isolated F1F0 ATP synthase was highly purified.  Wild type 
F1F0 ATP synthase isolated by this procedure remains functional and has normal subunit 
composition (Haji and Dmitriev, unpublished data).  Therefore, this purification procedure 
provides a suitable test to determine the assembly status of the ATP synthase complex with the 
a-c/2-c fusion.  The a-c/2-c fusion protein was found to co-purify with the full complement of 
F1F0 subunits (Figure 4.7), demonstrating that the a-c/2-c ATP synthase variant is assembled. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7:  F1F0 isolated from OM202recA/pBWU13 (wild type ATP synthase) and 
OM202recA/pHP808 (ATP synthase with a-c/2-c).  Coomassie stained gels as well as 
Western blots probed against the His6 tag are shown for each preparation.  The F1F0 subunits 
are labeled on the Coomassie stained gel panels.  The positions of the a and a-c/2-c proteins are 
labeled on both the gels and blots. 
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4.5  Activity of the a-c and a-c/2-c ATP synthase variants. 
4.5.1  The a-c fusion protein supports cell growth by oxidative phosphorylation but the a-
c/2-c fusion does not. 
The results presented in sections 4.3 and 4.4 showed that the a/c ATP synthase variants 
were assembled, which prompted us to examine their activity.  Bacterial strains that do not 
contain functional ATP synthase cannot survive on media containing succinate as the sole 
source of carbon.  Therefore, growth on these selective plates is indicative of the presence of 
functional ATP synthase.  The strains OM202recA/pBWU13 (wild type), OM202recA/pHP7 
(a-c), and OM202recA/pHP808 (a-c/2-c) were grown on succinate minimal plates to test the 
OxPhos capacity of the a/c ATP synthase variants (Figure 4.8).  OM202recA/pHP2 (a-c, in the 
absence of c10) and OM202recA/pBROD6 (a-c/2-c, in the absence of c10) were also tested, 
although they were expected to be non-functional, and show no growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8:  Growth of OM202recA cells transformed with plasmids encoding the ATP 
synthase variants on succinate.  pBROD6 and pHP2 encode the a-c/2-c and a-c constructs 
respectively, in the absence of the native c10 oligomer.  pHP808 and pHP7 encode the a-c/2-c 
and a-c constructs, in the context of the full ATP operon, respectively.  pBWU13 encodes wild 
type ATP synthase. 
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The OM202recA parental strain contains a chromosomal deletion of the atp operon and 
was used as a negative control.  OM202 showed no growth as expected.  Cells expressing wild 
type ATP synthase and the a-c variant grew well on succinate, although the cells expressing 
wild type ATP synthase grew more robustly.  Cells expressing the a-c/2-c variant showed no 
visible signs of growth, indicating that the a-c/2-c variant was unable to produce ATP.  These 
results show that when the fused c subunit has incorrect transmembrane topology relative to 
subunit a, activity is retained.  However, when the fused c has correct transmembrane topology 
relative to a activity is lost. 
 
The capacity of the a-c construct to support OxPhos on succinate plates suggested that 
the a subunit of the a-c fusion protein was able to interact with the c-ring to facilitate proton 
transport.  We hypothesized that because a-c had incorrect transmembrane topology, the fused c 
subunit may be displaced to the periphery of the ring allowing the a-c10 interaction to occur.  
Conversely, the a-c/2-c variant has correct transmembrane topology and it is therefore possible 
that the fused c subunit may integrate into the c-ring, obstructing movement of the rotor.  We 
conducted a series of activity assays, examining both ATP driven proton transport and passive 
proton transport through the F0 domain variants to test this hypothesis. 
 
4.5.2  ATP driven proton transport activity of the a/c ATP synthase variants. 
ATP dependent proton translocation, was measured for wild type ATP synthase as well 
as both a/c variants using ACMA fluorescence quenching assays (Figure 4.9).  Wild type ATP 
synthase showed strong fluorescence quenching upon the addition of ATP.  The a-c variant 
showed activity at approximately 50 % the level observed in wild type and the a-c/2-c variant 
showed negligible activity, which was consistent with oxidative phoshphorylation activity tests  
(section 4.5.1).  Activity of each variant was also measured in the presence of 
dicyclohexylcarbodiimide (DCCD), a specific covalent inhibitor that binds to D61 of subunit c 
and blocks proton transit.  Activity of the wild type enzyme and of the a-c variant was 
effectively blocked by DCCD, demonstrating that the fluorescence quench observed was truly 
related to F1F0 ATPase activity. 
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Figure 4.9:  ATP driven (A-C) and NADH driven (D-F) proton translocation as measured 
by ACMA fluorescence quenching.  Wild type subunit a was expressed from 
OM202recA/pBWU13 (A & D), a-c was expressed from OM202recA/pHP7 (B & E), and a-
c/2-c was expressed from OM202recA/pHP808 (C & F).  Time points where 2.0 mM ATP, 0.2 
mM NADH, and 2.0 µM FCCP were injected are indicated with arrows.  Black traces were 
recorded from untreated membranes, grey traces were recorded with membranes pretreated 
with 80 µM DCCD.  
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 NADH driven proton transport was used as a control for integrity of the membrane 
preparations.  NADH dehydrogenase is present in the membrane vesicles and upon the addition 
of NADH, protons are pumped into the lumen of the vesicles.  Rapid ACMA fluorescence 
quenching was observed in all of the NADH driven assays and showed that the different 
quenching levels in the ATP driven assays were not caused by non-specific proton leaks 
through the membrane, but were truly a reflection of ATP driven proton transport activity of the 
F1F0 variants.  As expected, DCCD had no effect on the NADH-driven proton transport, which 
confirmed that DCCD inhibition of ATP-dependent ACMA quenching resulted from specific 
inhibition of F1F0-ATPase, and not by causing protons to leak through the membrane. 
 
4.5.3  Passive proton conductance through F0 of the a/c variants. 
We needed to demonstrate that the lack of proton transport activity in the a-c/2-c variant 
was truly caused by tethering of the rotor and stator.  To test this, we examined proton transport 
through the F0 domain directly.  Removal of F1 from F0 by EDTA treatment converts the F0 
complex into a passive proton pore, which allows protons to flow across the membrane along 
their electrochemical gradient (Aris et al., 1985).  This process can be monitored by ACMA 
fluorescence quenching, using NADH dehydrogenase to create a proton gradient.  When F1 is 
attached to F0, or the proton pore is blocked, a concentration dependent ACMA fluorescence 
quench is observed.  However, if F1 is removed from F0, and the F0 domain is functional, 
protons are passively shuttled out the lumen and the electrochemical proton gradient is 
dissipated resulting in a reduced level of ACMA fluorescence quench. 
 
Passive proton translocation was measured for wild type ATP synthase as well as both 
a/c variants (Figure 4.10).  As expected, the wild type F0-domain showed a strong proton leak, 
which was blocked by treatment with the covalent proton transport inhibitor DCCD.  The a-c/2-
c variant showed very weak proton permeability.  This observation was consistent with the lack 
of growth on succinate and negligible ATP driven proton transport, and supported our 
hypothesis that the rotor and stator are tethered.  The a-c variant showed reduced capacity for 
passive proton transport compared to the wild type, which was also consistent with the reduced 
level of ATP-dependent proton transport and reduced growth on succinate.  The OM202recA 
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parental strain showed no proton leak before or after EDTA treatment, indicating that the 
membrane vesicles maintained their integrity through the F1 stripping procedure.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10:  Proton permeability of the F0 complexes with the a-c fusion proteins 
incorporated.  NADH driven proton transport measured by ACMA fluorescence quenching 
with wild type subunit a from OM202recA/pBWU13 (A), control membranes from the parental 
OM202recA strain (B), the a-c/2-c fusion protein from OM202recA/pHP808 (C), and the a-c 
fusion protein from OM202recA/pHP7.  Additions of NADH and FCCP are indicated with 
arrows.  The grey and black traces indicate activity measured from whole membranes, and 
whole membranes in the presence of 80 µM DCCD respectively. 
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4.5.4  F1-ATPase activity of the a-c/2-c ATP synthase variant. 
 We wanted to confirm that the lack of ATP dependent proton translocation in the a-c/2-
c ATP synthase variant was truly related to an immobilized rotor, and not a side effect of an 
assembly defect or uncoupling between F1 and F0.  The activities of the F1 and F0 domains of 
ATP synthase are tightly coupled; inhibition of activity in the F1 sector will cause reduced 
capacity for proton transport through F0, and vice versa.  However, the F1 domain of ATP 
synthase retains efficient ATPase activity when it is removed from the transmembranous F0 
domain.  The tether between the rotor and stator would prohibit c10 ring rotation and cause the 
apparent lack of proton transport seen in sections 4.5.1 – 4.5.3.  However, it was also possible 
that the presence of the a-c/2-c construct interferes with ATP synthase assembly, or coupling 
between F1 and F0, and the lack of activity may have been due to an improperly assembled or 
uncoupled F1F0 complex.  We hypothesized that the fused c subunit of the a-c/2-c variant, 
which is expected to have correct transmembrane topology, integrates into the c10 ring 
preventing rotation.  We also hypothesized that if the a-c/2-c variant were assembled and the 
coupling mechanism were intact, we should observe low or absent ATPase activity when F1 is 
bound to F0, and a subsequent restoration of ATPase activity when F1 is released from the 
obstructed F0 domain. 
 
To test our hypotheses, we examined the amount of F1 bound to F0 in both wild type 
ATP synthase and in the a-c/2-c variant.  The α and β subunits of the F1 domain were present in 
the membranes of cells expressing the a-c/2-c variant at approximately 60 % of the level 
observed in wild type (Figure 4.11).  However, the ATPase assays showed that the a-c/2-c 
variant had less than 20 % of the activity observed in wild type when F1 was bound to F0.  A 
significant increase in ATPase activity was observed upon removal of F1 from the a-c/2-c 
containing F0-complex.  Free F1 activity of the a-c/2-c variant per milligram membrane protein 
was approximately 50 % of the wild type, demonstrating that the a-c/2-c fusion protein does not 
interfere with assembly or coupling of the F1F0 complex.  Taken together, the results in sections 
4.1 – 4.5 lead us to conclude that the the a-c/2-c fusion protein is properly folded and the fused 
c of a-c/2-c becomes integrated into the c10 ring. 
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Figure 4.11: Coomassie stained SDS-PAGE gel of membranes and F1 isolated from cells 
expressing wild type ATP synthase and the a-c/2-c variant.  A) MB: indicates lanes 
containing whole membranes.  F1: indicates lanes containing isolated F1.  Each lane showing 
whole membranes was loaded with 10 µg total membrane protein.  The amount of isolated F1 
loaded on the gel was equalized per µg of membranes.  The positions of the F1 α and β subunits 
are shown.  B)  Band density traces from the isolated F1 lanes in the coomassie gel.  The red 
trace corresponds to the F1 lane from the a-c/2-c variant and the blue trace corresponds to the F1 
lane from wild type ATP synthase.  The black trace corresponds to the background strain. 
 
 
Table 4.1:  F1-ATPase activity of the a-c/2-c variant. 
Units of activity are µmol of Pi released per minute per milligram of protein (µmolPi/min*mg).  
Wild type and a-c/2-c variant ATP synthases were expressed in OM202recA E. coli cells.  
OM202recA cells that did not contain an ATP synthase expression vector were used as the 
negative control.  ND – not determined. 
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4.6  Extending the tether between a and c/2-c of the a-c/2-c fusion does not enhance proton 
transport. 
 We demonstrated that the a-c/2-c fusion protein is incorporated into an assembled ATP 
synthase complex, and that the fused subunit c is integrated into the c10 ring (sections 4.1 –  
4.5).  The short linker connecting the fused a and c subunits restricts movement of the rotor and 
prevents efficient proton transport.  Theoretically, it is plausible for limited back – and – forth  
movements of the c-ring, relative to subunit a, to facilitate proton transport through the 
uncoupled F0-complex.  In the a-c/2-c fusion variant, low levels of passive proton transport 
were observed (section 4.5.3) suggesting that although the tether between fused a and c 
occluded c-ring rotation, the length of the linker was sufficient to allow some back and forth 
oscillations of c10 relative to a. 
 
We hypothesized that lengthening the tether between a and c/2-c of a-c/2-c may 
enhance passive proton transit via oscillation of the c-ring.  Two linker extensions, four and 
twelve amino acids in length, were designed and incorporated between the a and c/2-c 
polypeptides in the a-c/2-c fusion (section 3.2.3).  Linker 1 was designed to allow back and 
forth oscillation of the c10 ring relative to the stator; it was short enough to occlude full rotation 
of the c10 ring.  Linker 2 was designed to be long enough to allow complete rotation of the c10 
ring, in principle, although the activation energy barriers of the linker passing through 
energetically unfavorable parts of conformational space may preclude full rotation in practice.  
The first linker (a-c/2-c-linker-1) encoded ‘GSAG’ and the second linker (a-c/2-c-linker-2) 
encoded ‘GSAGTASANSGA’ (Figure 4.12). 
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Figure 4.12:  Location of the linker extensions and theoretical geometries of the F0 
domains containing the a-c/2-c fusion protein and its derivatives.  Subunit a is shown in 
orange, fused subunit c is shown in green.  Topology diagrams and the theoretical F0 domain 
geometries of the a-c/2-c (A), a-c/2-c-linker1 (B), and a-c/2-c-linker2 (C) fusion constructs are 
shown, linkers are not to scale. 
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In OM202recA cells, both the a-c/2-c-linker-1 and a-c/2-c-linker-2 constructs 
incorporated into cellular membranes at levels comparable to the original fusion protein (Figure 
4.13).  The a-c/2-c-linker-1 and a-c/2-c-linker-2 proteins migrated at a higher molecular 
weights than the original a-c/2-c protein because of the additional 4 and 12 amino acids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13:  Western blot (left) and Coomassie stained gel (right) of whole membranes 
prepared from OM202recA cells expressing subunit a, the original a-c/2-c construct and 
the a-c/2-c construct with extended linkers between a and c/2-c.  Expression of wild type 
subunit a is shown for comparison.  Each lane was loaded with 10 µg total membrane protein.  
The Western blot was probed using anti-pentaHis HRP antibody (Qiagen, Mississauga, ON).  
Membranes from the parental OM202recA strain were loaded as a negative control.  Samples 
from intact membranes (F1F0 intact) and stripped membranes after F1 removal (F1 stripped) 
were loaded.  The bands corresponding to the α and β subunits of F1 are within the black box. 
 
 
Once we had established that the fusion protein derivatives were fully incorporated into 
cellular membranes we tested their ability to passively transport protons.  As discussed in 
section 4.5.3, F1 can be removed from F0 to generate a passive proton pore that allows protons 
to leak across the membrane.  Passive proton translocation was measured in F1 stripped 
membrane vesicles containing wild type F0, as well as the a-c/2-c fusion protein and its linker 
derivatives, using ACMA fluorescence quenching assays (Figure 4.14).  Wild type F0 facilitated 
rapid proton transport.  Consistent with the previous results (Figure 4.10), F0 with the original 
a-c/2-c fusion protein showed weak proton transport.  Both proteins with extended linkers 
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showed similar levels of passive proton transport and were undistinguishable from the original 
a-c/2-c construct.  There are two possible conclusions from this set of experiments: 1) the a-
c/2-c fusion protein facilitates low level proton transport through small back and forth 
movements of the c-ring, which cannot be enhanced by increasing mobility of the c-ring via 
longer tethers, or 2) proton transport does not occur through oscillatory mechanisms. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14:  Proton permeability of the F0 complexes with the a-c/2-c linker variant 
fusion proteins incorporated.  NADH driven proton transport measured by ACMA 
fluorescence quenching with wild type subunit a from OM202recA/pBWU13 (grey), control 
membranes from the parental OM202recA strain (red), and each of the a-c/2-c and the linker 
variants (shades of blue).  Additions of NADH and FCCP are indicated with arrows. 
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4.7   Expression and purification of subunit a and the a-c/2-c fusion. 
4.7.1   Optimization of protein expression. 
 We needed to achieve a high level of overexpression for both wild type subunit a and 
the a-c/2-c fusion protein for structural studies.  Initially, expression experiments with both 
wild type subunit a and the a-c/2-c protein were carried out using the OM202 parental strain.  
RecA activity in the OM202 parental strain caused a deletion mutation in the pHP808 plasmid, 
resulting in a truncated a-c/2-c expression product.  To abolish RecA activity and allow 
expression of the full length a-c/2-c protein, we generated a RecA deficient strain, OM202recA, 
by P1 transduction.  However, expression level in OM202recA was not high enough to produce 
sufficient quantities of protein for structural studies. 
 
 Expression of subunit a and the a-c/2-c protein was tested in C43(DE3) E. coli cells, 
which contain an uncharacterized mutation that allows them to highly overexpress toxic 
membrane proteins.  C43(DE3) E. coli cells expressed wild type subunit a approximately ten 
times better than OM202 or OM202recA (Figure 4.15).  Expression of the a/c constructs did not 
appear to be significantly improved relative to OM202recA expression.  When expressed in 
C43(DE3) cells the a-c/2-c construct migrated identically to wild type subunit a on SDS-
PAGE, indicating that the a-c/2-c construct was truncated when expressed in C43(DE3).  Like 
OM202, C43(DE3) expresses active RecA, which recognizes and recombines repetitive 
sequences of DNA, which can lead to deletions of repetitive DNA sequences.  RecA activity 
was also the likely cause of the low level of a-c/2-c expression in C43(DE3).  We generated a 
C43recA strain for testing expression of the a-c/2-c protein.  An approximate three-fold 
increase in expression levels was observed between OM202recA/pHP808 and 
C43recA/pHP808 (Figure 4.16). 
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Figure 4.15:  Western blot analysis of C43(DE3) expression of wild type subunit a and the 
a/c constructs relative to OM202 and OM202recA.  A) Western blot probed against the His6 
tag on subunit a and each construct using anti-pentaHis HRP antibody (Qiagen, Mississauga 
ON).  B) Coomassie stained SDS-PAGE equivalent of the Western blot in panel A shown as 
load control.  Each lane contains 10 µl of raw cells equalized to an optical density (OD600) of 
0.9.  The positions of the molecular weight markers in kDa is indicated on the left.  C43(DE3) 
without plasmid was loaded as a negative control.  OM202, OM202recA, and C43(DE3) 
transformed with pBWU13 express wild type subunit a.  C43(DE3) /pHP808 expresses the a-
c/2-c construct and C43(DE3) /pHP7 expresses the a-c construct. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16: Western blot analysis of a-c/2-c expression in the C43recA and OM202recA 
background strains.  Coomassie stained gel (left) and western blot (right) probed using the 
anti-pentaHis HRP conjugate antibody (Qiagen, Mississauga, ON).  Each lane contains 10 µg 
total membrane protein, lanes containing membranes from either C43recA/pHP808 or 
OM202recA/pHP808.  The positions of the molecular weight markers in kDa are indicated in 
the center. 
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4.7.2   Optimization of purification of subunit a and the a-c/2-c fusion protein from 
isolated F0. 
Optimization of purification followed optimization of protein expression.  Wild type F0 
was isolated using the method of Schneider and Altendorf (section 4.3) and used as the starting 
material for protein purification (Schneider and Altendorf, 1985).  Schneider and Altendorf 
developed a method for dissociating the F0 subunits from one another using trichloroacetate.  
We modified this protocol to use LiBr as a dissociation agent because it is safer and easier to 
handle.  Initially, we used size exclusion chromatography to separate the dissociated F0 
subunits.  However, we could not obtain samples of subunit a of sufficient purity using this 
method (data not shown).  We decided to use Ni-NTA chromatography to separate the His6 
tagged subunit a from the other F0 subunits.  Dissociated F0 samples were subjected to Ni-NTA 
affinity chromatography and subunit a was optimally eluted subunit a from the Ni-NTA resin 
between 20 mM and 250 mM imidazole. 
 
Initially, with the purification method described above, we achieved a maximum 
experimental yield of 22 % of the theoretical yield with wild type subunit a.  We found that as 
much as 60 % of the loss occurred during concentration of purified protein samples.  We 
developed a method for pre-treating Vivaspin-6 concentration devices to minimize protein loss 
(section 3.4).  Recovery of the purified protein was increased to approximately 80 % with the 
use of pre-treated Vivaspin-6 concentrators.  The final purification procedure, as described in 
section 3.4, yields highly purified subunit a ( > 95 % pure) (Figure 4.17). 
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Figure 4.17: Stages of purification for wild type subunit a.  Molecular weights of the marker 
proteins in kDa (St) are shown on the left.  Samples of whole cell membranes, isolated F0 
domain (5 µg), column washes (10 µl), and elution steps (10 µl) are shown. 
 
 
 The same procedure was applied to the a-c/2-c fusion protein.  Although the a-c/2-c 
fusion protein was highly purified using this method, the final purity was lower than observed 
with native subunit a (Figure 4.18).  Size exclusion chromatography and anion exchange 
chromatography did not significantly improve the purity of the a-c/2-c fusion protein (data not 
shown).  The final yields of purified subunit a and a-c/2-c fusion protein were 0.3 and 0.17 
mg/L of cell culture respectively, corresponding to the theoretical yield of approximately 80 %, 
which was calculated from the amount of F0 starting material. 
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Figure 4.18:  Purified subunit a and a-c/2-c fusion protein.  The Coomassie stained SDS-
PAGE gels contain samples of 1 µg, 3µg, and 5 µg of either purified protein.  The positions of 
molecular weight markers are indicated in kDa. 
 
 
4.7.3   Purification of the wild type subunit a from intact F1F0-ATP synthase. 
 We developed a second novel strategy for purification of subunit a from intact F1F0 
(section 3.5).  The aim of this procedure was to isolate subunit a using milder detergents than 
the sodium cholate and octylglucopyranoside used during purification of subunit a from 
isolated F0 (sections 3.4 and 4.7.1).  To do this, the intact F1F0 complex was isolated using a 
modified version of the protocol developed by Laubinger and Dimroth for isolation of the P. 
modestum F1F0-ATPase (Laubinger and Dimroth, 1988) (Haji and Dmitriev, unpublished data).  
This method involves solubilization of the F1F0 complex from the membrane using DHPC (a 
relatively mild detergent) and PEG fractionation to enhance purity of the intact ATP synthase.  
ATP synthase isolated by this method is approximately 76 % pure (Figure 4.19). 
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Figure 4.19:  Coomassie stained 10 % SDS-PAGE gel containing samples taken at each 
stage of ATP synthase isolation.  The numbers of the supernatants and pellets coorespond 
those in the purification scheme shown in Figure 3.13.  The subunits of ATP synthase are 
labeled on the gel.  * Supernatant-4 is the final purified F1F0 sample. 
 
 
 Subunit a was dissociated from the other F1F0 subunits and isolated using Ni-NTA 
chromatography (section 3.5).  After one round of Ni-NTA chromatography, subunit a was not 
sufficiently purified using this method.  Therefore, the elutant from the Ni-NTA column was 
buffer exchanged to remove imidazole and then loaded onto a second Ni-NTA column for 
another round of purification (Figure 4.20).  After two subsequent rounds of Ni-NTA 
chromatography the purified subunit a samples were of sufficient purity for structure studies.   
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Figure 4.20:  Stages of purification of subunit a from F1F0.  10 % coomassie stained SDS-
PAGE gels containing samples taken from the first round of Ni-NTA chromatography (A) and 
the second round (B).  The position of subunit a is indicated on each gel and the positions of the 
molecular weight markers (kDa) are indicated to the left of each gel. 
 
 
4.8   Characterization of subunit a preparations by NMR. 
4.8.1   Efforts to optimize spectral resolution of subunit a. 
NMR experiments were conducted with 15N labeled subunit a purified in LMPG 
micelles to assess spectral quality for structure studies.  LMPG was chosen because it is 
structurally similar to the naturally occurring phospholipids in cellular membranes and it has 
been shown to produce high quality NMR spectra with several other membrane proteins 
(Kruger-Koplin et al., 2004).  The HSQC spectrum of subunit a purified in LMPG micelles did 
not have high spectral resolution (Figure 4.21).  Several peaks corresponding to backbone and 
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side chain amide groups were well resolved, but spectral quality was not sufficient to make 
backbone amide chemical shift assignments. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.21:  1H, 15N HSQC spectra obtained from subunit a purified in LMPG micelles 
(A), LDAO micelles (B), LPPG micelles (C), and 2H-DPC micelles (D).  Backbone amide 
chemical shifts, as well as the side chain chemical shifts of glutamine and asparagine are shown 
in black.  Peaks corresponding to arginine side chains are shown in red.  Spectra were recorded 
at 600 MHz, 310 K, 128 increments in t1 with 16 scans per increment. 
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Detergent type and concentration are critical factors for NMR spectral quality of 
membrane proteins.  We developed a procedure for exchanging purified subunit a into different 
detergents and systematically screened several detergents in an effort to improve spectral 
resolution.  The detergents screened were: N,N-dimethyldodecylamine-N-oxide (LDAO), 1-
myristoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)] (LMPG), palmitoyl-2-hydroxy-
sn-glycero-3-[phospho-rac-(1-glycerol)] (LPPG), and deuterated n-dodecylphosphocholine 
(DPC).  The spectra obtained from subunit a purified in LDAO, LPPG and 2H-DPC micelles 
are shown in Figure 4.21 (C-D).  None of the detergents tested improved spectral resolution.  
Protein purified in LPPG had very similar spectral quality to the LMPG spectra shown in 
Figure 4.21-A.  Spectra obtained from subunit a purified in LDAO and 2H-DPC had lower 
resolution that the LMPG spectra. 
 
Our standard purification procedure for subunit a involves isolation of the F0 domain, 
dissociation of the ab2c10 complex, and Ni-NTA chromatography to isolate the His6 tagged 
subunit a (section 3.4).  The sodium cholate used to solubilize F0 in the standard purification 
procedure is a relatively harsh detergent, which may cause misfolding of subunit a, leading to 
poor spectral quality.  We decided to purify subunit a using milder solubilization and 
purification conditions in an attempt to improve spectral resolution.  Isolation of the intact F1F0 
ATP synthase, where DHPC is used for solubilization, is a relatively mild procedure that 
preserves functionality of the enzyme (Haji and Dmitriev, unpublished data).  We purified 
subunit a from the intact F1F0 ATP synthase in DHPC micelles.  However, the NMR spectra 
obtained had lower resolution than subunit a isolated from F0 (Figure 4.22-A).  Subunit a 
isolated by this method was exchanged from DHPC to LMPG and spectra were recorded 
(Figure 4.22-B).  Despite the mild purification conditions no improvement to spectral resolution 
was observed when compared to samples isolated using the standard protocol. 
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Figure 4.22:  HSQC spectra of 15N labeled a purified from intact F1F0.  A) HSQC spectrum 
from subunit a in DHPC micelles.  B) HSQC spectrum from subunit a in LMPG micelles.  In 
both panels backbone amide chemical shifts are shown in blue.  The arginine side chain peaks 
are shown in green. 
 
 
4.8.2  Assignment of the R210 side chain peak for future functional studies. 
 The chemical properties and surrounding environment of each residue in subunit a 
contribute to the position of the chemical shift of each backbone amide group in the HSQC 
spectra.  Arginine side chain amide groups have a characteristic chemical shifts and are 
expected to occur in a predictable zone on the HSQC spectra.  Subunit a contains four arginine 
residues and four well resolved peaks were visible in the arginine side chain region of the 
HSQC spectrum.  We used selective mutagenesis to determine which of the arginine side chain 
peaks corresponded to R210 (Figure 4.23).  Subunit a with arginine 210 mutated to glutamine 
was expressed from the C43(DE3)/pHP20Q strain, 15N labeled during expression, purified, and 
analyzed by NMR.  The R210Q mutant of subunit a produced a similar spectrum to that of wild 
type subunit a, except for the absence of the peak corresponding to the side chain amide of 
arginine 210.  We assigned the side chain amide peak of arginine 210 by overlaying the wild 
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type subunit a spectrum with the aR210Q spectrum and identifying the peak in the wild type 
spectrum that was absent in the aR210Q spectrum (Figure 4.23).  Ultimately, chemical shift 
assignment of R210 is meaningful because it provides an excellent reporter group for functional 
studies.  For example, we may conduct functional NMR studies to determine the pKa of R210.  
Furthermore, we may be able to use the R210 reporter group to investigate the binding of novel 
proton transport inhibitors to the proton channel. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.23:  Chemical shift assignment of the R210 side chain amide.  A) HSQC spectrum 
of wild type subunit a.  B) Expanded view of the wild type arginine side chain region.  C) 
Expanded view of the R210Q mutant arginine side chain region.  Identical arginine peaks from 
each spectrum are aligned.  The position of arginine 210 is indicated.  
 
 
4.8.3  R210 is not resolved in HSQC spectra recorded from a-c/2-c. 
 The a-c/2-c construct was originally designed for X-ray crystallographic studies.  
However, the fusion protein also had the potential to allow NMR functional investigations into 
the chemical shift perturbations of the critical R210 residue in an environment that mimics the 
proton channel.  We recorded NMR spectra from the a-c/2-c fusion protein to see if the arginine 
side chain region would be well resolved for functional studies (Figure 4.24).  Spectral 
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resolution of the a-c/2-c construct was poor and the arginine side chain region was heavily 
overlapped making the R210 peak indiscernible.  There are two key factors contributing to the 
poor spectral resolution in the arginine side chain region of the a-c/2-c fusion protein spectra 
relative to wild type subunit a.  First, the a-c/2-c fusion protein contains eight arginine residues, 
while subunit a contains only four, which complicates the spectra.  Second, the a-c/2-c 
construct is considerably larger than subunit a, which potentially reduces resolution. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.24:  1H, 15N HSQC spectrum from the a-c/2-c fusion protein purified in LMPG 
micelles.  A) Full HSQC spectrum, backbone amide signals are shown in black and arginine 
side chain signals are shown in red.  B) Expanded view of the arginine side chain region.  
Spectra were recorded at 600 MHz, 310 K, with 80 increments in t1 and 256 scans per 
increment. 
 
 
 Arginine 210 is thought to form a salt bridge with aspartic acid 61 of subunit c; the pKa 
of R210 is suspected to be uncharacteristically low due to close interaction with cD61.  We 
hypothesized that it may have been possible to resolve the R210 peak from the other arginine 
peaks based on its low pKa.  HSQC spectra were recorded at various pH values in an effort to 
separate the R210 signal from the other arginine side chain peaks.  We titrated a sample of 
purified a-c/2-c from pH 4.0 to 8.5, and recorded HSQC spectra at each pH.  Spectra recorded 
with the a-c/2-c construct below pH 5.5 showed some relative changes compared to spectra 
recorded at the standard pH 6.0.  The spectra recorded at pH 5.0 showed the appearance of one 
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peak outside the unresolved region (Figure 4.25).  Spectra recorded with the a-c/2-c sample at 
pH levels higher than 7.0 had no detectable signal in the arginine side chain region; this was not 
unforeseen because NMR spectral quality is dependent on the pH of the sample.  Samples at 
high pH values experience rapid proton exchange with water, which causes line broadening and 
loss of signal intensity.  The optimal pH range for protein NMR is 4.0 to 6.0.  Although we did 
observe minimal chemical shift perturbations in response to pH, we were unable to determine if 
the spectral differences were genuine or an experimental artifact.  Therefore, we were unable to 
assign the a-c/2-c R210 side chain peak. 
 
 
 
 
Figure 4.25:  Arginine region of the a-c/2-c HSQC spectra.  Arginine side chain peaks from 
spectra recorded at pH 6.0 are shown in red.  A) arginine side chain peaks from spectra 
recorded at pH 4.5 are shown in purple.  B) Arginine side chain peaks from spectra recorded at 
pH 5.0 are shown in green.  The peak appearing outside of the unresolved region is denoted 
with an arrow. 
 
4.9  Crystallization of subunit a.  
 The ultimate goal of our work is to determine the high resolution structure of subunit a 
and gain a detailed understanding of the mechanism of proton transport.  Although the NMR 
work discussed in section 4.8 provides opportunities for functional studies, the poor spectral 
resolution makes structure determination by NMR impossible.  We worked to crystallize both 
wild type subunit a and the a-c/2-c fusion protein for structure determination. 
 
 
A B 
	   	  117 
4.9.1  Crystal screening:  aggregation state of subunit a. 
Monodisperse protein samples have a higher propensity toward crystallization.  DLS 
analysis as well as gel filtration chromatography allowed us to assess the aggregation state of 
subunit a purified in LMPG micelles.  DLS experiments showed that subunit a was 
monodisperse in solution both at 20 oC and 25 oC (Figure 4.26).  Purified subunit a samples 
produced one broad DLS peak where the peak maximum corresponded to a calculated 
hydrodynamic radius of approximately 2.6 nm (Figure 4.26).  The theoretical Rh value for 
subunit a in detergent micelles is approximately 3.0 nm, which is close to the experimental 
value of 2.6 nm, leading us to conclude that purified subunit a was monomeric and  
monodisperse. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.26:  DLS of pure subunit a in LMPG micelles.  Purified subunit a was concentrated 
to 7.0 mg/mL for DLS experiments.  This trace was recorded at 27 oC. 
 
 
 Analytical gel filtration chromatography is another a commonly used method for 
determining protein aggregation state.  Purified subunit a was subjected to gel filtration 
chromatography using a Superdex-200 GL 10/300 column.  One sharp peak was observed in 
the elution profile at a retention volume of 14.6 mL (Figure 4.27).  To determine the molecular 
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weight of subunit a the retention volume of 14.6 mL was compared to retention volumes of 
protein standards.  The molecular weight of subunit a was calculated to be 48 kDa, which was 
in the expected range for monomeric subunit a in LMPG micelles.  The peak had a shoulder 
extending from 16.5 mL to 22.5 mL.  We assumed that the shoulder was caused by protein-
detergent complexes with various numbers of LMPG molecules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.27:  Elution profile of subunit a on the Superdex 200 GL 10/300 gel filtration 
column.  The elution trace is shown in blue.  10 % coomassie stained SDS-PAGE gel 
containing a sample of purified subunit a before gel filtration (A) as well as samples from the 
peak gel filtration fractions (B).  The void volume (VO) was 7.6 mL and the total volume (Vt) 
was 24 mL.  The kav for subunit a was calculated to be 0.427.  The estimated molecular weight 
of subunit a in LMPG micelles was 48 kDa. 
 
 
4.9.2  Subunit a has been successfully crystallized. 
Subunit a was purified in LMPG micelles for preliminary crystal screening (section 
3.4).  The high throughput screens were conducted at the high throughput crystal screening 
facility at the Hauptman Woodward Institute, in Buffalo New York, using the microbatch under 
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oil crystallization method.  Promising conditions from the initial 1,536 conditions were 
identified (Figure 4.28). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.28:  Preliminary hits from the ‘Membrane Protein Crystallization Screen’ – 
MSC4-1563 cocktail screen.  Purified subunit a was concentrated to 7.0 mg/mL for 
preliminary crystal screening.  The well number of the MC4 cocktail screen is indicated in at 
the top left of each image.  The crystallization conditions are written below each image. 
 
 
We also conducted primary LCP screening in collaboration with professor Hartmut 
Luecke (University of California – Irvine).  Preliminary LCP screening of subunit a was carried 
out using the following standard membrane protein crystallization screening kits from 
Molecular Dimensions: MemGold 1-36, MemFac 1-48, MD 1-25, and MD 1-44.  The most 
promising conditions from the preliminary LCP screens are shown in Figure 4.29.  The crystals 
shown in panels A and B of Figure 4.29 showed weak birefringence and were confirmed to be 
proteinaceous by X-Ray diffraction.  Diffraction experiments were carried out at the Stanford 
Synchrotron Radiation Lightsource (SSRL) in collaboration with Dr. Luecke. 
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        X-Ray diffraction pattern from crystal B 
 
 
Figure 4.29:  Crystals of subunit a obtained from preliminary LCP screening.  A) 
Proteinaceous object grown in 44 % PEG 400, 0.1 M Tris-HCl pH 8.0, and 0.2 M CaCl2.  B) 
Different crystalline form of subunit a grown in the same condition as the object shown in 
panel A.  C) Crystals grown in 7.7 % w/v PEG-1500, 0.02 M MES, pH 6.5, 0.02 M NaCl, 0.01 
M MgSO4, 0.02 M CaCl2.  The diffraction pattern obtained from the crystal in panel B is shown 
on the right. 
 
 
 The crystals shown in Figure 4.29 – A and B, had poor diffraction quality.  The 
resolution of the diffraction pattern was in the range of 30 Å.  High resolution structure 
determination is dependent on diffraction resolution below 4 Å.  No diffraction data was 
obtained with sample C.  Therefore, further screening was required.  We have continued in-
house refined crystal screening at the University of Saskatchewan using the hanging drop vapor 
diffusion method.  Promising conditions from both the Hauptman Woodward screen and the 
preliminary LCP screens were selected for refinement.  The components of the crystallization 
conditions were systematically altered: the buffer concentration, buffer type, pH, salt 
concentration, salt type, PEG concentration and PEG type were adjusted.  Approximately 900 
refined vapor diffusion conditions were screened.  Several promising conditions were identified 
and subjected to diffraction on the small gap undulator beamline (08-ID-1) at the Canadian 
Light Source (CLS) at the University of Saskatchewan.  One set of conditions produced 
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proteinaceous crystals.  The crystals formed platelike clumps made up of several smaller 
crystals, showed minimal birefringence under polarizer analysis, and had a slightly yellowish 
appearance under white light.  The crystals showed Bragg reflections from 30 Å – 14 Å 
resolution (Figure 4.30). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.30:  Diffraction pattern collected from subunit a crystals at the small gap 
undulator beamline at the CLS.  Crystallization conditions: 18 % PEG 400, 0.2 M CAPSO, 
pH 9.5, 0.2 M LiBr.  The white spot marked with a blue ‘+’ is a void in the diffraction pattern 
caused by the beam stop.  i) potentially, averaged diffraction from alpha helical segments.  ii) 
Individual Bragg reflections at ~ 25 – 20 Å resolution.  iii) Bragg reflections at ~18 Å 
resolution.  iv) Bragg reflections at ~ 14 Å resolution. 
 
 
4.10  Optimization of purified a-c/2-c protein yield and stability for future crystallization 
trials. 
The a-c/2-c fusion protein could be obtained at an approximate 82 % purity (as 
estimated by band densitometry, data not shown).  As a general rule for protein crystallography, 
samples should be greater than 90 % pure, but high resolution structure determination is still 
possible with protein samples of less than 90 % purity.  Therefore, we accepted that the 
optimized 82 % purity of our a-c/2-c samples was sufficient for preliminary crystal screening.  
In addition to relatively low purity, the a-c/2-c fusion protein presented us with three 
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challenges: 1) the purified samples formed aggregates in solution, 2) truncation of the a-c/2-c 
protein occurs during optimal overexpression in C43recA cells, and 3) the yield of purified 
protein was very low (0.17 mg per liter of cell culture). 
 
Purified a-c/2-c was subjected to SDS-PAGE analysis.  We found that purified a-c/2-c  
formed high molecular weight aggregates, which react with anti pentaHis antibody (Figure 
4.31).  Since the purity of the a-c/2-c samples exceeded 80 % it was unlikely that the aggregates 
were occurring between a-c/2-c and other protein types.  Enhanced electrophoretic mobility is a 
common property among membrane proteins.  Therefore, the bands between 45 and 97 kDa in 
Figure 4.31 may correspond to dimers, trimers, and tetramers of a-c/2-c, although it does not 
appear that the molecular weights of the aggregates correlate to multimers.  However, the 
C43recA strain, which optimally overexpressed the a-c/2-c fusion protein (section 4.7.1) also 
expressed a truncated a-c/2-c product at approximately 5 – 10 % the level of full length a-c/2-c 
(Figure 4.31).  Therefore, we cannot exclude the possibility that the aggregates correspond to 
multimers of the truncated a-c/2-c protein.  A third possibility is that the aggregates are formed 
by complexes of a-c/2-c with native subunit c.  We conducted several experiments in an effort 
to isolate the monomeric a-c/2-c.  Size exclusion chromatography, ion exchange 
chromatography, and re-purification under stringent dissociation conditions were all 
insufficient to remove the aggregates (data not shown). 
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Figure 4.31:  Coomassie stained 10 % SDS-PAGE gel and Western blot of purified a-c/2-c 
fusion protein.  Molecular weight standards (kDa) are indicated.  Left panel: Coomassie 
stained gel showing samples of 1µg, 3 µg, and 5 µg purified a-c/2-c.  Right panel: Western blot 
probed against the His6 tag on a-c/2-c.  The position of the monomeric full length a-c/2-c 
protein is indicated with a red arrow.  Positions of the potential dimeric, trimeric and tetrameric 
a-c/2-c aggregates are indicated with blue arrows.  The position of truncated a-c/2-c fusion 
protein is also indicated. 
 
 
The truncated expression product was not observed when a-c/2-c was expressed in the 
OM202recA strain.  We believed the truncation occurred because of residual RecA activity in 
the C43recA parental strain.  RecA recognizes and recombines repetitive sequences of DNA, 
like the repeating gene segments encoding cTMH-II of the a-c/2-c fusion protein.  We used two 
strategies to eliminate the truncated protein.  First, we screened several C43recA P1 
transductants for RecA activity and chose the transductant with the highest UV sensitivity, and 
presumably the lowest RecA activity, for additional expression testing (data not shown).  There 
was only marginal reduction in the level of truncated expression product using this approach.  
Second, we moved the N-terminal His6 tag of a-c/2-c to the C-terminus in an attempt to prevent 
binding of the truncated product to Ni-NTA agarose during purification.  Consistent with 
previous observations in our lab (Uhlemann and Dmitriev, unpublished data) the C-terminal 
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His6 tag on subunit c was not detectable by Western blot, and was not useful for protein 
purification (data not shown).  Therefore, we were unable to prevent formation of the truncated 
expression product.  Because the truncated expression product is present at less than 10 % the 
level of the full length a-c/2-c fusion protein, we are hopeful that it will not interfere with future 
crystallization trials. 
 
Subunit c is a naturally oligomeric protein and interactions between the fused c subunits 
may contribute to oligomerization of the purified a-c/2-c fusion protein samples.  We 
hypothesized that if the cL31F assembly mutation was introduced into the fused c subunit of a-
c/2-c, oligomerization may not occur in the purified protein samples.  As discussed in section 
4.2, we generated a series of pHP808 derivative plasmids that contain the L31F mutation to 
investigate the membrane insertion requirements of a-c/2-c.  These same plasmids were also 
used to express the a-c/2-c fusion protein in the presence of the L31F assembly mutant, in an 
attempt to prevent aggregation in the purified a-c/2-c samples, as well as to prevent potential 
aggregation with native subunit c.   In the pHP8014 plasmid the gene encoding subunit c 
contains the L31F point mutation.  In the pHP8015 plasmid the gene encoding a-c/2-c contains 
the L31F mutation.  In pHP8016 both the genes encoding native subunit c and a-c/2-c contain 
the L31F mutation.  C43(DE3) E.coli cells transformed with the pHP808, pHP8014, pHP8015 
and pHP8016 plasmids expressed the a-c/2-c fusion protein at similar levels (Figure 4.32).  The 
a-c/2-c fusion protein was purified from each strain by Ni-NTA affinity chromatography 
(section 3.6).  Unfortunately, the L31F mutations, regardless of their location, had only 
marginal effects on the aggregation state of a-c/2-c and did not improve purity of the a-c/2-c 
preparations compared to the original construct (Figure 4.33). 
 
 
 
 
 
 
 
 
 
	   	  125 
a-c/2-c 
pHP8014 
!
a-c/2-c a-c/2-c 
pHP8015 
!
pHP8016 
!
97.4 
66.2 
45.0 
31.0 
21.5 
14.4 
kDa 
97.4 
66.2 
45.0 
31.0 
21.5 
14.4 
A B 
kDa 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.32:  Expression of the a-c/2-c construct in the presence of the L31F mutations.  
Expression was tested in the C43recA background strain.  Each lane was loaded with 10 µg 
total membrane protein.  A) Coomassie stained 10 % SDS-PAGE gel.  B) Western blot probed 
against the His6 tag on the a-c/2-c fusion protein using anti-pentaHis HRP conjugate antibody 
(Qiagen, Mississauga, ON). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.33:  Coomassie stained 10 % SDS-PAGE gel of purified a-c/2-c with L31F 
mutations present in monomeric c, fused c, and both fused and monomeric c.  1.0 µg, 5.0 
µg and 20.0 µg of each purified protein were loaded.  pHP8014 expresses a-c/2-c with the 
L31F mutant in monomeric c.  pHP8015 expresses a-c/2-c with the L31F mutation in fused c.  
pHP8016 expresses the a-c/2-c with the L31F mutation present in both fused and monomeric c.   
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 We also attempted to express the a-c/2-c fusion protein under the control of an inducible 
promoter to improve the yield of purified protein.  We observed that the a-c/2-c fusion protein 
was incorporated into cellular membranes in the absence of native subunit c (Figure 4.2) and 
hypothesized that the a-c/2-c fusion construct could be expressed independently of the other 
ATP synthase subunits.  pBAD-102 is an expression vector which tightly regulates gene 
expression through	  an arabinose inducible promoter.  The gene encoding the a-c/2-c fusion 
protein was inserted into pBAD-102 (plasmid pHP805) and expression was tested in both 
TOP10 and OM202recA E. coli cells (Figure 4.34).  Expression of MdfA, an alpha-helical 
transmembrane multidrug transport protein, from pBAD-102 was used as a control.  
Unfortunately, the a-c/2-c fusion protein was not expressed from pBAD-102 under any of the 
conditions that worked well for MdfA.  The weak bands in Figure 4.34 – B, at approximately 
27 kDa, 21 kDa and 8 kDa were attributed to non-specific antibody binding. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.34:  Expression of the a-c/2-c fusion protein from pBAD102.  Panel A: Coomassie 
stained SDS-PAGE.  Panel B: Western blot probed with Anti-pentaHis HRP conjugate antibody 
(Qiagen, Mississauga, ON).  All lanes contain samples of whole cells taken from 
TOP10/pHP805 or OM202recA/pHP805.  Increasing arabinose concentration from 0.00002 % 
to 0.2 % (TOP10) and 0.002 to 0.8 % (OM202recA) is indicated at the top of each panel.  
ODM1016 cells express the multi-drug transport protein, MdfA, were loaded as a positive 
control for expression. 
 
 
 Membrane incorporation of subunit a is thought to be dependent on the presence of 
subunits b and c (Hermolin and Fillingame, 1995).  Subunit a is rapidly degraded when it is not 
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incorporated into the membrane (Akiyama et al., 1996).  We hypothesized that the apparent 
lack of expression observed from pHP805 was due to rapid breakdown of the a-c/2-c protein, 
because of the absence of subunit b.  Therefore, we generated two additional pBAD102 
derivative plasmids, where the a-c/2-c fusion protein was co-expressed either with the gene 
encoding subunit b only (pHP80-102), or with the genes encoding atpI, subunit b, and subunit c 
(pHP8024).  Unfortunately, the a-c/2-c fusion protein was not expressed at detectable levels in 
either case (data not shown). 
 
Despite the difficulties we experienced with protein purity, stability, and yield, we 
conducted crystallization trials of the a-c/2-c fusion protein using the same approach as 
described for subunit a (section 4.9).  The a-c/2-c fusion protein was expressed in C43recA 
cells, purified using the method described in section 3.4, concentrated to approximately 5 
mg/mL, and sent for preliminary screening at the Hauptman Woodward Institute (Buffalo, NY).  
Some promising conditions were identified (Figure 4.35).   
 
 
 
 
 
 	  	  
 
Figure 4.35:  Promising conditions from the preliminary crystal screening of the a-c/2-c 
fusion protein.  The well number of the MSC4 screen is indicated in at the top left of each 
image.  The crystallization conditions are written below each image. 	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5   Discussion. 
5.1   Assembly of the F0 domain:  Interaction with monomeric subunit c drives insertion of 
subunit a into the membrane and primes formation of the a-c10 complex. 
The membrane insertion requirements for the F0 components have been studied 
extensively.  Previous reports have shown that insertion of subunit a into the membrane is 
dependent on the presence of subunits b and c (Hermolin and Fillingame, 1995).  However, 
little is known about the stepwise assembly process of the F0 domain.  We posed the following 
question: is interaction with an assembled c-ring required for membrane insertion of subunit a, 
or is interaction with the monomeric c subunit sufficient?  We hypothesized that if interaction 
with monomeric subunit c were sufficient, the a-c/2-c fusion protein would insert into the 
membrane in the absence of wild type c, which was indeed observed (Figure 4.2).  
Incorporation of the a-c/2-c fusion protein in the absence of native c shows that monomeric 
subunit c is able to chaperone the insertion of subunit a into the membrane and a pre-assembled 
c10 ring is not obligatorily required.   
 
Formation of the c10 ring is known to be disrupted by two distinct mutations in subunit 
c, cG23D and cL31F (Kol et al., 2006).  Subunit c is incorporated into the membrane in the 
presence of the  cG23D and cL31F mutations but the c-ring does not form.  Both c-ring 
assembly mutants were able to facilitate membrane insertion of subunit a at levels comparable 
to the wild type (Figure 4.4) which further supports our hypothesis.  Also, the cG23D mutant 
was incorporated into the membrane at sub-stoichiometric levels which indicates that 10:1 c:a 
stoichiometry is not required to bring subunit a into the membrane.  Membrane insertion of the 
a-c/2-c construct in the absence of native c, incorporation of subunit a in the presence of the c-
ring assembly mutants, and the normal level of subunit a incorporation at sub-stoichiometric 
levels of the G23D subunit c mutant demonstrate that monomeric subunit c chaperones 
insertion of subunit a and primes formation of the a-c10 complex.  However, because the a-c/2-c 
construct contains two copies of cTMH-II we cannot rule out the possibility that two c 
monomers are needed to chaperone subunit a into the membrane.  In the mature enzyme, 
subunit a is in direct contact with two c monomers (Lau and Rubinstein, 2012; Hakulinen et al., 
2012; Moore and Fillingame, 2008); it is reasonable to assume that chaperoning of subunit a in 
the membrane is likely dependent on the presence of two c monomers rather than one. 
	   	  129 
In E. coli cells all of the ATP synthase subunits are encoded on the chromosomal DNA.  
However, in eukaryotic cells subunits a and c are encoded in the mitochondrial DNA while the 
remaining subunits are encoded in the nucleus.  Subcellular localization of these genes in 
eukaryotic cells suggests that expression and insertion of subunits a and c into the membrane 
are tightly linked, which supports our findings.  Interactions between subunit b and F1 
contribute the bulk of free energy required in binding F1 to F0 (Krebstakies et al., 2005) and 
subunit b is undoubtedly crucial to the assembly of the mature complex (Perlin et al., 1983).  
However, the stage at which subunit b is integrated into the F0 domain is under debate.  The 
findings of Aris and co-authors, and Pati and co-authors suggest that subunit b assembles with 
the a-c10 complex prior to the attachment of F1 (Aris et al., 1985; Pati et al., 1991).  Pre-
assembly of the proton transport machinery in the membrane presents a potential problem: if 
the pre-fabricated ab2c10 complex is embedded in the membrane it may facilitate passive proton 
transport and disrupt the PMF (Schneider and Altendorf, 1985), which could be fatal to cells.  
However, Pati and co-authors have suggested that all three components of the F0 domain 
assemble as an ‘immature proton impermeable form’ that cannot facilitate efficient proton 
transport (Pati et al., 1991), which supports the plausibility of the ab2c10 complex as an 
intermediate of ATP synthase assembly in living cells.   Reports have also shown that proton 
transport capability is induced after the attachment of the F1 domain, to a pre-fabricated F0 
domain, (Brusilow, 1987) and remains even after F1 is removed, suggesting that the binding of 
F1 to F0 displaces the unknown factors involved in modulating immature F0 activity.  There is 
also contradictory evidence showing that subunit b cannot insert into the membrane unless it is 
associated with the F1 complex (Cox et al., 1981) which leads to a model where the a-c10 
complex is built and then the b2-F1 intermediate complex binds. 
 
In yeast, formation of the F1 α3β3 hexamer is facilitated by chaperones (Ackerman et al., 
1992; Bowman et al., 1991) and it is reasonable to assume that a similar process occurs in E. 
coli.  Assembled F1 can be readily associated with and dissociated from the F0 domain in both 
bacterial and eukaryotic systems.  The activity of F1 ATPase is inhibited by the ε subunit when 
F1 is detached from F0, which implies that cells may indeed produce assembled F1 that can be 
bound to the pre-assembled F0 domain in one concerted step. 
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 This information taken together leads us to posit the following model for F1F0 
assembly.  Monomeric or dimeric subunit c chaperones the insertion of subunit a and primes 
the formation of the a-c10  complex.  Once the a-c10 complex is formed the assembly can take 
one of two routes: 1) the b2 dimer can bind to a-c10 and serve as a docking point for F1 binding, 
or 2) b2 forms an intermediate complex with the F1 subunits and binding of b2-F1 to the a-c10 
complex occurs concertedly.  Our model of F1F0 assembly is summarized in Figure 5.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1:  Theoretical model of the F1F0 assembly mechanism.  A) Membrane integration 
of subunit a and its c chaperone (one or two copies may be present).  B) Formation of the a-c10 
complex.  C) Attachment of the b2F1 intermediate complex in one concerted step.  D) 
Interaction of subunit b with the a-c10 complex which serves as a docking point for the pre-
assembled F1 domain. 
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5.2   Membrane insertion of subunits a and c is a tightly linked process. 
 The data presented in section 4.1 showed that wild type subunit a was efficiently 
incorporated into the membrane when co-expressed either with wild type subunit c, or subunit c 
mutants containing cG23D or cL31F, which prevent the formation of c-rings in the membrane.  
In contrast, the a-c/2-c fusion protein incorporated into the membrane at the same high level as 
subunit a in the presence of the wild type subunit c, but not with the cL31F or cG23D variants.  
Interestingly, the amount of G23D or L31F mutant c subunit was also dramatically reduced in 
the presence of both a/c fusion constructs compared to the wild type subunit a.  To better 
understand the cause of these unexpected differences, we investigated effect of the L31F 
mutation location on membrane incorporation of the a-c/2-c fusion protein.  In the first atp 
operon construct, the L31F mutation was placed in the fused c subunit of the a-c/2-c protein, 
but not in native subunit c.  In the second construct, L31F was present both in the a-c/2-c 
protein and in native c.  The third construct, as described above, contained the L31F mutation 
only in native c, but not in the a-c/2-c protein.  Intriguingly, the combination of wild type 
sequence in the fused copy of c with the L31F mutation in the monomeric c, resulted in the 
lowest level of a-c/2-c membrane incorporation and almost no detectable c in the membrane.  
The amounts of both a-c/2-c and monomeric c in the membrane for the other two constructs 
were significantly higher, although, still lower than with all wild type c-sequences.  These 
complex results brought us to the conclusion that insertion of subunits a and c into the 
membrane may be best understood in terms of individual protein – protein interactions in a 
ternary complex consisting of subunit a and two copies of subunit c (a-c2 priming complex).  
As discussed in section 5.1, formation of the a-c2 complex is a crucial step in the insertion of 
subunits a and c in the membrane, and this priming event in F0 assembly is also consistent with 
the fact that subunit a interacts with two c-subunits in the native ATP synthase enzyme.  In the 
particular case of the a-c/2-c fusion protein, one of the c-subunit copies of the priming complex 
is covalently linked to a, whereas the other is a monomeric native c subunit. 
 
 Stability of the a-c2 priming complex can be viewed as a sum of two types of protein – 
protein interactions, those between a and c, and those between c and c.  Mutations which 
interfere with either the a – c or c – c interactions will decrease stability of the a-c2 complex, 
and will cause poor membrane incorporation of both subunits a and c once their cumulative 
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effect exceeds a certain threshold.  Although the cG23D and cL31F mutations destabilize the c 
– c interactions they have no significant effect on the a – c interactions, and the a-c2 complex 
retains sufficient stability.  Therefore, no difference in the levels of subunit a or subunit c in the 
membrane was observed when subunit a was co-expressed either with wild type subunit c, or 
the cG23D or cL31F mutations.  By comparison, additional destabilizing factors come into play 
in the a-c/2-c protein.  The unpaired cTMH-II in the a-c/2-c protein may interfere with optimal 
docking of the monomeric subunit c, and therefore result in less favorable a – c interactions.  
By itself, this effect is insufficient to significantly destabilize the a-c2 complex, and therefore 
when co-expressed with wild type subunit c, the a-c/2-c protein is incorporated into the 
membrane as efficiently as wild type subunit a.  However, combined with weakened c – c 
interactions caused by the L31F mutation, the destabilizing effect of the extra helix in a-c/2-c is 
sufficient to cause the breakdown of the priming complex and poor insertion of the a-c/2-c 
protein.  The extent of destabilization caused by the L31F mutation will depend on its location, 
as indeed was observed in our experiments.  The amount of L31F c in the membrane correlates 
with the amount of the a-c/2-c fusion protein, or subunit a.  We believe that formation of a 
stable priming complex promotes partial oligomerization of cL31F in the form of a-cx, or, in the 
case of the fusion protein, a-c/2-c-cx-1, where x = 2 - 10, which protects subunit c from 
proteolytic degradation.  In the absence of the priming complex, L31F c remains mostly 
monomeric and undergoes proteolytic degradation, which explains its low amounts in the 
membrane.  This explanation appears to contradict the earlier statement that L31F mutation 
impairs assembly of the c10 ring, however, there is no evidence that the subunit c containing the 
L31F mutation exists in the membrane strictly in monomeric state.  In fact, the cL31F mutation 
did not completely abolish ATP driven proton transport (Figure 4.3; Kol et al., 2006), 
suggesting that the mutant protein retains some oligomerization propensity.  Therefore, there 
are likely multiple oligomeric species of L31F c-subunits present in the membrane.  The G23D 
mutant appears to have an even lower oligomerization propensity than L31F.  Therefore, 
cG23D would be mostly present in the monomeric form, which is rapidly degraded in the 
membrane, or it would be integrated into the a-c2 complex and protected from degradation.  
Indeed, even in the presence of wild type a, G23D subunit c, was present in the membrane in 
much lower amounts than either wild type, or L31F mutant (Figure 4.4). 
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5.3   Validation of the a-c/2-c fusion construct as a model protein for studying the dynamic 
a/c interface. 
 The a-c/2-c fusion protein consists of genetically linked subunits a and c, in 
theoretically correct transmembrane topology.  The a-c/2-c fusion protein was generated in an 
effort to produce a stable, single protein model of the dynamic a/c interface for structural 
studies on the E. coli ATP synthase proton channel.  We wanted to confirm that the a-c/2-c 
fusion protein adopted a conformation that was representative of the native a/c interface to 
validate it as a model polypeptide for structural analysis of the proton channel.  The first piece 
of evidence suggesting that the a and c proteins maintained their native folds and contact 
interface, when fused together, was observed in the membrane incorporation tests.  The a-c/2-c 
fusion protein incorporated into the membrane in the absence of native subunit c.  Membrane 
insertion of subunit a is known to be dependent on the presence of subunit c.  The cellular 
machinery that inserts subunit a into the membrane was able to recognize the a and c 
components of the fusion protein and facilitate membrane incorporation of a-c/2-c in the 
absence of native subunit c, demonstrating that the fusion protein was properly folded.  This 
evidence was further supported when we observed that the a-c/2-c protein co-purified with the 
other F0 subunits in stoichiometric amounts, which showed that it was integrated into an 
assembled F0 domain.  We also examined the assembly status of the complete F1F0 complexes 
containing either wild type subunit a or the a-c/2-c fusion and found that a-c/2-c fusion does 
not interfere with F1F0 assembly, which further supports the conclusion that a-c/2-c adopts the 
native folds of both the a and c components. 
 
 Assuming the five-helix model of subunit a, the a-c fusion protein has inverted 
orientation of the fused subunit c TMHs relative to subunit a.  Consequently, the a-c fusion did 
not insert into the membrane in the absence of the native subunit c.  However, in the presence 
of native c, the a component of the a-c construct inserted into the membrane and assembled 
correctly with the other F0 subunits, suggesting that the a subunit determines the 
transmembrane orientation of the a/c fusion proteins.  This, taken together with the membrane 
incorporation of the a-c/2-c construct in the absence of native c provides additional supporting 
evidence for the five-helix model of subunit a with the carboxyl terminal end located in the 
cytoplasm. 
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The a-c construct was able to sustain growth on succinate and showed both ATP driven 
and passive proton transport activity at levels approximately 50 % the level of wild type ATP 
synthase.  The most likely explanation for this observation is that the a subunit of a-c interacts 
with the c10 ring normally to allow coupled proton transport.  In order for this to occur, the 
fused c subunit would have to be displaced to the periphery of the ring.  The fact that the rate of 
proton transport was half the rate observed in wild type can be attributed to a reduced turnover 
rate of the a-c ATP synthase variant, fewer functional ATPase molecules present in the 
membrane, or non-specific leaks in the membrane.  However, the specific proton transport 
inhibitor, DCCD, effectively suppressed both ATP driven and passive proton transport in the a-
c variant, demonstrating that subunit a of a-c does in fact contribute to a functional proton 
channel in connection with c10.   
 
Conversely we observed no growth on succinate with the a-c/2-c fusion protein and 
very low passive proton transport when compared to wild type.  The question raised at this 
point was, is the lack of activity due to misfolding of a-c/2-c, or is it caused by tethering of the 
rotor and stator?  The a-c fusion protein retained the native fold of subunit a and was able to 
facilitate proton transport, indicating that the a-c/2-c fusion protein should be able to tolerate 
one additional helix (c/2) without  misfolding.  Additionally, we had established that a-c/2-c did 
not interfere with assembly of the F1F0 complex, suggesting that the fold was native.  We 
hypothesized that because the a-c/2-c fusion protein had correct transmembrane topology, the 
fused c subunit could be readily incorporated into the c-ring.  In this case, the assembled ATP 
synthase was expected to be inactive, because the rotor would be tethered to the stator by the 
linker peptide.  Both passive and active proton transport were dramatically reduced in the a-c/2-
c ATP synthase variant, supporting this hypothesis. 
 
In addition to the proton transport assays, we examined the coupling status of the F1 and 
F0 sectors of the a-c/2-c ATP synthase variant.  The activities of the F1 and F0 domains are 
tightly coupled; a blockage in proton transit through F0 will cause reduced catalytic activity in 
the F1 sector, and vise versa.  When the F1 domain is released from F0, for example by EDTA 
treatment, it retains ATPase activity.  If the lack of ATP dependent proton translocation 
observed in the a-c/2-c variant was truly caused by an immobilized rotor, we expected to 
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observe a restoration of ATPase activity when F1 was released from F0.  If, on the other hand, 
the rotor was not properly assembled or subunit a was misfolded, and the fine coupling between 
F0 and F1 was disrupted, we expected to see comparable F1 ATPase activity in both bound and 
free F1.  In the intact membranes containing a-c/2-c, the α and β subunits were present at 
approximately 60 % the level observed in the wild type.  However, the specific ATPase activity 
of the a-c/2-c membranes was less than 20 % of the wild type.  When F1 was released from the 
membranes by EDTA treatment, we observed a restoration of ATPase activity to approximately 
50 % of the wild type level.  The reduced level of F1 present in the a-c/2-c membranes can be 
explained in three ways: 1) the introduction of a-c/2-c fusion construct in the atp operon may 
cause lower expression of the other F0 and/or F1 subunits, 2) the expression level of the a-c/2-c 
fusion protein may be lower than that of wild type subunit a, and 3) the F1F0 complex 
containing a-c/2-c may not be assembled efficiently in the cell.  These data demonstrated that 
although the amount of a-c/2-c containing ATP synthase was approximately 40 % lower than 
wild type, the majority of F1F0 present in the membrane was assembled and coupled.  The ATP 
driven proton transport data, taken together with the F1-ATPase data described above, 
demonstrate that the the fused c of a-c/2-c integrates into the c-ring and tethers the rotor to the 
stator.  We then considered the possible geometries of F0 containing the a/c fusion variants 
(Figure 5.2).   
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Figure 5.2:  Models of a/c fusion protein incorporation into F0.  The TMH segments of 
native subunit c, subunit a, and the fused subunit c are shown in blue, orange and green 
respectively.  A) Wild type F0, B – C) F0 containing the a-c/2-c fusion protein shown in two 
possible configurations, and D) F0 containing the a-c fusion protein with fused c displaced to 
the periphery of the ring. 
 
 
 The location of the unpaired cTMH-II in the assembled F0 domain is not clear.  
Structural modeling experiments published by Fillingame’s group indicate that the c-ring is 
inherently flexible and can readily accommodate up to two additional c subunits without 
significantly altering helical contact points (Fillingame and Dmitriev, 2002).  Intuitively, the 
model shown in panel C of Figure 5.2 is the most favorable.  The inner ring, which is composed 
of multiple copies of cTMH-I, is tightly packed, while the outer ring (consisting of the cTMH- 
II) is less compressed and can feasibly accommodate the unpaired cTMH-II of a-c/2-c.  This 
scenario is also favorable because it would maintain the a to c helical interactions that occur in 
the native enzyme.  However, it is possible that the unpaired cTMH-II is displaced to the 
periphery of the rotor, similarly to the helix arrangement proposed for a-c. 
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The data discussed above demonstrate that the a-c/2-c fusion protein adopts a fold 
which is representative of the interaction between native subunits a and c in the assembled ATP 
synthase enzyme.  This work validates that the a-c/2-c as a suitable model system for structural 
studies on the dynamic a/c interface. 
 
 
5.4   Letting out the leash: lengthening the tether between a and c/2-c of a-c/2-c did not 
enhance passive proton transport. 
We demonstrated that the a-c/2-c fusion protein is incorporated into an assembled ATP 
synthase complex, and that the fused c subunit is integrated into the c10 ring.  The short linker 
connecting the fused a and c subunits restricts movement of the rotor and prevents efficient 
proton transport.  The F0 domain with the a-c/2-c fusion protein incorporated retained a very 
low level of proton transport activity (section 4.5) relative to the wild type.  This low level of 
activity was DCCD sensitive both in passive and active transport assays.  It is possible that the 
very short linker connecting a and c of the a-c/2-c fusion protein is sufficient to allow limited 
back and forth oscillation of the c-ring relative to the fused ab2 stator in the passive transport 
assays.  If passive proton transport truly occurs through an oscillatory mechanism it would 
imply that the ‘ratchet’ which prevents the rotor from slipping backwards, or moving in the 
wrong direction, must be located within F1 rather than F0.  We hypothesized that increasing the 
length of the linker between subunits a and c may enhance proton transport though F0 
containing the a-c/2-c construct by allowing more back and forth oscillation of the c10 ring 
relative to the fused stator.  The results presented in section 4.6 showed that increasing the 
length of the tether in the a-c/2-c fusion protein did not enhance proton translocation relative to 
the original a-c/2-c F0 domain variant.  Although low levels of proton transport were observed 
in the a-c/2-c F0 variant, activity appears to be independent of the length of the tether.  Perhaps 
the low level of passive proton transport observed in the a-c/2-c construct is the maximum 
capacity attainable through oscillatory mechanisms; or proton transport does not occur through 
oscillatory mechanisms.  Unfortunately, the results we obtained were inconclusive. 
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5.5   Towards the structure of the proton channel. 
We have made some progress toward solving the structure of subunit a and the proton 
channel.  We have designed and validated a stable model protein for structural investigations on 
the dynamic a/c interface.  Wild type subunit a was found to be optimally overexpressed in the 
C43(DE3) parental strain, while the a-c/2-c fusion protein was optimally expressed in C43recA 
cells.  We have also developed a novel and efficient method for the purification of both wild 
type subunit a and the a-c/2-c fusion protein.  We have achieved greater than 95 % purity with 
wild type subunit a and greater than 80 % purity with the a-c/2-c fusion protein.  We have 
conducted primary NMR experiments using subunit a and the fusion protein.  Primary 
crystallization screens have been conducted with the a-c/2-c fusion protein and have yielded 
promising results.  Finally, we have successfully crystallized wild type subunit a in multiple 
crystal forms for X-ray crystallographic studies. 
 
NMR analysis of wild type subunit a and the a-c/2-c fusion protein 
NMR can be used to determine protein structures as well as study the functional 
dynamics of proteins.  Extensive NMR studies have been conducted on subunit a purified in a 
mixed polarity solvent (4:4:1, chloroform : methanol : water) (Dmitriev et al., 2004).  Dmitriev 
and co-authors were able to obtain high quality NMR spectral data and make nearly complete 
backbone amide chemical shift assignments for subunit a (Figure 5.3).  The effects of mixed 
polarity solvents on membrane proteins are unknown and spectral data obtained from subunit a 
purified in mixed organic solvents may not be biologically relevant.  Therefore, NMR 
investigation of subunit a purified in detergent micelles that closely mimic the environment of 
the lipid membrane was necessary.  The NMR spectrum shown in Figure 5.3 serves as a 
benchmark for comparing the quality of spectral data collected from subunit a purified in 
detergent. 
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Figure 5.3:  TROSY spectrum of subunit a purified in chloroform, methanol and water 
(4:4:1).  Each peak in this spectrum corresponds to a single backbone amide group or side 
chain amide group from arginine and tryptophan.  The chemical shift assignments are indicated. 
[Image taken from (Dmitriev, 2004a)].  Reprinted with permission from J. Biol. NMR. 
 
 
The HSQC spectra obtained from subunit a purified in LMPG micelles did not have 
sufficient spectral resolution for structure determination (Figure 4.21).  Detergent screening and 
optimization of NMR experiments did not improve the resolution.  We hypothesized that the 
use of harsh detergents during isolation of the F0 complex may have caused partial misfolding 
of the protein which contributed to the poor spectral resolution.  However, previous 
experiments have shown that preparations of purified subunits a, b, and c using these same 
detergents could be reconstituted into proteoliposomes to generate a functional proton channel 
(Altendorf et al., 2000; Schneider and Altendorf, 1987), suggesting that any denaturing effects 
are reversible.  We developed a second novel purification procedure to isolate subunit a using 
milder detergents.  The method developed by Laubinger and Dimroth for isolation of ATP 
synthase from P. modestum (Laubinger and Dimroth, 1988), under relatively mild conditions, 
was adapted for E. coli ATP synthase (Haji and Dmitriev, unpublished data).  This alternate 
purification procedure did not contribute any significant improvement to spectral resolution 
(Fig 4.22).  Molecular weight plays a role in spectral resolution.  The gel filtration experiment 
	   	  140 
showed that subunit a in detergent micelles is approximately 48 kDa in size, which is 
significantly larger than the calculated molecular weight of subunit a alone (approximately 31 
kDa).  Although it is possible that the poor spectral resolution is caused by misfolding of 
subunit a it is also possible that the large size of the protein – detergent complex results in poor 
resolution.  It is also possible that the optimal sample conditions and NMR experimental 
conditions were not found in this study and that resolution may still be improved under 
different conditions. 
 
The resolution in the arginine side chain region of the HSQC spectrum was sufficient to 
allow assignment of the arginine 210 side chain chemical shift.  Assignment of the R210 side 
chain is important because the chemical shift is very sensitive to the chemical environment.    
Therefore, assignment of R210 provides an excellent reporter group for functional studies, 
including determination of the pKa of R210 and characterization of the binding of novel 
antibiotic compounds to the proton channel. 
 
The a-c/2-c fusion protein exceeds the current size restrictions for NMR and was 
designed for X-Ray crystallographic structure determination.  However, we hypothesized that 
the arginine side chain region of the a-c/2-c spectra may have had sufficiently high resolution to 
conduct functional studies on R210 in an environment that mimics the proton channel.  HSQC 
spectra were recorded with purified a-c/2-c, but the arginine side chain regions of the spectra 
were poorly resolved.  There were two main factors contributing to poor resolution in the 
arginine side chain region.  The size of the a-c/2-c construct is considerably larger than wild 
type subunit a, which potentially reduces resolution.  Also, wild type subunit a contains four 
arginine side chain residues while the a-c/2-c fusion protein contains eight, which contributes to 
signal overlap in the a-c/2-c spectra. 
 
Subunit a’s arginine 210 and subunit c’s aspartic acid 61 are thought to form a salt 
bridge, which is expected to cause the pKa of arginine 210 to be uncharacteristically low.  We 
hypothesized that it may have been possible to resolve the R210 peak from the other arginine 
side chain peaks in the a-c/2-c spectra based on it’s low pKa.  HSQC spectra were recorded at 
various pH values in an effort to perturb the R210 side chain amide peak.  Unfortunately, pH 
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titration did not have a significant impact on the chemical shift of the R210 side chain, which 
eliminated the option of using the a-c/2-c fusion protein to study the functional dynamics of 
R210 in the environment of the proton channel.  For future studies it may be possible to 
examine this interaction by recording HSQC spectra with 15N labeled wild type subunit a, 
titrated with unlabeled (NMR invisible) wild type subunit c.  If the two subunits interact in a 
way that is representative of their interaction in the native enzyme this type of study could 
provide valuable information on role of R210 in proton transport. 
 
Crystallography 
 Monodisperse protein samples have a higher propensity towards crystallization than 
polydisperse samples.  DLS and size exclusion chromatography are commonly used methods 
for determination of protein aggregation state.  Membrane proteins solubilized in detergent 
micelles are not ideal for DLS analysis because micellar dynamics can cause changes in particle 
size and lead to broad DLS peaks.  Subunit a samples showed one broad peak with an 
approximate hydrodynamic radius of 2.6 nm corresponding to 99 % mass in the DLS analysis.  
Although the peak was broad compared to a monodisperse soluble protein, the absence of 
higher order peaks indicated that purified subunit a was monomeric.  The gel filtration 
experiment supported this conclusion: subunit a eluted in one sharp peak, which corresponded 
to the estimated molecular weight of 48 kDa, the expected size for monomeric subunit a in 
LMPG micelles.  Both the DLS and gel filtration data demonstrate that purified subunit a 
samples are monomeric, although micellar dynamics create a range of micelle sizes. 
 
We have conducted extensive crystallization screening with wild type subunit a and 
obtained three distinct subunit a crystal forms.  The diffraction quality of the crystals obtained 
from LCP screening was poor, with diffraction in the range of 30 Å.  A second crystal form was 
obtained during the refined vapor diffusion screening and the resultant diffraction resolution 
was improved to a maximum resolution of 14 Å.  However, the improved diffraction resolution 
was still not sufficient for high resolution structure determination.  The successful 
crystallization of subunit a constitutes a significant step toward determining the structure of the 
proton channel, and efforts toward improving diffraction resolution will be continued in the 
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future.  Many hurdles remain, including optimization of crystal quality to achieve diffraction 
resolution better than 4 Å, phase determination, and structural modeling. 
The a-c/2-c construct has presented more challenges than subunit a.  The yield of 
purified a-c/2-c was very low in comparison to subunit a.  Samples of purified a-c/2-c had poor 
stability and formed aggregates in solution.  Subunit c is a naturally oligomeric protein and 
interactions between the fused c subunits may have contributed to the oligomerization of the 
purified a-c/2-c protein samples.  We hypothesized that if the cL31F point mutation, was 
introduced into the fused c subunit of a-c/2-c, oligomerization may not occur in the purified 
samples.  However, the introduction of the cL31F mutation did not alleviate the aggregation 
problem.  The L31F mutant did not fully abolish proton transport activity when co-expressed 
with wild type subunit a (Figure 4.3).  Therefore, it was possible that the L31F mutant did not 
completely inhibit oligomerization of subunit c.  The cG23D mutation may provide more 
effective suppression of oligomerization of the purified a-c/2-c samples, in future studies.  The 
a-c/2-c fusion protein could only be isolated at 0.17 mg / L of cell culture, which was 
prohibitive to in house crystal screening trials.  We also worked to improve the yield of the a-
c/2-c fusion protein to provide more material for crystal screens.  Several plasmids containing 
different combinations of F0 subunits, under the control of the PBAD promoter, were generated 
in an effort to overcome poor expression (section 4.10).  Unfortunately, each inducible 
expression system failed to express a-c/2-c at detectable levels.  In future studies a more 
suitable inducible vector that can accommodate the entire atp operon may provide better yields. 
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6   Conclusions and Future Work. 
6.1   Conclusions. 	   We have successfully generated and validated a stable, single polypeptide model of the 
dynamic a/c interface for structural studies on the proton channel.  We have demonstrated that 
monomeric subunit c chaperones membrane insertion of subunit a and primes formation of the 
a-c10 complex.  In 2011, we published our work demonstrating that the a-c/2-c fusion protein 
provides a suitable platform for structure studies on the proton channel, as well as the work 
showing that monomeric c facilitates membrane incorporation of subunit a, in the Journal of 
Biological Chemistry (Pierson et al., 2011).  Our studies with the c-ring assembly mutants and 
the a/c fusion proteins have shown that the mechanisms that govern membrane insertion of 
subunits a and c are linked in a complex manner.  A novel purification method for wild type 
subunit a was developed; purity exceeded 95 % which is excellent for structural studies.  The 
purification procedure developed for subunit a can also be used to isolate the a-c/2-c fusion 
protein, although at lower purity.  Wild type subunit a was successfully crystallized during our 
studies, which constitutes a major step toward determining the structure of the proton channel.  
In 2012, the procedure for purification of wild type subunit a, and the preliminary NMR data 
were published in Protein Science (Uhlemann et al., 2012). 
 
 
6.2   Future Work. 
 The ultimate goal for future studies is to determine the high resolution structure of the 
proton channel of E. coli ATP synthase.  The a-c/2-c fusion protein is a very attractive target 
for structure studies, because it provides a stable snapshot of the a-c10 interaction.  Currently, 
the relatively low purity and poor yield constitute major hurdles toward structure studies with 
the a-c/2-c protein.  Overexpression of a-c/2-c should be optimized to improve the yield of pure 
protein.  Also, the purification procedure should be optimized to enhance the purity of a-c/2-c 
samples for crystallization trials.  The G23D mutation should be introduced into the fused c 
subunit of a-c/2-c to prevent protein oligomerization in the purified samples; G23D has a 
stronger effect than L31F and may be more effective.  When the sufficient the purity and yield 
are achieved , preliminary and refined crystallization screening should be conducted. 
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 Optimal overexpression and purification of the wild type subunit a was achieved during 
this study, however, more work needs to be done to optimize crystallization conditions to 
enhance diffraction resolution.  This should be done concurrently with NMR experiments 
aimed at determining the global fold of subunit a through selective isotopic labeling.  Both the 
crystal structure and the global fold of subunit a will be significant contributions to the field.  
Functional NMR experiments to determine the pKa of subunit a’s R210 residue should be 
conducted to confirm the aR210 – cD61 salt bridge.  Additionally, this should be 
complemented with pKa measurements in an environment which mimics proton channel.  The 
a-c/2-c fusion protein mimics the proton channel, but was not suitable for such measurements.  
However, NMR investigation of the interaction between isolated subunits a and c may help to 
reconstruct the chemical environment of R210 in the proton channel for analysis of the aR210 – 
cD61 interaction. 
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Figure 7.1: Multiple sequence alignment of ATP synthase subunit a from various species. 
Residues colored with blue and green align poorly.  Residues colored in orange and yellow 
align well.  Residues colored in red are highly conserved.  TMH segments are indicated above 
each segment of the sequence alignment.  The universally conserved arginine residue is 
indicated with the red arrow.  Sequence alignment was conducted using the T-Coffee server 
(Notredame et al., 2000). 
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